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Summary 
Based on the theme of this thesis, Chapter 1 introduces the concept cells as the paramount example of 
compartmentalization in nature and the use of polymeric assemblies encapsulating enzymes as mimics. It 
then proceeds to discuss the principles behind self-assembly of polymers and applications of such systems. 
Building on that, Chapter 2 states the aim of the thesis, delineating its background and the vision that lead 
to a coherent research  process. For this thesis, vesicular polymeric compartments composed of the triblock 
copolymer PMOXA-b-PDMS-b-PMOXA were produced, harbouring various proteins in their lumen and 
membranes, for catalysis and membrane permeabilization.  
In a first step, I contributed to the development of multicompartment cell mimics, micrometer-
sized polymeric vesicles that behave like cells in their internal organization and segregation, 
triggered environmental responses and architectural plasticity. In Chapter 3, such assemblies are 
able to sense the redox potential of the exterior and, with a cascade resembling receptor-
mediated pathways in cells, activate responses ranging from enzymatic activity to selective 
permeability and cytoskeleton reorganization. 
In Chapter 4 and 5, the polymeric vesicles were “shrunk” to diameters of 200 nm and less, to 
work on biological settings, using sizes smaller than cells for future biomedical applications, with 
binary mixture of vesicles encapsulating a single type of enzyme. They lost their internal 
compartmentalization but gained a more intimate relationship with living matter, acting first as 
cell models, then as symbionts to detoxify the cell medium from uric acid (Chapter4.1) and finally 
as artificial organelles to study the effect of the overproduction of the signaling molecule cGMP 
through an already-present cascade (5.1). These two studies shed light not only on the general 
behavior of binary cascades at the nanoscale, but also on technological limitations of such 
system, that is the difficult transmembrane diffusion through the porin OmpF, and the effect of 
distance. 
To solve the first matter, we studied melittin as a replacement for OmpF. The pore-forming 
peptide was studied in its interaction with PMOXA-b-PDMS-b-PMOXA membranes (Chapter 6), 
and we determine the parameters governing their interaction, both from the polymer (stiffness, 
length, chain dispersity, roughness),  from the geometry of the assembly (curvature) and its 
stability when it interacts with the peptide. A kind of catalytically active polymeric vesicles was 
produced to prove melittin’s functionality. 
To solve the problem of substrate diffusion, we designed clusters of catalytic vesicles, tethered 
via complementary DNA strands, and permeabilized by melittin. Enzymes part of the same 
     4 
cascade were in close proximity, below 20 nm, leading to a net gain in reaction efficiency when 
compared to the same unclustered conditions. Additionally, the DNA clusters adhered to the 
surface of lung cells, suggesting a future as targeted delivery. The conclusions of Chapter 8 
summarize the results of this work and suggest the future outlook for research in this field, 
whereas Chapter 9 lists all the materials and methods used. 
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1 Introduction1 
This chapter introduces key concepts and current scientific literature concerning this work, to provide 
basic knowledge for the comprehension of this work. It consists of an overview of the concept of 
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compartmentalization in biology, with a special focus on cells and sub-cellular structures. The concept 
of vesicular polymeric micro- and nanostructures as, respectively, cell and organelle mimics will be 
discussed, presenting several examples from recent literature, their fabrication techniques and their 
applications. The dissertation presents the construction of vesicular micro- and nanoreactors made of 
amphiphilic block copolymers and their organization to perform specialized cascade reactions, 
mimicking cells in shape, compartmentalization, internal structure and complexity of their 
environmental responses. The concept is then expanded in this thesis, showing possible applications of 
such systems, ranging from tools to translate cell logics into novel materials, to cell-like materials acting 
upon real cells.  
1.1 Compartments as the basis of bottom-up synthetic biology   
The field of synthetic biology field is diverse, as are the disciplines falling under this term, but can 
broadly be divided into two main themes: top-down approaches to design systems based on known 
biology to perform a specific task, and bottom-up approaches creating truly de novo artificial life,1 via 
the emergence of life-like properties from the interactions of non-living building blocks. of nanometer 
building blocks, which provide spatiotemporal organization to the reactions.2 A key concept in bottom-
up synthetic biology is The resulting emergent behaviors between the derived compartments are more 
than the sum of the parts, since their interactions provide an additional layer of complexity. Life, in a 
broader sense, can be defined as an emergent phenomenon arising from smaller fundamental 
components.3 Cells, the basic unit of life, are themselves compartments; moreover, they tend to 
specialize, which leads to the creation of consortia (unicellular organisms living in symbiosis), to the 
organization found in multicellular organisms, where different tissues perform specific functions. To an 
extent, cell biology can encroach into the territory of ecology, when considering the relationships 
between units.4 
 
1.2 Cell membrane and compartmentalization  
In both prokaryotic and eukaryotic cells, the plasma membrane (cell membrane) is the element that 
encapsulates the content of the cell, controls the flow of molecules in and out of the cell, involved in 
both passive and active transport to and from the cell, helping to maintain balance even when 
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conditions outside the cell change. The plasma membrane consists of two layers of phospholipids 
(bilayer phospholipids), where the amphiphilic molecules self-assemble into a bilayer with the 
hydrophilic segments oriented towards the water layer and hydrophobic tails towards the center of the 
sheet to minimize their free energy, delimiting an inner aqueous lumen, effectively separated from the 
external environment.2 
In eukaryotic cells, the DNA is contained in the nucleus, which is wrapped in a nuclear membrane.  
However, within eukaryotic cells, internal subcompartments are found, called organelles, with 
specialized functions: for example, the nucleus, the mitochondria, the endoplasmic reticulum, the Golgi 
apparatus and so on (Figure 1). 
For instance, the nucleus is the organelle that regulates the hereditary characteristics of the organism 
by performing processes such as protein synthesis and cell division, among others, by separating its 
DNA from the rest of the cell, as well as keeping the translation machinery close to it. 
If the DNA was not sequestered, it would be vulnerable to damage by hazards such as enzymes, 
pathogens and free radicals, which would lead to defective protein production. Although part of the 
function of the nucleus is DNA compartmentalization, the molecules must still be able to move in and 
out (e.g. RNA), through the protein channels known as nuclear pores. Such organelle is an example of 
how membranes, within the cell, keep reactions separate, limiting and regulating flows, create 
specialized environments, protect them from external harmful agents and add an additional layer of 
complexity represented by the membrane itself.  
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Figure 1 Schematic representation of the internal organization of a eukaryotic (animal) cell. 
 
 
 
1.3 Mimicking cells with amphiphilic block copolymers 
To its core, cell mimicking requires defined compartment, most often delimited by a barrier holding its 
catalytically active content and regulating its communication with the external environment. This basic 
organization can be repeated within the same cell mimic (sometimes called protocell or artificial cell), 
with internal subcompartments providing segregation. These cell mimics can also be defined as 
catalytic compartments, underlining their two basilar features. We chose to adopt this naming over the 
alternative micro/nanoreactor as it stresses the need of a localized catalyst –e.g. an enzyme– to work 
as intended. 
In cells, compartmentalization is provided by the phospholipid membrane (although exceptions exist5); 
a plethora of cell mimics have been developed, from simple membrane-less droplets6 to lipid-based 
mimics,7 polymeric micelles and particles,8 inorganic particles,9 proteinosomes10 and so on. Our focus 
was on polymeric structures, as polymers, natural and synthetic, are a broad and versatile class of 
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compounds that offers an incomparable diversity of possible chemical modifications and physical 
characteristics, which makes them an attractive choice for nanotechnological applications aimed at 
overcoming the limitations of lipids.11 More specifically, we were particularly interested in amphiphilic 
block-copolymers, which can be engineered to induce self-assembly into micro/nanostructures, or 
assemble on a template, forming spheroidal structures with an internal lumen, very close to the basic 
geometry of a cell, while retaining the advantages of polymeric materials.12  
Amphiphilic block copolymers, much like phospholipids, are formed of a hydrophobic and a hydrophilic 
section and can thus self-assemble in 3D structures; the most common hydrophilic blocks are PMOXA, 
PEG and PIAT; the hydrophobic blocks are most often PDMS, PS and PMA. In the case of layer-by-layer 
(LbL) capsules, layers of PDA and PLL are also frequently used.  
When considering size and material, hollow spherical catalytic compartments are classified on whether 
they are nanometer or micrometer sized (Figure 2). Listed in the nanometer range are:  polymersomes, 
polymeric vesicles and PICsomes (Polyion Complex), obtained through the interactions of oppositely 
charged polymers. In the micrometer-size range are GUVs (giant unilamellar vesicles), that is 
micrometric vesicles. The complexity of such nano- and micro-sized compartments can be further 
extended by self-organization into clusters with specific geometry 13 or by creating compartments-in-
compartments, for example as capsosomes, polymeric capsules containing liposomal 
subcompartments. 
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Figure 2 Polymeric catalytic compartment architectures. (A) Catalytic reactions within polymersomes with inserted membrane proteins to 
allow substrate passage and PICsomes with inherently permeable membranes; (B) Catalytic reactions occurring in tandem within 
multicompartment structures such as capsosomes with the enzyme located within liposomes and giant unilamellar vesicles with the 
enzyme located within polymersomes. 
In this thesis, we will mainly treat PMOXAx-b-PDMSy- b-PMOXAx/PMOXAx- b-PDMSy (triblock and 
diblock)-based vesicles (Figure 3). We chose this polymer due to it biocompatibility and its 
impermeability which, associated to its ability to accommodate membrane proteins, peptides and 
ionophores results in membranes that can be made selective towards specific molecular species, using 
the same components that regulate cell permeability. 14  
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Figure 3 Structure of a PMOXA-PDMS-PMOXA triblock copolymer and PMOXA-PDMS diblock copolymers. 
 
1.4 Self-assembly of amphiphilic block copolymers 
1.4.1 Governing parameters  
Amphiphilic block copolymers are able to self-assemble a wide range of nano- and micro-sized 
structures in aqueous solution, notably nanoparticles, micelles (spherical, cylindrical, and worm-like), 
and polymersomes, hollow vesicles. The choice of copolymers and their block ratio is very important, 
as the physico-chemical properties determine the behavior of the resulting assembly.15 
The critical aggregation concentration (CAC), i.e. the concentration at which an amphiphilic molecule 
starts to form a colloidal system. For block-copolymers it is up to 10000-fold lower than for lipids,16 
increasing the assembly stability.  
Different assemblies result from the inherent molecular curvature arising from the relative size 
difference between the hydrophilic and hydrophobic blocks. This principally defines the geometric 
packing of block copolymers in the resulting copolymer assemblies in aqueous solution, which is known 
as critical packing parameter, CPP (Figure 4), is defined as the ratio between the volume of the 
hydrophobic block and the contact area of head group (times length of hydrophobic block).17 CPP 
corresponds to the ratio of the molecular volume of the hydrophobic block to the actual volume 
occupied in the resulting assemblies. Depending on its value, different polymer structures can 
assemble. For example, spherical micelles are formed when CPP ≤ 1/3, cylindrical micelles are formed 
with 1/3 < CPP ≤ 1/2, and vesicles are formed when 1/2 ≤ p ≤ 1 (Figure 2B).18   
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Figure 4 Schematic illustration of CPP. V0 is the volume of the hydrophobic chain, a is the equilibrium area per molecule at the aggregate 
interface and l0 the length of the hydrophobic chain. Adapted with permission from reference 18a.  
Another important parameter is the glass-transition temperature Tg, which determines the flexibility of 
the membrane as a function of temperature and can go from -70 °C for rubbery materials to above 200 
°C for some plastics.19 Obviously, in case of mixed polymers, their reciprocal miscibility is fundamental 
as well. Finally, Tg and the block ratio are extremely important when integral membrane proteins must 
be incorporated, since membrane proteins have very precise hydrophobic and hydrophilic domain 
distribution and must insert with the least mismatch.18a, 20 
 
1.4.2 Preparation techniques 
To induce the assembly of block-copolymers into vesicular structures, various techniques are used. Film 
rehydration consists in water hydrating an anhydrous polymer film, swelling it and inducing self-
assembly. Similarly, electroformation uses an oscillating electric field to assist the rehydration. In 
polymerization-induced self-assembly (PISA), the polymerization of hydrophilic monomers creates a 
hydrophobic block that induces the assembly.21    
Solvent exchange is a family of diverse techniques involving the removal of the organic solvent 
dissolving the polymer, to expose it to an aqueous solution and induce aggregation. A variation of 
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solvent exchange is LbL, where alternating layers of oppositely charged materials are deposited on a 
template (usually a core particle that can be dissolved). Materials other than block-copolymers are also 
used and can be considered as template-assisted self-assembly. Another variant uses microfluidics, 
forming water/oil/water double emulsions where the organic phase hosts the polymer. The double 
emulsion forces polymers to orient with the polar heads toward water thus initiating the assembly.21  
Film rehydration is the most widely used for polymersomes and GUVs; the derived electroformation is 
reserved for GUVs. PISA too finds use for polymersomes. “Classical” solvent exchange is versatile, used 
for polymersomes and PICsomes; LbL is applied to PICsomes and capsosomes. Microfluidics is used for 
giant vesicles. 
1.4.3 Drawbacks and possible solutions 
One of the drawbacks from which polymers tend to suffer is variability (dispersity, Đ) in their chain 
lengths, which causes in turn heterogeneity in their physical features.12a The dispersity of the 
assemblies is another issue, as most techniques produce non-uniform collections of sizes of the 
assemblies. Another issue with any kind of formulation is the encapsulation efficiency, which is the 
amount of cargo that can be loaded into a nanocompartment and can be quite low, especially when 
multiple enzymes are co-encapsulated. Microfluidics, albeit currently limited to micrometer-sized 
vesicles, is a possible way of both increasing size dispersity and encapsulation efficiency. In the future, 
the former problem may also be solved with the use of discrete block molecules, the latter by clustered 
assemblies.13, 22  
 
1.5 Communication across synthetic membranes 
Membranes protect catalytic compounds (enzymes, proteins, mimics) from several external agents, for 
example proteolytic attack,23 allow otherwise incompatible reactions to take place24 and, with their 
increased stability, biocompatibility and functionalization potential, are an attractive option for enzyme 
delivery and other biomedical applications. However, to obtain functional compartments able to 
produce in situ active molecules by using encapsulated catalytic compounds, the passage of substrates 
and products of the reaction across the membrane needs to be enabled. The permeability of a 
membrane can be due to inherent porosity (Table 1 and 2); the permeability can also be triggered by 
temperature and/or pH 25, or a chemical or enzymatic reaction. 20b, 26 A bioinspired approach is to 
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permeabilize the membrane by insertion of ionophores or membrane proteins; in the case of PMOXA-
PDMS block-copolymers, to achieve higher selectivity, several ionophores and membrane proteins20b, 
27 can be inserted into the membrane. For catalysis purposes, channel proteins represent a convenient 
choice, as they allow the passage of many substrate molecules while keeping the enzymes inside. As 
seen in Table 1, bacterial OmpF is widely used, thanks to its high molecular weight cut-off of 600 Da 
(300 Da for a mutant), surpassed by α-HL, with a 4 kDa cut-off.28 Another important feature of OmpF is 
the ability to retain its function when engineered to be reduction- or pH-sensitive thus expanding 
possible applications.29 It must be remarked that polymeric membranes are thicker than natural lipid 
membranes20b, creating a hydrophobic mismatch for all natural pores between the hydrophobic 
domain of the synthetic membrane and that of the protein. For this reason, the vast majority of 
membrane proteins were inserted only into PMOXA-PDMS or PB-PEO membranes, thanks to their high 
flexibility.20b  
 
1.6 Michaelis-Menten enzyme kinetics 
Before describing the state of the art of polymeric catalytic compartments, we must open a 
parenthesis on enzyme kinetics, a fundamental aspect of their characterization. 
Enzymes assist in reactions by lowering the needed activation. Speeding up the rate of the reaction as 
it allows the product to be formed faster. Enzymes have an active site made up of a few amino acids, 
where the reaction occurs in the optimal conditions (e.g. changing local pH, proximity of 
nucleo/electrophilic residues, water exclusion etc.), whereas the rest of the enzyme acts as a scaffold. 
The active site is almost complementary to the substrate’s shape and adapts slightly to fit it perfectly 
upon substrate binding. This forms the enzyme-substrate complex, ES. This is the induced fit model, a 
development of the lock and key hypothesis, postulating perfect fit before binding. Only weak bonds 
between the enzyme and substrate hold them in place, to allow dissociation afterwards. An enzyme 
has a high affinity for the transition state (the molecular species between substrate and product), 
higher than for its substrate, to quickly force the latter into the transition state. In enzymatic 
reactions, the conversion of the ES complex to the product is usually rate limiting and its rate) is 
directly proportional to the concentration of ES. The concentration of ES changes as the reaction 
progresses and, therefore, the rate of product formation also changes over time. When the reaction 
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reaches equilibrium (steady state) the concentration of ES (= rate) remains relatively constant. In 
presence of a lot of substrate, the reaction follows three different stages: pre-steady state (burst of ES 
complexes, speeding up as ES forms), steady state (constant concentration of ES, constant rate) and 
post-steady state (depletion of ES, slowing down as the substrate runs out). Since the pre-steady state 
is usually very fast, the steady state is the one used to measure the so-called Michaelis-Menten (MM) 
kinetics. 30 
 
The equation of the steady state is  
𝑣 =
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑀 + [𝑆]
 
Equation 1 
Where [S] is the substrate concentration, Vmax is the maximum rate of reaction when all enzyme 
active sites are saturated with substrate and KM (Michaelis-Menten constant) is the substrate 
concentration that gives half maximal velocity. KM can be described as a measure of the affinity that 
enzyme has for its substrate, as a lower KM means that less of the substrate is required to reach half 
of Vmax. 30 The information obtained by the equation is how the initial reaction rate V0, is affected by 
the initial substrate concentration, [S]0, so only looking at the beginning of the reaction (Figure 5). 
This allows the equation to ignore the reverse reaction where substrate is formed from product, since 
at the start of the reaction there is no product present to go the inverse way around. Some molecules 
can hinder the reaction. Competitive inhibitors, competing for the active site, increase the KM but do 
not alter the maximal velocity. The opposite is true for non-competitive inhibitors, binding to different 
locations on the enzyme, so that it is not the enzyme’s affinity to be affected, but its ability to change 
its conformation to form the product. Many enzymes also suffer from product inhibition, where 
excessive concentrations impede the production of additional product. This mechanism holds true for 
most reactions,31 but relies on the assumption that molecules can freely diffuse to and from the 
enzymes. This is not necessarily true when the enzymes are segregated and the flow is limited or 
channeled: this is the case of compartmentalized reactions and in cells too and must accounted for in 
the description of such systems, where conditions become more complex.32 
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Figure 5. Generic MM kinetic curves, showing graphically the parameters obtained by plotting the substrate concentration vs the 
reaction rate, and how different kinds of inhibitors influence them. Adapted with permission from30b.  
 
1.7 Cell-like polymeric catalytic compartments, state of the art 
1.7.1 Encapsulation 
Small molecules and proteins are encapsulated within the catalytic compartments to provide protection 
and stability so reactions can efficiently take place in complex biological fluids or in vivo.23a, 33 With some 
techniques, mainly film rehydration and solvent exchange, it is possible to also encapsulate 
nanocompartments or even bacteria into micrometer-sized vesicles, separating catalysts or even entire 
life forms from the exterior.20b, 34  
 
1.7.2 Compartmentalization of enzymatic cascade reactions 
Cascade reactions are processes where the product of a first (upstream) reaction becomes the 
substrate of, or facilitates, a second (downstream) reaction, without requiring the isolation of 
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intermediates; the great majority of biological processes are series of enzyme-mediated cascades, 
acting in parallel and in specific locations. 
Compartmentalization is thus a topic of tremendous interest in biocatalysis and synthetic biology; 
besides the already mentioned protection offered to the enzymes, segregation can influence the 
cascade reaction kinetics by keeping enzymes in proximity, by separating possible competing pathways 
and by forming locally high enzyme concentrations within the compartment, for instance lowering the 
Michaelis Menten constant (KM).35 Cascades themselves are a special case, where the interplay 
between substrates, cofactors and enzymes with different kinetics produces sometimes unexpected 
results.35c, 36 
It is evident why any kind of nano-biotechnological approach and application must take into account 
and acknowledge the fact that Nature is not a one-pot reaction but rather a network of communicating 
processes: consequently, compartmentalization is key for facilitating catalysis, and cell mimicking must 
rely on it.35a, 37 In fact, several of the examples listed in Table 1 and Table 2 involve multienzymatic 
cascades, adopting biological logics.38  
 
 
1.7.3 Relative enzyme positions in compartments 
The most common approach in compartmentalization consists of encapsulating a single enzyme in a 
single vesicle, polymersomes being the most widely used in this case (Table 1 Table 2). 
To increase complexity, several enzymatic cascades have been developed with various strategies. Co-
encapsulation is a possible setup.23b, 25a, 27, 39 Partial segregation, obtained by adsorption on the outer 
or inner part of the membrane of one enzyme have also been used.24, 40 Segregation in completely 
independent assemblies is not extensively used, as the reaction rate is decreased due to the slow 
diffusion between vesicles.23a, 41  
Alternatively, enzymes can be separated from one another in different subcompartments, all part of 
the same micrometric multicompartment system.  
 
1.7.4 Biomedical applications 
Combining the ability to modulate membrane properties with the ability to encapsulate active 
molecules within the inner compartment, thus obtaining sophisticated catalytic compartments, propels 
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their use for multiple applications. One prominent application is in the field of enzyme replacement 
therapy, where non-functioning or non-native enzymes can be introduced, via encapsulation in the 
catalytic compartments, to perform a specific reaction or even a cascade.23a, 28, 33, 42 The compartments 
work to protect the enzyme thus allowing for longer circulation times and prolonged activity. 
Alternatively, catalytic compartments can generate active chemotherapeutics from prodrugs at select 
locations, thus reducing the off-target toxicity. Recently, the potential of such a system was 
demonstrated in vivo where innately permeable compartments with encapsulated β-Gal efficiently 
converted the prodrug Doxgal to its active form Doxorubicin.43 The local production of a 
chemotherapeutic agent can be combined with a precise initiation of the enzymatic reaction based on 
a stimulus for a dual activity in vivo. In an example of such an assembly, the block-copolymer forming 
the polymersome is composed of the prodrug of camptothecin, while GOX is encapsulated inside the 
polymersome.25b Under acidic conditions, glucose can permeate through the polymersome membrane 
initiating the enzymatic reaction to produce H2O2 and in turn triggering the release of camptothecin 
and reducing A549 tumors in mice. By co-encapsulating a photosensitizer, enzymatic activity can also 
be paired with photodynamic therapy (PDT).26a For other applications such as treatment of diabetes, 
the polymer can be modified to respond to disease specific triggers such as increase in glucose levels 
and H2O2. The advantage is the ability to modulate the catalytic reaction, where the reaction takes place 
only in presence of high blood glucose levels and is terminated once the blood glucose decreases, 
preventing the risk of hypoglycemia.26c By encapsulation of hemoglobin inside polymersomes equipped 
with OmpF it resulted a catalytic compartment with a dual functionality: oxygen storage and ability to 
detoxify harmful peroxynitrites.44 Immobilization of the nanocompartments on a solid support is also 
possible and used as a tactic to obtain antimicrobial surfaces that locally produce a desired antibiotic45. 
 
1.7.5 Artificial cells and organelles 
Another major field of interest revolves around developing catalytic compartments that mimic naturally 
occurring organelles or cells, the so-called artificial organelles/cells. A common application involves 
using these systems as a tool to understand complex cellular reactions within a simplified platform that 
retains many characteristics of the natural cell (Table 1 and 2). Additionally, these types of 
compartments can be designed to perform explicit reactions that, when incorporated into natural cells, 
will restore or enhance cellular functionality. For example, polymersomes with co-encapsulated SOD 
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and LPO were shown to effectively detoxify reactive oxygen species once incorporated into cells, acting 
as artificial peroxisomes.23b Larger multicompartment systems can be incorporated into macrophages 
and perform model cascade reactions, thus proving their potential future use for therapeutically 
relevant applications.46 Artificial organelles that are responsive to an external stimulus, resulting in 
increased membrane permeability and initiation of an enzymatic reaction were developed. In one such 
example, a channel protein modified to include a reduction sensitive molecular cap was inserted into 
enzyme-loaded polymersomes.47 Once up-taken by cells, the increased intracellular glutathione levels 
released the molecular cap, opening the channel protein and allowing the passage of substrate into the 
polymersome. The nanocompartments also maintained their structure and activity in vivo in Zebra 
fish.47  
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Table 1 List of recent nanometric polymeric compartments: used polymer(s), encapsulated protein(s), setup, system of membrane permeabilization 
and envisioned application. Adapted with permission from reference38. 
Assembly Polymer 
Encapsulated 
protein 
Organization Permeabilization Application 
Ref
. 
N
an
o
m
et
ri
c 
P
o
ly
m
er
so
m
e
 
PMOXA-PDMS-
PMOXA 
GOX Enzyme-loaded Melittin Glucose sensor 48 
PEG-PHMA-co-
PPFMA 
GOX, HRP Enzyme-loaded Light-triggered Model for triggered permeabilization 49 
PMOXA-PDMS-
PMOXA 
UOX, HRP 
Enzymes loaded 
separately 
OmpF 
Treatment of hyperuricemia, model for substrate 
diffusion 
23a
 
PMOXA-PDMS-
PMOXA 
HRP Enzyme-loaded 
Stimuli responsive-
OmpF 
Model for in vivo triggered permeabilization 47 
PMOXA-PDMS-
PMOXA 
HRP Enzyme-loaded 
Stimuli responsive-
OmpF 
Model for triggered permeabilization 29b 
carbohydrate-PPG β-Gal Enzyme-loaded Inherent Enzyme delivery, drug production 43 
PEG-PHPMA GOX, HRP 
Enzymes loaded 
separately 
Inherent Model for PISA-mediated entrapment 41 
PMOXA-PDMS-
PMOXA 
AGE, NAL, CSS 
Enzyme-loaded + 
surface-
immobilized 
OmpF mutant Model for reaction segregation 24 
PEG-poly(Ser-S-NI) GOX, insulin Enzyme-loaded 
H2O2- and glucose- 
responsive 
Insulin patch for diabetes 26c 
PMOXA-PDMS-
PMOXA 
PGM Enzyme-loaded α-HL Enzyme replacement therapy 28 
PMOXA-PDMS-
PMOXA 
HRP Enzyme-loaded Ompf Model for molecular crowding 35g 
PEG-P(CPTMA-co-
PEMA) 
GOX Enzyme-loaded 
pH-driven 
permeability 
Cancer therapy 25b 
PMOXA-PDMS-
PMOXA 
RDH Enzyme-loaded GlpF Biosensor 20b 
PEG-PS 
(Stomatocyte) 
GOX, Cat 
Co-encapsulated 
enzymes 
Shape transformation Model for cargo loading and release 39 
PMOXA-PDMS-
PMOXA 
HRP Enzyme-loaded 
Stimuli responsive-
OmpF 
Model for triggered permeabilization 29a 
PLGA Cat Enzyme-loaded Inherent + rupture Oxidation therapy, enhancement PDT 26a 
PMOXA-PDMS-
PMOXA 
PA Enzyme-loaded OmpF Antimicrobial surface 45 
PNVP-PDMS-PNVP Lac Enzyme-loaded Inherent Oxidizing agents for industrial applications 50 
PDEAEM, PDMIBM Mb, HRP, GOX 
Co-encapsulated 
enzymes 
pH-driven Model for diffusion control 25a 
PMOXA-PDMS-
PMOXA, PS-PIA 
GOX, HRP 
Enzyme-loaded 
polymersome 
OmpF + inherent Model for artificial cell 51 
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within 2nd 
polymersome 
PS-PIAT, PS-PEG SOD, Cat 
Enzyme-loaded 
co-encapsulated 
Inherent Antioxidant 52 
PMOXA-PDMS-
PMOXA 
SOD, LPO/Cat 
Co-encapsulated 
enzymes 
OmpF Artificial peroxisome 23b 
PS-PAA cytC, Ccox 
Ru(II)-modified 
enzyme complex 
in membrane 
Light-driven Model for artificial chloroplast 27 
PMOXA-PDMS-
PMOXA 
Hb Enzyme-loaded OmpF Antioxidant, O2 transport 44 
PEG-P(S-co-TMI) CalB 
Enzyme-loaded 
polymersome 
within 
colloidosome 
Inherent Model for enzyme catalysis in biphasic systems 53 
PS-PAA Tr Enzyme loaded Impermeable Model for molecular confinement 54 
PS-PIAT GOX, HRP, CalB 
Encapsulated, in 
membrane and 
surface-
immobilized 
enzymes 
Inherent Model for enzyme positioning 40 
PMOXA-PDMS-
PMOXA 
SOD Enzyme loaded Inherent Antioxidant 55 
P
IC
so
m
e
 PEG-P(Asp), P(Asp-
AP) 
L-ASNase Enzyme-loaded Inherent Model for enzyme replacement therapy 33 
PEG-P(Asp),  
Homo-P(Asp-AP) 
β-Gal Enzyme-loaded Inherent Enzyme delivery, drug production 42a 
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Table 2 List of recent micrometric polymeric compartments: used polymer(s), encapsulated protein(s), setup, system of membrane permeabilization and 
envisaged application. 
Assembly Polymer 
Encapsulated 
protein 
Organization Permeabilization Application Ref. 
M
ic
ro
m
et
ri
c 
G
U
V
 
PMOXA-PDMS-PMOXA HRP Enzyme-loaded OmpF Model for artificial cell 56 
PEO-PB Cat Enzyme-loaded Inherent + rupture Model for cargo release 26b 
PLL+ PMAc + PDA 
GLDH, GTR, β-Gal, 
GOX, Cat 
Enzyme-loaded 
liposomes embedded 
within 
Inherent Model for artificial cell 57 
C
ap
so
so
m
e
 
PAH/PMA/PNMD/PEG-
P(DEAEMA-stat-BCP) 
Cat, Mb, GOX 
Enzyme-loaded 
polymersomes 
embedded within 
Temperature- and 
pH-driven 
Model for artificial cell 25c 
PLL/Liposomes/PMA/ 
PMAc/PNVP 
GOX, HRP Enzyme-loaded Inherent Model for artificial organelle 46 
PLL/Liposomes/PDA/PMA/ 
PMAc 
Cat 
Enzyme-loaded 
liposomes embedded 
within 
Inherent 
Model for tissue engineering/cell structural 
support 
58
 
PLL/Liposomes/PDA/ 
PEG/RGD 
GOX 
Enzyme-loaded 
liposomes embedded 
within 
Inherent Model for artificial organelle 59 
PLL/PMAc/Liposomes/PD
A 
PAL 
Enzyme-loaded 
liposomes embedded 
within 
Inherent Enzyme replacement therapy 42b 
PLL/PMAc/Liposomes/PD
A 
UOX , HRP, AO 
Enzyme-loaded 
liposomes embedded 
within 
Inherent Model for artificial cell 60 
M
u
lt
ic
o
m
p
. G
U
V
 PMOXA-PDMS-PMOXA Lipase 
Enzyme with co-loaded 
with particle-entrapped 
substrate 
Inherent for DTT 
Model for reduction-responsive 
subcompartments 
61 
PS-PIAT,PB-PEO 
PAMO, CalB, Alc, 
ADH 
Enzymes-loaded 
polymersomes co-
encapsulated in bigger 
enzyme-loaded vesicle 
Inherent Model for artificial cell 62 
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2 Aim of the thesis 
Billions of years of evolution and natural selection lead to the emergence of systems optimized for 
complex sets of reactions, making cells unmatched reactors, genuine microscale computers. Any man-
made material that wants to be “smart” is basically required to adopt some kind of biological logics, 
such as self-regulation, environmental sensitivity, or catalytic activity. 
When I first approached the topic of  cell mimesis, the question asked was: to what extent can we treat 
networks of synthetic, specialized micro- and nano-objects as quasi-living systems? Self-assembled 
PDMS-PMOXA catalytic compartments, imitating the shapes and functions of organelles and cells had 
been known for several years, having physical behaviors comparable to that of lipid membranes, but 
more stable, non-immunogenic and chemically versatile; however, as many biological phenomena can 
be said to be emergent, deriving from the combination of simpler units, these kind of reactive structures 
had the same potential, i.e. to be able to relate with one another in cascades, mimicking cells and 
interacting with real ones, the way an organelle or symbiont could do. In synthetic biology, such 
approach is called bottom-up and is aimed at constructing living (or close to living) systems from non-
living matter, what we may call abiotic life. The task I decided to undertake was to expand the concept 
of catalytic compartments, using their biomimicking features to make them bioactive materials, and to 
develop as much as possible the potential of the technology. Far from having exhausted all possibilities, 
the tiny, uncharted territory that I explored showed that it is definitely possible to treat the same 
biological-synthetic hybrid materials (polymer vesicles + proteins) both as cell models for fundamental 
research and as applied tools.  
Rather than starting with a pre-determined set of hypotheses to probe, this work is a non-exhaustive 
list of attempts at expanding the concept of bottom-up synthetic biology as a network of man-made 
objects operating in synergy; the story told is that of several systems, each building on the previous one 
and studying different aspects of this hybrid material. For the first time, polymeric catalytic 
compartments could be used to mimic cellular environments and serve as platform to screen 
cytoskeletal drugs; building on this concept, catalytic nanocompartments in cascades could be used to 
detoxify cells from toxic species or elicit cellular changes in homeostasis via the production of second 
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messengers. The concept was then optimized by studying how the permeabilization can be improved, 
and by controlling relative distances between compartments, improving the reaction efficiency. 
 The conclusion, the thesis, is emergent like the properties of the studied systems: billions of years of 
trial and error led to logics that can be now applied, with very little tweaking, to largely unnatural 
materials, in humanity’s quest to simultaneously understand Nature and consciously adapt to it. 
 
 
 
3 Mimicking cells2 
In nature, cells respond to dynamic changes and can sense external environmental changes to maintain 
biological functions.63 Mimicking cells, in this regard, means materials that are capable to sense an 
external change (stimulus) and modify their internal organization in response and activate specific 
pathways. Our aim was to adapt two fundamental features of eukaryotic cells: hierarchical spatial 
segregation, which is found in organelles, and responsiveness to stimuli. These two components would 
allow our artificial cells to have internal subcompartments that segregate small and macromolecules 
from the rest of the construct (and from the bulk solution), and the ability to change their internal 
organization based on environmental stimuli. Doing so paves the way for real cell-mimicking materials, 
beyond the vague concept of artificial cell / protocell. 
                                                     
2 PARTS OF THIS CHAPTER HAVE BEEN PUBLISHED AND REPRINTED WITH PERMISSION FROM: 
THAMBOO, S.; NAJER, A.; BELLUATI, A.; VON PLANTA, C.; WU, D.; CRACIUN, I.; MEIER, W.; PALIVAN, C. G., MIMICKING CELLULAR SIGNALING PATHWAYS 
WITHIN SYNTHETIC MULTICOMPARTMENT VESICLES WITH TRIGGERED ENZYME ACTIVITY AND INDUCED ION CHANNEL RECRUITMENT. ADVANCED 
FUNCTIONAL MATERIALS 2019. 
BELLUATI, A *, THAMBOO, S*, NAJER, A, MAFFEIS, V., VON PLANTA, C, CRACIUN, I.; MEIER, W.; PALIVAN, C. G., MULTICOMPARTMENT POLYMER VESICLES 
WITH ARTIFICIAL ORGANELLES FOR SIGNAL-TRIGGERED CASCADE REACTIONS INCLUDING CYTOSKELETON FORMATION 2020. ADVANCED FUNCTIONAL 
MATERIALS 2020. 
ANDREA BELLUATI AND SAGANA THAMBOO HAVE CONTRIBUTED EQUALLY TO THE WORK PRESENTED IN THIS CHAPTER.  
 
     34 
3.1 Stimuli-responsive multicompartment systems 
3.1.1 Introduction  
Stimuli-responsive systems are based on copolymers with a special chemical nature, inducing a change 
in the membrane permeability or even its disintegration upon a change in their environment, 
transducing a physical or chemical signal, such as light, temperature, pH, redox potential, temperature, 
light, magnetic fields, electric fields and mechanical force.61, 64 We decided to use cell-sized polymeric 
structures as cell membrane stand-ins,  harboring stimuli-sensitive and -insensitive nanostructures 
which could act both as “receptors” of environmental changes and artificial organelles segregating their 
cargos, until stimulated. A self-contained system of this sort could act, for example, as biosensor or as 
a platform to screen the effect of drugs on specific cell processes, which can be replicated in these 
structures, free from interactions happening in actual cells that can cause false readings. 
3.1.2 Previous work on reduction sensitive compartments 
3.1.2.1 Reduction-sensitive nanoparticles as artificial organelles 
For this study, we needed to segregate molecules, keeping them “inactive” within the lumen of 
polymeric vesicle, and release them on demand. Stimuli-sensitive nanoparticles are an attractive 
choice, as they can harbor useful compounds (e.g. therapeutics) and release them once their 
surrounding environment changes as desired, and have been widely studied for drug delivery.65  Our 
strategy was to use reduction-sensitive nanoparticles (NP-Graft) based on (poly(2-methyl-2-
oxazoline)88-graft(SS)-poly(ε-caprolactone)238 (PMOXA88-g(SS)-PCL238) (with a grafted disulfide bridge 
connecting the two copolymers), capable of entrapping hydrophobic compounds and releasing them 
once disaggregated by a reducing agent (Figure 6), 54, 58 as they had been already characterized and 
could be confidently used as internal subcompartments.61, 66 
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Figure 6 Structure and self-assembly of PMOXA-g(SS)-PCL nanoparticles. Adapted with permission from reference 66b. 
 Transmission electron microscopy (TEM) indicated the formation of spherical nanoparticles, and 
dynamic light scattering (DLS) revealed hydrodynamic diameters of circa 50 nm.61 Once loaded in 
PMOXA-PDMS-PMOXA giant unilamellar vesicles (GUVs) via film rehydration in a 300 mM sucrose 
solution, they could only be disassembled by the reducing agent dithiothreitol (DTT), as other reducing 
agent could not cross the membrane encasing the NP-Grafts. 61 
When entrapping the hydrophobic dye Bodipy 630/650, and co-loaded with polymersomes 
encapsulating the dye Sulforhodamine B, in situ FCS could follow, inside the lumen of the GUVs, the 
selective disassembly of reduction-sensitive NP-Graft, whereas non-reduction sensitive polymersomes 
stayed intact (Figure 7). This way, the NP-Graft showed a twofold function: as artificial organelles, 
separating species within the lumen, and as intracellular receptors, being the responsive species to an 
external stimulus and enacting an internal change.67 
     36 
 
Figure 7. Reduction sensitiveness of 2-compartment multicompartments. In presence of DTT (red) loaded NP-Graft disassembles, while 
non-reduction sensitive polymersome stays intact within the giant vesicle after incubation of 24 h. In absence of stimuli (DTT) (black) both 
types of subcompartments are stable within the GUV according to FCS measurements. Also, the diffusion times and number of particles in 
the GUV show that in presence of DTT (red) only the reduction sensitive NP-Graft disassembles, while both types of subcompartments are 
intact in absence of DTT (black) (N=3 GUVs before and after DTT and for channel). Adapted with permission from reference 61. 
3.1.2.2 DTT-triggered enzyme activity  
Having shown the robustness of such system, an enzymatic reaction based on a hydrophobic and 
fluorogenic substrate was chosen, allowing its visualization via CLSM. The most obvious enzyme 
candidate was lipase, as it is specialized in hydrolyzing hydrophobic compounds. Its substrate 1,2-Di-O-
lauryl-rac-glycero-3-(glutaric acid 6-methylresorufin ester) (DGGR) 68 was first incorporated in the NP-
Graft to segregate it from lipase; preliminary results in sucrose showed a very limited effect on the 
reaction of the solution found inside the GUV lumen, after DTT had caused the disassembly of the 
nanoparticles (Figure 8). 
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Figure 8. Enzymatic reactions in solutions (PBS and sucrose). In PBS: Lipase mixed with DGGR loaded NP-Graft and DTT (black), Lipase and 
DGGR loaded NP-Graft alone (red), DGGR loaded NP-Graft and DTT alone (pink); Lipase, DGGR loaded NP-Graft, DTT and lipase inhibitor 
Orlistat (blue). In sucrose: Lipase mixed with DGGR loaded NP-Graft and DTT (dark green); DGGR loaded NP-Graft and DTT alone (light 
green). Error bars are given as mean ± standard deviation (n = 3. Ex/Em 529/600 nm. Adapted from reference 61. 
 
DGGR-NPs and lipase were then co-loaded inside GUVs. With DTT added to the exterior medium, it first 
penetrates the GUVs, it induces the disintegration of the NP-Graft and the release of DGGR, which was 
then accessible by lipase. Being an interface membrane, lipase tended to adsorb to the polymer 
membrane; this, added to the fact that the main product of the reaction is the hydrophobic 
methylresorufin, made the fluorescence concentrate on the inner wall of the GUV (Figure 9). 
     38 
 
Figure 9. Compartmentalization of enzyme reaction. (A) Schematic representation of signaling pathway resulting in lipase activity. The 
DGGR loaded NP-Graft and lipase were co-encapsulated in the giant vesicles. The substrate was released in presence of DTT and was 
transformed by lipase to form the fluorescent product (methylresorufin) which preferentially associated with the giant vesicle membrane. 
(B) CLSM imaging of DGGR loaded NP-Graft and lipase loaded giant vesicles in absence (left) and presence of DTT (right). Histogram along 
diagonal of fluorescence image (top), fluorescence image (middle) and bright field image (bottom). Scale bars, 5 m. Adapted from 
reference 61. 
3.1.2.3 DTT-triggered ion channel recruitment  
In parallel with DGGR-loaded NPs, the DTT-triggered release of the pore-forming peptide gramicidin A 
(gA) was developed, based on the same principle of encapsulating a hydrophobic compound (gA) in the 
NP core (gANP). In this case, its release would induce the spontaneous insertion of this pore into the 
GUV membrane, allowing the passage of monovalent cations. 61, 69 This system, where specific 
membrane permeability is induced by an external trigger, simulated the recruitment of membrane 
proteins from internal compartments, found for example in neurons, activated by specific stimuli. 70   
gANPs were encapsulated in the Na+ - free GUV lumen, together with the Na+-sensitive dye Asante 
Natrium Green 2 (ANG2); the GUVs were then put in a Na+-containing buffer. Only upon addition of DTT 
was gA released, reconstituted into the membrane and able to let the ions go through, as confirmed by 
the activated fluorescence of ANG2 (Figure 10) 
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Figure 10. Triggered gramicidin ion channel recruitment from internal subcompartments to the polymer membrane of a multicompartment 
using CLSM imaging. Schematic representation (top) of gA mediated import of sodium ions. Upon the addition of DTT, encapsulated gA is 
released from its NP-Graft and inserts into the GUV membrane boundary. This allows sodium ions from the outside to enter the GUV cavity 
where they activate the sodium sensitive dye ANG2. Bright field image (left), fluorescence image (middle) and histogram along the diagonal 
of fluorescence image (right) in presence (middle) and absence (bottom) of DTT. Adapted from61. 
3.1.3 Two-compartment DTT-dependent lipase activation 
We then decided to study how the reaction would be affected by a double subcompartmentalization, 
that is two different artificial organelles communicating within the same cell mimic: the partially 
segregated enzyme, adsorbed (thanks to its hydrophobicity) on the outer membrane leaflet of PMOXA-
PDMS-PMOXA polymersomes (LipVes), and the DGGR-NPs. Vesicle-adsorbed lipase maintained its 
activity, again only achieved after DTT had freed DGGR from the nanoparticles. This allowed us to co-
load both DGGR-NP and LipVes in the same GUVs (Figure 12 and Figure 11). 
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Figure 11. (A) Schematic representation of enzymatic reaction using substrate (DGGR)-loaded NP-Graft and enzyme (lipase)-adsorbed 
polymersomes (LipVes), co-loaded into GUVs. Substrate was released from NP-Graft in presence of DTT and transformed into the 
fluorescent product (methylresorufin). (B) CLSM imaging of DGGR loaded NP-Graft and LipVes in GUVs in presence (top, middle) and 
absence (bottom) of DTT. Bright field image (left), fluorescence image (center) and histogram along diagonal of fluorescence image (right). 
Due to the hydrophobicity of methylresorufin, it either partitioned into the hydrophobic part of the GUV’s membrane or also to the 
remaining NP-Graft debris or non-responsive LipVes membrane. Scale bars, 5 μm. 
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Figure 12. Enzymatic reactions in 300 mM sucrose. Lipase adsorbed on vesicle (LipVes) and DGGR loaded NP-Graft in solution in presence 
(black) and in absence (red) of DTT. Error bars are given as mean ± SD (n = 3). Ex/Em 529/600 nm. Adapted from 61. 
What we remarked, compared to the previously published study, is that we did not only observe the 
fluorescence rings, but also a part with filled lumen(Figure 13 A-B), again not without DTT (Figure 13 
C). Since the loading of nano-objects in GUVs via film rehydration is a stochastic phenomenon, only a 
part of the GUVs had enough vesicles for the methylresorufin to adsorb preferentially to the internal 
compartments, and 10% of them was not loaded enough to be detectable (Figure 13 D). It must be 
noted that the GUVs had quite a broad size distribution with sizes between 4 and 29 m, a limitation 
of the film rehydration technique (Figure 13 E). 
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Figure 13. Efficiency of the compartmentalization of enzyme reaction in presence of 10 mM DTT after 24 h incubation time and 
corresponding GUV size distribution. (A-C) Plot profile of the fluorescence intensity along the diagonal of the image (left), CLSM image of 
LipVes and DGGR-NP co-loaded in giant vesicles (middle) and corresponding bright field image and merge (right), indicating: (A) production 
of methylresorufin adsorbed to the polymer membrane (55%), (B) production of methylresorufin in the lumen, (C) absence of DTT (and 
fluorescence). (D) Percentage of GUVs showing activity, and in what form. (E) Sizes of GUVs, showing the broad distribution. Adapted 
from71. 
3.1.4 Two-compartment DTT-dependent ionophore release  
To explore the triggered release from internal stores (artificial vacuoles), in an advanced study we 
produced sodium-filled polymersomes (Na+Ves), coencapsulated with gANP and ANG2, with both the 
lumen of the GUV and the outside buffer sodium-free. Like previously seen, GUVs in absence of DTT 
were completely non fluorescent; with the stimulus, sodium ions could flow outside of their small 
vesicles, activating the fluorescence of ANG2 (Figure 14 A-B).  
The GUVs had a size distribution between 6 and 43 m (N = 40 GUVs, Figure 14 C). 73% of 
multicompartments were functional and induced the dye activation via two internal types of artificial 
organelles within the GUVs (Figure 14 D). No fluorescence was detected in the remaining 27%, probably 
due to insufficient loading of gA in NP-Graft, sodium ion in the Na+Ves, ANG2 into the GUVs, or a 
combination thereof. In addition, a fraction of gA inserted in the GUV membrane, due to being made 
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of the same polymer. The surface offered to gA by the encapsulated Na+Ves is roughly 125 µm2 for the 
sum of the encapsulated polymersomes (1000 per GUV), versus 452 µm2 for the membrane of a GUV 
(volume 1112 µm3) would mean comparable recruitment to the artificial organelle membrane. 
organelle membrane, yet we could not observe any difference in kinetics compared to the case of 
insertion and ion flux across the GUV membrane due to gA insertion in GUVs membrane. 
 
 
 
Figure 14. Efficiency of the compartmentalized gA reconstitution into the polymer membrane to import sodium ions in presence of 10 mM 
DTT after 24 h incubation and corresponding size distribution. (A-B) Plot profile of the fluorescence intensity along the diagonal of the 
image (left), CLSM image of gA loaded NP-Graft and sodium loaded polymersomes (Na+Ves) in giant vesicles (middle) and corresponding 
bright field image and merge (right), indicating: (A) remain empty (27%, no fluorescence) and (B) activation of ANG2 by sodium ions (73%, 
fluorescence). (C) Histogram of efficiency of gA loaded NP-Graft and ANG2 in giant vesicles in presence of DTT. (D) Histogram of size 
distribution of measured gA loaded NP-Graft, sodium loaded polymersomes (Na+Ves) and ANG2 in GUVs in presence of DTT after 24 h 
incubation (N=40 GUVs). Scale bars, 5 μm. Adapted from reference 61. 
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3.2 Triggered actin polymerization 
We further expanded on this multistep system, taking advantage of the fact that this induced 
permeabilization causes a change in ion concentration within the GUV, a change in osmolarity. It is 
known that high salt concentrations cause the spontaneous polymerization of the cytoskeleton protein 
actin from its G (globular) form to the F (filamentous) form; in our GUVs this would have led to changes 
in the internal structure of the cell mimics in a biosimilar manner, as already demonstrated in 
liposomes, 72 mimicking a basic component of cells responsible for both structural stability and dynamic 
shape modifications. 72b, 72c, 73 
3.2.1 Subcompartment-free artificial cytoskeleton 
To optimize our strategy, we investigated the formation of an actin cytoskeleton in our biomimetic 
system. We first confirmed fluorometrically, the concentration ranges for polymerization with 
monomeric pyrene-actin in solutions, showing formation of filaments in presence of various salt 
solutions ( of KCl, CaCl2 and MgCl2): the higher the degree of polymerization, the higher the fluorescence 
of pyrene (Figure 15). 
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Figure 15. Pyrene fluorescence assays of G-actin polymerization in the dependence of salts. Actin-pyrene in sucrose (300 mM, brown), in 
CaCl2 (100 mM, purple), in KCl (100 mM, blue) and in MgCl2 (100 mM, gold). The actin polymerized almost immediately, showing stable 
filaments for the following 90 minutes. Ex/Em 365/407 nm. Adapted from71. 
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To favor the creation of an ordered network with thick filaments (and for ease of visualization), we 
mechanically stabilized our actin (supplemented with ATTO488-G-actin for its visualization) 
cytoskeleton with the actin-binding protein filamin, a physiological mechanosensor, confirming the 
formation of actin-filamin bundles in ion rich solutions and only monomeric form in HEPES buffer 
(Figure 16).  
 
 
Figure 16. Confocal images of actin networks polymerized in bulk solution in presence of different solutions. In presence of the crosslinker 
filamin, G-actin stays in its monomeric form in HEPES buffer (300 mM) in contrary to the solutions containing KCl, CaCl2 and MgCl2 induce 
actin polymerization and form actin-filamin networks (green). The samples were incubated for 3 h. Scale bars, 20 μm. Adapted from71. 
 
We then developed a protocol for the loading of G-actin (labeled and unlabeled) and filamin. Upon 
addition of ions and corresponding ionophores such as ionomycin (IoNo), for the passage of Mg2+ and 
Ca2+ or gramicidin A (gA) for transport of K+ ions, to the external medium, actin polymerization was 
induced inside the polymer compartment (Figure 17) within 24h. 73d, 74 The hydrophobic dye 
Bodypy630/650 was used to visualize the GUV membrane. In absence of pores and/or salts G-actin 
stayed in its monomeric form.  
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Figure 17. Actin filament polymerization in synthetic GUVs. Actin monomers (G-actin) and the actin crosslinker filamin was loaded into 
giant vesicles after 24 h incubation. Pores (gA or IoNo) were introduced to the vesicle solution resulting in permeabilization of the GUV 
membrane towards specific ions (K+ or Ca2+ and Mg2+). (A) Schematic representation of the actin polymerization in GUVs. (B) In absence 
of pores, the monomers stayed intact, and no filaments were formed since no ions could enter the GUV cavity. (C) When pores where 
added to the surrounding solution, they reconstituted into the membrane boundary of the GUV. Then ions entered the GUV cavity, actin 
starts to form filaments and the bundling agent filamin crosslinks the filaments into a network. Scale bars, 5 m. Adapted from71. 
 
To visualize better the morphology of the GUV cytoskeleton, we additionally used a high resolution 
microscopy technique, 3D structured illumination microscopy (3D-SIM), showing that the actin network 
within the GUVs is composed of both thin actin filaments and actin bundles with thicker fibers (Figure 
18).  
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Figure 18. Projections of actin filaments (green) polymerized within GUVs in presence of pores and ions recorded with super-resolution 3D-
SIM. High resolution images (3DSIM) of Actin GUVs in salt solutions (200 mM KCl, 150 mM CaCl2 and 150 mM MgCl2) in presence of 
corresponding pore (gA, IoNo) after incubation of 48 h. Scale bars, 5 μm. Adapted from71. 
 
3.2.2 Ionophore release for actin polymerization 
Having confirmed the capability to induce actin polymerization by adding ionophores from the exterior, 
we went back to the concept of NP-Graft as stimuli-responsive units, by encapsulating either gA again 
(gANP), or ionomyicin (IonoNP), as they both enter spontaneously the membrane of the GUV 
encapsulating them, and co-loading them with actin and filamin, making multicompartment GUVs 
(Actin MC). 
In presence of DTT, the pore-loaded NP-Graft disassembled and released their cargo (gA or IoNo). This 
allowed the passage of K+, Mg2+ or Ca2+ from the exterior solution, leading to the polymerization of actin 
in the GUV (Figure 19, Figure 20). 
Observations of mostly cortical rings in the case of triggered actin polymerization via responsive 
artificial organelles  could be due to a lower amount of gA or IoNo incorporated into the membrane 
compared to addition from the outside, as it depends on the loading and subsequent release from 
subcompartments (Graft-NPs). Limited amount of ion influx could lead to a more localized actin 
polymerization directly below the membrane where the local concentration of ions will be highest upon 
channel insertion. This explanation is also suggested by the fact that addition of ionophores from the 
outside allows fast and plentiful influx of ions that leads to higher chance of creating extended networks 
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within lumen, whereas the actin rings below the membrane are also present in the cases of more ion 
influx. Such mechanistic considerations will need to be further investigated. 
 
Figure 19. Stimuli-triggered actin polymerization in synthetic multicompartments. (A) Schematic representation of pore mediated import 
of ions resulting in the formation of actin filaments. Upon DTT addition, the encapsulated pores are released from its NP-Graft and inserts 
into the GUV membrane boundary. Ions enter from the surrounding solution into the cavity of the GUV, where the actin monomers start 
to polymerize into filamentous structures. (B) CLSM imaging of actin monomer (G-actin, green) and crosslinker filamin co-loaded GUVs 
(red) remaining in its monomeric form in absence of salts and pores. (C) CLSM micrographs of actin filaments (green) in the lumen and 
inner leaflet of the GUV membrane (red), where actin polymerization is induced in presence of DTT. (D) Projections of actin filaments 
(green) in GUVs (red) via stimuli-responsiveness via internal subcompartments, were imaged with CLSM. The actin samples were incubated 
for 24 h. Scale bars, 5 m. Adapted from71. 
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Figure 20. Surface profile along the surface (left) and plot profile along the diagonal (right) of the stimuli-triggered actin polymerization in 
multicompartments (fluorescence intensity of the CLSM images of Figure 19). Adapted from71. 
The formation of an internal protein network was also expected to affect the Brownian motion of 
encapsulated species, due to molecular crowding. To study the change in viscosity of GUVs due to 
triggered actin polymerization in situ FCS measurements in GUVs loaded with IonoNP and non-
responsive fluorescent subcompartments (SRBVes, sulforhodamine B-loaded vesicles) was performed. 
After selective disassembly of NP-Graft by adding DTT, and formation of filaments after ion influx, we 
measured FCS within the actin loaded GUV. We observed that the FCS curves shifted towards the right 
due to slower diffusion of SRBVes resulting in diffusion time changes from 4555 s to 70277 s after 
polymerization. Therefore, we calculated from the diffusion time a change in dynamic viscosity from 
8.9*10-4 Pa*s to 1.4*10-2 Pa*s after actin polymerization. The actin filaments within the GUV made the 
lumen more crowded, replicating the molecular crowding of cells (Figure 21).  
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Figure 21. FCS autocorrelation curve of SRBVes of two-type multicompartments before and after triggered actin filament polymerization. 
Change in diffusion time can be indicated as viscosity change. (N=3 GUVs before and after addition of DTT). Adapted from71. 
We then performed a complete morphology analysis. Regarding the shape of the cytoskeleton, we 
could remark that web-like structures were the main type for actin GUVs (between 71% and 92%). In 
contrast, formation of cortical actin rings was predominantly observed for actin MCs (between 75% and 
80%, N=100 GUVs) (Figure 22A-B). The shape of non-spherical actin MCs was also analyzed: the biggest 
population was represented by elongated vesicles (38%), then vesicles connected through tubular 
protrusions of their non-ruptured membranes (“beads on a string”) and finally round vesicles showing 
long protrusions (N=60 GUVs) (Figure 22C). All these shapes were formed by underlying cortical actin 
rings. Various parameters such as concentrations of actin, filamin, ions, ionophores, stiffness of the 
membrane and of the filaments and more, influence the overall shape of the GUVs, which will have to 
be studied in more detail to depict the mechanism by which these structures are formed and how they 
dynamically change over time. 
3.2.3 Influence of the Membrane on the Diffusion of Polymerization Inhibitors 
Actin polymerization is the main target of several natural compounds, which exert their toxic activity 
by inhibiting the polymerization of actin, which leads to aberrations in cell transport, motility and 
division.75 Such natural toxins are candidate cytoskeletal drugs, as their interaction with actin can be a 
way to inhibit cell proliferation, making them anticancer agents, or biopesticides.76 These toxins have 
different potency, meaning that the concentrations needed to achieve an effect can vary due to various 
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uptake mechanisms and interactions with other cellular targets.76b An important factor to consider, 
when studying cytoskeletal drugs, is whether they rely on passive diffusion or transporters;77 
additionally, secondary targets for the toxins in cells must be accounted for when characterizing their 
interaction with actin, as the observed cytotoxicity might derive also from other interactions.76a  
Our system can be used as a cytoskeletal drug screening platform to study the inhibitory action of small 
molecule actin-polymerization inhibitors. This system developed by narrowing down “cells” into two 
components: a cell-mimicking membrane, through which molecules can only passively diffuse, and a 
cytosol-mimicking lumen containing actin, will allow us to study the direct effect of the drugs on 
mechanical properties of cell-like systems.78 To test such an application, we induced actin 
polymerization through DTT-triggered release of ionomycin from NP-Graft and flow of Mg2+ in presence 
and absence of  externally added actin polymerization inhibitors. As a proof of concept, we tested four 
different toxins, all membrane-permeable: latrunculin A (LatA), chaetoglobosin A (ChaetA), 
cytochalasin B (CytB) and cytochalasin D (CytD). The simultaneous addition of one of four toxins meant 
that the DTT-triggered actin polymerization had to compete with the compounds, which had in turn to 
diffuse across the polymer membrane. All screened compounds were added at the same concentration, 
above their reported EC50,79 so that the only discriminants would be their ability to cross the membrane, 
and their intrinsic activity. All toxins showed significant ability of reducing what we called relative F-
ratio, the ratio between GUVs presenting at least one filament and the total population, compared to 
the untreated MCs. We observed the highest effect with LatA, known to be one of the most potent 
polymerization inhibitors.80 We found no significant differences between Chaet A, CytB and CytD. These 
results suggest that the differences in potency between the compounds could partially be explained by 
their ability to diffuse through membranes, in addition to their intrinsic activity (Figure 22D). ChaetA 
was a remarkable case, as its addition led to the disassembly of a great number of vesicles (Figure S24), 
hinting that it interacts with both the membrane and actin, which could be a future research direction 
to elucidate its toxic action in biological settings. We envision that finding polymerization inhibition in 
our system is an indicator of potential toxicity of the compound, since the compound could act on many 
different cells in the body through passive diffusion across the membrane. Interesting drug candidates 
would be inhibitors of actin polymerization in solution, but present no activity in our system. Such 
compounds could potentially be delivered to cancer cells specifically using targeted nanocarriers. Our 
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findings present a possible application of our system, to screen for specific parameters affecting the 
action of compounds of pharmacological interest.  
 
Figure 22 Analysis of actin filament shapes, GUV shapes and the effect of actin polymerization inhibitors on Actin MCs. (A) An 
actin GUV with a cortical ring cytoskeleton. (B) Bar graph showing filament shape frequency for actin GUVs (solid color) and 
actin MCs (striped color), in presence of different salts. Green: cortical rings, blue: web-like networks. The population of 
cortical rings increases noticeably in actin MCs (N = 100).  (C) Shape distribution of non-spherical Actin MCs, showing a 
prevalence of elongated vesicles with cortical rings, closely followed by bead-like structures and then vesicles with 
protrusions (N = 60). (D)  Relative F-ratio of untreated Actin MCs (set as 100%) and MCs treated with different toxins. The F-
ratio determines how much a molecule can hinder the polymerization of actin. Error bars given as Mean ± SD (binomial 
distribution), n between 15 (ChaetA) to 55 (CytD). Values compared through one-way ANOVA, with Tukey’s post hoc test. 
*** p < 0.001; n.s. not significant. Scalebar, 5 µm. Adapted from71. 
 
 
3.3 Conclusions 
The complex architecture of living cells including simultaneous action of a myriad of dynamic processes 
are the inspiration for creating sophisticated cell mimics / protocells, aimed at assembling artificial cells 
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from of bottom-up. The work of this chapter shows our efforts to develop a synthetic protocell model 
based on the self-assembly amphiphilic block copolymer, aimed at recreating the responsiveness of 
living cells. Membrane functionality, sensitivity towards a specific external stimuli and internal response 
of the multicompartment system was investigated. Driven by an external stimulus, we could kick start 
enzymatic activity permeability without compromising the polymeric architecture of the GUVs, making 
the responsive nanoparticles both artificial organelles and intracellular DTT receptors; inspired by 
signaling pathways in cells, our subcompartments could trigger multistep signaling pathways in our 
system. Desired molecules (enzymes, reporter compounds) together with corresponding partners 
(substrates, ionophores) entrapped in responsive nanoparticles were simultaneously co-encapsulated 
within GUVs to be spatially segregated. Once having crossed the GUV membrane, DTT induced the 
disintegration of the sensitive nanoparticles and subsequent release of their content. In the case of 
LipVes, the enzyme was no longer segregated from its substrate DGGR.  Building on this mechanism, 
ion channels (gA) were released and recruited to the membrane of Na+Ves, allowing the flow of sodium 
ions to the lumen of the GUV.  
To mimic the cellular cytoskeleton, actin polymerization was triggered within the interior of a synthetic 
protocell, thanks to changes in ion concentration. This was obtained both by directly adding ionophores 
(ionomycin, gA) to the membrane, or by first entrapping them in NP-Graft and then releasing with DTT. 
We observed an increase in diffusion time for non-responsive subcompartments after triggering actin 
polymerization inside multicompartments, which can be attributed to a change in viscosity and gives 
another indication of successful cytoskeleton formation. In the future, quantitative analysis of the actin 
loaded GUVs in terms of viscoelasticity and tension can be studied to generate more detailed 
knowledge of the interplay between actin fibers and the polymer membrane. The combination of the 
three main cytoskeletal components (actin filaments, microtubules and intermediate filaments) within 
the GUVs would be another interesting to study with respect to morphology of the synthetic systems.  
As a first proof of concept, we showed how we could differentiate the influence of cross-membrane 
diffusion of different actin polymerization inhibitors. Future research will aim at using less potent 
reducing agents (e.g. GSH), which will require insertion of additional membrane proteins to 
permeabilize the polymeric membrane for such molecules.14c, 81 The lack of control over the size 
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distribution of multicompartments will be improved with the adoption of a microfluidic-based assembly 
approach.82 
Our developed strategy for cell-like materials has the advantages a very simple preparation method, 
high versatility and a straightforward manner to induce auto-controlled sequences of 
reactions/changes inside microcompartments and, for the first time, we showed how such a versatile 
cell mimic could be used as a drug screening platform. 
 
4 Orthogonal interaction with cells 3 
For this topic, we decided to refer to enzyme-loaded polymersomes, usually referred as nanoreactors, 
as catalytic nanocompartments (CNC), a more general term that highlights one of their defining 
features, the segregation of the catalytic unit from the bulk. Before our work, cascade reactions 
reported within nanocompartments mainly involved encapsulation of one type of enzyme and 
providing the second enzyme in the surrounding medium. 83 However, if one partner of the cascade 
reaction is free in solution it might be degraded, resulting in a decrease -or even termination- of the 
overall reaction. Co-encapsulating enzymes within the same nanocompartment solves this issue, but 
only a low co-encapsulation efficiency was obtained due to the stochastic process of formation of multi-
enzyme-loaded polymersomes. 84 A higher encapsulation efficiency of different enzymes can be 
achieved by linking the two enzymes together prior to encapsulation or the formation of compartments 
within compartments where small compartments and free enzymes are encapsulated inside 
micrometer-size compartments.62, 85 Both binding the enzymes in one complex and the approach of 
compartments within compartments, which often uses organic solvents and emulsions, have the 
disadvantage of affecting the catalytic activity of the enzymes thus decreasing the efficiency or blocking 
the reaction. One approach, which allows for modularity while preserving the protection of the 
enzymes involved in the cascade reaction is to design catalytic compartments working in tandem. 84 
                                                     
3 PARTS OF THIS CHAPTER HAVE BEEN PUBLISHED AND ADAPTED WITH PERMISSION FROM: 
Belluati Andrea, Craciun Ioana, Liu Juan, Palivan Cornelia G. Nanoscale enzymatic compartments in tandem support 
cascade reactions in vitro. Biomacromolecules. 2018. 
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However, there are only very few examples of tandem of (CNC) 25a, 86 and, up to this point, none had 
been evaluated in physiologically relevant environment or in vitro. In addition, the kinetics of the 
cascade reactions in separate compartments and the molecular factors affecting them were not 
investigated to determine whether such catalytic compartments still function in a more complex 
medium than buffers or to propose a therapeutically relevant solution. We used an amphiphilic block 
copolymer poly(2-methyloxazoline)-block-poly(dimethylsiloxane)-block-poly(2-methyloxazoline) 
(PMOXA6PDMS44PMOXA6) for the formation of the nanocompartments 87, and their membrane was 
rendered permeable by insertion of the bacterial porin Outer membrane protein F (OmpF). 88 Thanks 
to this setup, we could study the concept of a two-step, two-compartment cascade reaction as an 
orthogonal, non-native cascade to detoxify uric acid. 
4.1 Bioactivity of a non-native cascade: UOX-HRP cascade 
4.1.1  Introduction 
For this work, we selected as enzymes for the cascade reaction uricase (UOX) and horseradish 
peroxidase (HRP), which uses H2O2 resulting from the UOX reaction as the substrate to initiate the 
second reaction (Figure 23). 89 This orthogonal combination of enzymes serves to simultaneously 
decrease the concentration of uric acid, and of H2O2, resulting in a possible dual therapeutic approach. 
First we were interested to understand the molecular factors supporting the cascade reaction between 
separate compartments such to optimize their overall function. Next, we investigated their ability to 
function at increasing distances to mimic intra- and intercellular bio-distances as well as in human 
serum prior to applying them to decrease uric acid and H2O2 from the cellular milieu to explore their 
therapeutic application. 
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Figure 23 Schematic representation of catalytic nanocompartments working in tandem, and detailed cascade reaction mediated by a 
combination of uricase (UOX) and horseradish peroxidase (HRP). The oxidation of uric acid results in formation of 5-hydroxyisourate and 
hydrogen peroxide. The later serves as substrate for HRP reaction in the presence of co-substrate Amplex Red, AR. The final product, 
resorufin, can be monitored by fluorescence spectroscopy. 
 
 
4.1.2 Physical characterization of CNCs  
We encapsulated UOX and HRP inside the supramolecular assemblies formed during the self-assembly 
process of the copolymer by using film rehydration method due to its mild conditions, which does not 
affect the biomolecules 35g, 84. The architecture of the supramolecular assemblies in presence and 
absence of enzymes was established by a combination of light scattering and transmission electron 
microscopy. We used static light scattering to obtain the radius of gyration Rg, and dynamic light 
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scattering for the hydrodynamic radius, Rh because the ratio of these values Rg/Rh, called ρ-factor, is 
indicative of the different architectures, e.g. 1 for hollow spheres while 0.77 for solid spheres 90. In the 
case of empty supramolecular assemblies, Rg and Rh values were 70 nm and 84 nm respectively, and 
the calculated ρ-factor of 0.96 indicates hollow sphere architecture, thus formation of polymersomes. 
In the presence of UOX (UOX-CNC), we determined for the supramolecular assemblies Rg of 68 nm and 
Rh of 73 nm (ρ = 0.95), while in the presence of HRP (HRP-CNC) they had Rg of 74 nm and Rh 85 nm (ρ = 
0.87) (Figure 24).  
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Figure 24 Zimm fits (from SLS) of A: empty polymersomes. B: UOX-CNC. C: HRP-CNC. The Zimm plot, obtained from SLS data, is built from 
a double extrapolation to 0 concentration and 0 angle from different measured angles and coefficients. 
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In both cases, the enzymes did not affect the self-assembly process and the resulting polymersome 
architecture, in agreement with the TEM micrographs, which show now remarkable differences in 
presence of UOX, HRP or OmpF, with small aggregates that could be seen regardless of the content, 
due to the sample preparation under vacuum. (Figure 25, Figure 26, Figure 27, Figure 28 A,C).  
 
Figure 25 TEM micrographs of UOX-CNCs. Scale bar 1000 nm (A, B) and 500 nm (C, D). 
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Figure 26 TEM micrographs of HRP-CNCs. Scale bar 1000 nm (A, C) and 500 nm (B, D).  
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Figure 27 TEM micrographs of UOX-CNCs OmpF-less (A) and HRP-CNCs OmpF-less (B). The spherical shape is maintained regardless of the 
insertion of OmpF in the membrane. Scale bar 500 nm. 
 
 
In order to quantify the amount of encapsulated enzymes inside the nanocompartments we used a 
combination of brightness measurements in fluorescence correlation spectroscopy (FCS), and 
bicinchonic acid assay (BCA). Fluorescence auto-correlation spectroscopy (FCS) measures the 
fluorescence fluctuations due to the Brownian motion of fluorescent species in a fL-sized volume, 
yielding molecular parameters, such as diffusion time and the number of particles that can be used to 
evaluate interactions/encapsulations of the fluorescent dyes with/into supramolecular assemblies91. 
By labelling the vesicle membrane with BODIPY 630/650, and using a 2-component fit (fixing the 
diffusion time of free dye as one of the components) we obtained their average diffusion time (D 5000 
µs for both CNCs, compared to D = 57 µs of the free dye) and overall number of fluorescent vesicles in 
solution. The fraction of dye-polymersomes was 99% for UOX-CNC and 94% for HRP-CNC (2.6×1011 and 
3.9×1011 polymersomes × µL-1, respectively), while that of the free dye, of 1 and 4% indicated that the 
great majority of the dye partitioned into the polymersome membrane. The confocal volume of 1 fL, 
was obtained by a calibration with free BODIPY (Figure 28B and D).  
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Figure 28 Formation of UOX-CNCs and HRP-CNCs. TEM micrograph of UOX-CNCs (A) (scale bar: 200 nm). B: normalized FCS autocorrelation 
curve of the dyed UOX-CNC (dots: normalized raw data; solid line: fitted data, black line: free BODIPY 630/650). TEM micrograph of HRP-
CNCs (C) (scale bar: 200 nm). (D): normalized FCS autocorrelation curve of the dyed HRP-CNC (dots: normalized raw data; solid line: fitted 
data, black line: free BODIPY). 
 
A total protein concentration of 30 µgmL-1 for UOX and 18.6 µgmL-1 for HRP, respectively, was obtained 
by bicinchonic acid assay (BCA) (Figure 29).  
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Figure 29. Calibration curves for BCA assay, using UOX (A) and HRP (B) standards instead of BSA. 
 
Dividing the protein concentration by the number of polymersomes obtained by brightness 
measurements, we determined an average of 117 enzymes in UOX-CNCs and 62 enzymes in HRP-
CNCs. An encapsulation efficiency of 3612 % for UOX and 224% for HRP inside CNCs was obtained, 
in agreement with the encapsulation efficiency values obtained for other enzymes inside 
polymersomes. 35g, 84 
 
 
4.1.3 Influence of encapsulation on kinetics 
Having determined the amounts of encapsulated enzymes, we used the same concentrations in bulk to 
evaluate the efficiency of the cascade reaction. The cascade reaction takes place when the enzymes are 
free or encapsulated in separate nanocompartments equipped with OmpF (Figure 30A). On the 
contrary, the reaction cannot proceed when the membrane of the nanocompartments is not equipped 
with OmpF to allow molecular passage through (Figure 30B) or when one of the enzymes or substrates 
is removed from the cascade (Figure 30C). 
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Figure 30 Cascade reaction with different setups. A: Enzyme kinetics when both enzymes are free (red), only HRP is free (light green), only 
UOX is free (dark green) and both UOX and HRP are encapsulated inside polymersomes (blue). B: Cascade with permeabilized CNCs (blue), 
unpermeabilized UOX-loaded polymersomes (olive), unpermeabilized HRP-loaded polymersomes (black). C: Cascade reaction with both 
CNCs and the corresponding substrates (blue), and in the absence of one of the reaction compounds: HRP (orange), UOX (brown), AR 
(grey), and uric acid (purple). Error bars are given as mean ± SD (n = 3), in some cases bars are smaller than the corresponding dot. 
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As expected, the cascade reaction between separate nanocompartments is significantly slower than 
that of the free enzymes. We were interested in establishing the effect of the molecular diffusion 
through OmpF of substrates and products, the probability that the product of the first reaction 
penetrates in a second CNC containing the HRP and the distance between different CNCs on each step 
of the reaction and on its overall efficiency. The conversion of Amplex Ultra Red (AR) to resorufin (AR 
conversion) was used as a comparison standard, because it represents the last step of the cascade 
reaction and therefore accounts whether the whole cascade reaction takes place. First, we studied the 
influence of molecular diffusion through OmpF as a key factor, which might limit the in situ enzymatic 
reaction inside CNCs. Having one of the enzymes free in solution and the second one encapsulated in 
the CNCs, AR conversion decreased compared with that of free enzymes. When HRP was surrounding 
UOX-CNCs, a slight decrease in AR conversion to 92% was observed, while when free UOX was free 
around HRP-CNCs a significant decrease of AR conversion to 13% was obtained (Figure 3). When both 
enzymes were inside CNCs working in tandem, AR conversion value decreased significantly, to 3% after 
15 minutes. As H2O2 is known to rapidly diffuse through OmpF and it passes through the same barriers 
(membrane and inter-vesicle space) regardless of which enzyme is inside the CNCs, its effect is only 
minor and is due to its probability to interact with HRP. When only UOX is inside CNCs, the slight 
decrease in AR conversion is due to an inhomogeneous distribution of UOX, as source of H2O2, only 
inside the nanocompartments. When HRP is inside CNCs, the higher decrease of AR conversion is 
related to the slow diffusion of AR through OmpF pores, which represents the bottleneck for the 
cascade reaction for CNCs in tandem, as well (Figure 31).   
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Figure 31 Conversion of AR to resorufin by a cascade enzymatic reaction when: both enzymes are encapsulated (blue), both enzymes are 
free (red), only UOX is encapsulated (UOX-CNCs) and HRP is free (green), and only HRP is encapsulated (HRP-CNCs) and UOx is free 
(yellow). Error bars are given as mean ± SD (n = 3). 
 
In the case of CNCs in tandem another factor inducing the decrease of in the overall reaction efficiency 
is the inhomogeneous enzyme distribution when encapsulated inside polymersomes, which decreases 
the probability that the substrates of the second reaction reach the HRP-CNCs and support the second 
step of the cascade reaction. Besides, the necessity of H2O2 transfer from UOX- CNCs to HRP-CNCs is 
proven by introducing free catalase to the reaction mixture, as a competing enzyme that converts H2O2 
to water and oxygen: when added, catalase strongly hinders the reaction (Figure 32).  
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Figure 32 A: interruption of cascade reaction by catalase, removing hydrogen peroxide. B: relative activity of UOX (green) and HRP 
(magenta) at their respective pH optima (set as 100%).  C: residual activity from unspecific binding on the vesicles’ outer surface: enzymes 
were added to unpermeabilized vesicles, which were then purified and their activity tested. D: activity of nanocompartments (blue) and 
free enzymes (red) after incubation at 75 °C: the nanocompartment activity is apparently much higher than after milder incubations. Error 
bars are given as mean ± SD (n = 3). 
 
 
4.1.4 Kinetic parameters of encapsulated enzymes 
It is already known that encapsulation in polymersomes affects the kinetic parameters of enzymes, by 
increasing their affinity for the substrates or decreasing the velocity, because they are in a different 
environment than in bulk solution 35g. To fully characterize the behavior of CNCs in tandem, we 
compared the kinetic parameters of CNCs when isolated and in cascade by using the Michaelis-Menten 
model. (Figure 33, Table 3, Table 4).  
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Figure 33 Michaelis-Menten kinetics for UOX, UOX + HRP (2x), UOX-CNC, HRP, HRP-CNC and UOX-CNC + HRP CNC. In some cases, error 
bars are smaller than the dots on the graphs. (n = 3) 
Both steps of the cascade reaction can be modelled in a first approximation by using Michaelis-Menten 
kinetics because for the first step (UOX-CNCs) uric acid is added in excess, and for the second step both 
substrates are in excess in the surroundings of HRP-CNCs (AR added in the medium, and H2O2 generated 
by UOX-CNCs with Vmax of 1.47x10-3 M/min, which is one order of magnitude higher than Vmax of HRP, 
as presented in Table 1 and 2). 
KM, the Michaelis-Menten constant, defines the affinity of the enzyme for the substrate, and the 
apparent Vmax represents the maximal velocity at which the enzyme operates once it is saturated by 
the substrate (when they are encapsulated inside CNCs). As both KM and Vmax are intrinsic enzymes 
characteristics in specific conditions, it is expected that these parameters are not affected by the 
enzyme encapsulation (if the substrate/products diffusion is not changing due to possible barriers). 
However, we observe a completely different situation: both KM and Vmax are affected by enzyme 
encapsulation (Table 1 and 2). 
The apparent KM of both enzymes is lowered once confined into a nanocompartment, 4-times for UOX-
CNC and 1.5 times for HRP-CNC. This is not surprising, as the hollow cavity of a polymersome offers a 
more confined space, increasing the probability of the substrate to access the catalytic center of the 
enzyme35g. In addition, there is a decrease in Vmax and kcat values. The decrease of both Vmax and kcat is 
significant in the case when UOX is encapsulated in CNCs (both for free HRP and for HRP-CNCs) (Table 
3). On contrary, when HRP is encapsulated (free UOX and UOX-CNCs) the decrease of Vmax and kcat values 
is significantly smaller (Table 4). We assume the change of kcat values to be associated to a slower influx 
of the substrates to the enzyme’s active site, a slower efflux of the products or a combination thereof 
when the enzymes are inside CNCs (due to various barriers associated with the polymersomes 
architecture). Besides, the inhomogeneous spatial distribution of enzymes when one enzyme or both 
are inside CNCs is affecting the accessibility of each enzyme by its corresponding substrates. 
Similarly, kcat /KM values are decreased when the enzymes are inside the CNCs. While the substrate can 
easily encounter the enzyme once inside the compartment, the permeation through the membrane 
that is mediated by OmpF pores effectively hinders the total activity of the cascade. The effect of 
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diffusion to the enzyme is a well-known parameter affecting and altering enzyme kinetics, as it can 
become the actual limiting factor in their efficiency. 92 
 
Table 3 Apparent kinetic parameters for UOX: Michaelis-Menten constant (KM), maximal enzyme velocity (Vmax ), turnover rate (kcat) and catalytic 
efficiency (kcat/ KM ). 
 UOX UOX in cascade UOX-CNC 
UOX-CNC in 
cascade 
KM (µM) 3.70×102 3.68×102 8.32×101 9.09×101 
Vmax (µM/min) 2.47×10-1 2.77×10-1 1.22×10-4 1.47×10-3 
kcat   (1/s) 2.72 2.55 1.34×10-3 2.00×10-3 
 
kcat  /KM (1/(M s)) 7.30×10-3 
 
7.52×10-3 1.60×10-5 2.20×10-5 
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We exclude that the decrease in enzyme activity inside the CNCs is due to the confinement of enzymes: 
encapsulated UOX (molecular radius 4.27 nm 93) and HRP (molecular radius 2.98 nm 94) move 
completely free in a 1000-fold and 12000-fold greater volume, respectively. We calculated the inner 
volume of polymersomes by assuming a membrane thickness of 10.7 nm (measured for a PMOXA6-
PDMS44-PMOXA6 compartments of the same block length). 95  
4.1.5 Effect of encapsulation of enzyme stability 
In a similar manner as is the case for liposomes, the polymeric membrane of nanocompartments is 
expected to offers protection of the encapsulated payload from external agents that would degrade it, 
as for example proteolytic attack 96. We were interested to establish the protective role of the 
nanocompartments in the presence of physical factors (high temperatures and different pH values) and 
degrading agents (Guanidine Hydrochloride (GdnHCl), Proteinase K). We quantified the “activity 
retention” as the ratio between the production of resorufin under standard conditions (RT, pH 7) and 
in the presence of degrading conditions.  
While below 37°C both encapsulated and free enzymes preserve their activity, for higher temperature, 
a decrease in activity is observed, but to a significantly higher degree for the free enzymes (Figure 34, 
Table 4 Apparent kinetic parameters for UOX: Michaelis-Menten constant (KM), maximal enzyme velocity (Vmax ), turnover rate (kcat) and 
catalytic efficiency (kcat/ KM ).  
 HRP HRP in cascade HRP-CNC 
HRP-CNC in 
cascade 
KM (µM) 3.50×10 3.0×10 2.22×10 1.92×10 
Vmax (µM/min) 7.82×10-4 8.19×10-4 4.21×10-5 1.32×10-4 
kcat   (1/s) 1.14×10-2 1.12×10-2 1.94×10-3 6.19×10-3 
 
kcat  /KM (1/M/s) 4.10×10-4 
 
4×10-4 2.80×10-4 3.22×10-4 
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Figure 35 A). The ability of the polymeric membrane to protect the encapsulated payload from the 
effect of higher temperatures, which denatures the enzymes, is essential for translational applications.  
 
Figure 34 TEM micrographs of a mixture of UOX-CNCs and HRP-CNCs after 30 minutes of incubation at 60 °C (A, B) and 75 °C (C, D). Broken 
vesicles and non-vesicular structures can be seen after the incubation at higher temperature, which could possibly lead to a partial release 
of the enzymes. Scale bar: 500 nm (A, C) and 200 nm (B, D). 
 
The effect of pH was less straight forward, as these two enzymes have different pH optima: basic for 
UOX and acidic for HRP. 97 While at pH 3 there is no apparent gain in activity from the enzyme 
encapsulation, at pH 9 the CNCs are significantly more active than the free enzymes acting in tandem. 
This increase in activity might be due to optimum pH 9 conditions for the first enzyme, UOX, involved 
in the cascade reaction (Figure 35B). However, we chose a neutral pH to evaluate the CNCs in tandem 
to be closer to physiological conditions, at which both enzymes are still active (Figure 32A), and where 
both the free enzymes and encapsulated ones have similar activity retention values. 
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To mimic a proteolytic attack, we added Proteinase K both to free enzymes and to CNCs for 2 hours. 
While a significant decrease in activity retention was observed for the free enzymes (18%1), in the 
case of CNCs the decrease was considerably smaller(83%3), additionally showing that a small fraction 
of enzyme molecules was adsorbed at the outer interface of the polymersome 98 (Figure 32C). The 
addition of a chemical agent inducing denaturation of enzymes, such as GdnHCl induced a decrease in 
the enzymes activity, which is significantly more pronounced when the enzymes are free, clearly 
indicating the protective role of compartmentalization (Figure 35D). The decrease of the activity 
retention value in the case of CNCs in tandem is due to the probable diffusion of GdnHCl (95 Da) through 
OmpF, which has a weight cut-off of 650 Da. 99  
 
Figure 35 Stability of catalytic nanocompartments and free enzymes (activity normalized against CNCs (blue) or enzymes (red) at RT, 
neutral pH, no agents). A: protection from heat. B: protection from extreme pH. C: protection from denaturing agent GdnHCl. D: 
protection from proteolysis. Error bars are given as mean ± SD (multiple t - test, * p < 0.05, ** p < 0.01, *** p < 0.001, n = 3). 
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 It was not possible to determine the amount of enzyme adsorbed or how adsorption affected its 
activity. Therefore, we considered the overall activity of the CNCs as a whole; however, by adding free 
enzyme to empty vesicles and then purifying them, it was possible to detect a certain amount of activity 
due to unspecific binding in the cascade for HRP, estimated to be around 3% of the total (Table 5). The 
auto-oxidation of AR was also taken into account, and subtracted in all blanks. 
 
Table 5 the activity of HRP (arbitrary fluorescence units) unspecifically adsorbed to the outer polymersome surface is 
comparable to that obtained from free HRP at 10 ng mL-1, meaning that only around 3% of the signal (used concentration: 
300 ng mL-1) derives from external HRP. 
HRP setup a.u. (595 nm) 
HRP adsorbed to polymersomes 19.5 ± 0.4 
Free HRP 10 ng mL-1 18 ± 1 
 
4.1.6 Influence of distance on reaction efficiency 
The passage through barriers and diffusion between compartments represents an essential point in 
bio-communication because products have, in some cases, to travel to different cellular compartments 
or take part in inter-cellular communication. Most organelle-to-organelle communications in the cell 
happen via close association below 50 nm 100 and the average synaptic cleft is around 20 nm 101, 
whereas it is estimated that a single cell can effectively communicate between 5 and 10 μm in autocrine 
signaling and up to 250 μm in paracrine signaling. 102 In such cases of communication between 
organelles or cells, there is no longer a homogeneous distribution of enzymes or receptors but local 
high concentrations and otherwise empty or low density interstices. We used our CNCs in tandem to 
mimic communication between bio-assemblies and see the effect of distance on the overall cascade 
reaction efficiency. We assumed a cubic volume for the compartments, so that the mean inter-
compartment distance is calculated, based on the polymersome density obtained by FCS.  
The AR conversion values in the case of CNCs in tandem remains almost constant (with some values 
higher than 100% as values fluctuate around the mean obtained at 0.8 µm, set as reference) until the 
mean distance between CNCs is 1.29 μm, then the values decrease significantly. This suggests that the 
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diffusion of molecules through the OmpF pores represents the dominant factor for distances lower than 
approx. 1.30 μm. Interestingly, the ratio between the mean compartments distance and their diameter 
is about 10, which has the same order of magnitude as the ratio between a mean cell-cell 
communication distance and a cell diameter for 1 μm, such as bacteria103. For distances between CNCs 
higher than 1.3 mm, the cascade reaction is rapidly hindered due to a decrease of the probability that 
H2O2 encounters a HRP-CNC (Figure 5). These distances are consistent with distances typical of 
autocrine signaling. Therefore, our findings based on the simple CNCs in tandem provide the behavior 
of such confined space reactions in relevant bio-conditions. 
 
Figure 36 Cascade activity at different mean intervesicle distances. Error bars are given as mean ± SD (n = 3).  
4.1.7 The therapeutic potential of CNCs in a cascade 
We then evaluated the functionality of the CNCs tandem in biological conditions, both in biofluids and 
upon incubation with cells, as more apropriate to advance translational applications. First, we used 
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human blood serum where uric acid was dissolved to reach levels similar to those considered typical 
for hyperucemia (>6.8 mgdL-1 in men). A simple model, defined as 
∆𝐴𝑏𝑠290𝑒𝑛𝑧𝑦𝑚𝑎𝑡𝑖𝑐
∆𝐴𝑏𝑠290𝑠𝑒𝑟𝑢𝑚 
 
Equation 2 
for the dilutions of HRP-CNCs gives the relative efficiency of the cascade reaction, which we called 
Relative Urate Degradation (R.U.D.) (Figure 37A). Interestingly, in such a complex medium, CNCs induce 
the clearance of uric acid as fast as the free enzyme. In human serum, as a physiological medium CNCs 
lost most of the disadvantage against free enzymes they had in buffer. Further studies, beyond the 
scope of the present one, are necessary to understand the bio-molecular factors affecting the efficiency 
of the overall cascade reaction between CNCs in human serum.  
Secondly, we determined the ability of the CNCs to metabolize uric acid and degrade H2O2 upon 
incubation with cells, as an essential step towards medical applications. Prior, we evaluated the 
cytotoxicity of CNCs when incubated with HEK293T cells overnight in different concentrations of the 
CNCs (measured in polymer concentration) by MTS assay. CNCs have no cytotoxic effect on the cells, 
even at the highest polymer concentration (0.19 µgmL-1) (Figure 37B). Next, CNCs were incubated with 
HEK293T epithelial cells for 24 h in the presence of increasing amounts of uric acid (250 and 350 µM): 
at physiological concentration and at the lower end of hyperuricemia values. Cell viability decreased to 
around 60% in the presence of 250 µM uric acid. By addition of either free enzymes or the CNCs, the 
cell viability was unaffected by the presence of uric acid. An increase in the amount of uric acid to 350 
µM reduces the viability of the cells to 2%, while the cascade reaction of the free enzymes and of CNCs 
in tandem induce a protective effect against uric acid. In addition, due to the combination of enzymes, 
H2O2 as well is degraded thanks to the succesful cascade reaction process (Figure 37C and D).  
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Figure 37 Activity of CNCs and free enzymes in blood serum and their interaction with cells. A: clearance of urate with both CNCs (solid 
blue), UOX-CNC only (striped blue, no HRP-CNC), both free enzymes (solid red) and UOX only (striped red, no HRP-CNC) B: cell viability of 
HEK293T cells incubated with CNCs at different concentrations (expressed as polymer concentration). C: scheme of the CNC-cell interaction 
and detoxifying activity of the UOX-HRP cascade on cells only (green), cells with free enzymes (blue) and cells with CNCs (red). Error bars 
are given as mean ± SD (multiple t - test, * p < 0.05, ** p < 0.01, *** p < 0.001, n = 3). 
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5 Integration of CNCs into cell metabolism4 
Current pharmacological research aims to replace whole cellular pathways that are damaged or 
missing, and disciplines such as tissue engineering and synthetic biology often need metabolome-
spanning agents 104. These extensive modifications are usually achieved via genetic engineering, but 
when the need for transient modifications of cell behavior arises (e.g. cell differentiation, gene 
induction) this could be obtained via the in situ production of natural messenger molecules with known 
physiological effects. 
A possible tool in enzyme supplementation or even cell engineering that can be used to correct 
aberrant signaling pathways, is the use of specialized reactive compartments, as the spatiotemporal 
compartmentalization of reactions allows a more precise kinetic regulation,2 creating specialized 
environments and protecting them from the exterior.37a This concept has already been applied in 
nanotechnology where enzymes are entrapped into nano-sized objects such as protein cages, or 
lipid/polymer based compartments.105 Polymer compartments with nanometer sizes, called 
polymersomes are particularly appealing to host in situ enzymatic reactions, as their membrane is 
more stable than that of liposomes and can be functionalized with different moieties to support 
targeting or immobilization on surfaces, while, if appropriately selected,  retaining biocompatibility.13, 
38, 84 When loaded with enzymes and rendered permeable for substrates/products, polymersomes 
serve as efficient catalytic nanocompartments (CNCs) with a broad range of applications depending 
on the encapsulated enzyme.38  
                                                     
4 PARTS OF THIS CHAPTER HAVE BEEN ADAPTED FROM THE MANUSCRIPT: 
Belluati Andrea, Craciun Ioana, Palivan Cornelia G. Bioactive catalytic nanocompartments integrated into cell physiology 
and their amplification of cGMP signalling cascade. 2020 Under Revision. 
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5.1 The case of iNOS-sGC 
 
5.1.1 Introduction 
An example of an enzymatic with wide-spanning effects is the cascade reaction mediated by nitric oxide 
synthase (NOS) and guanylyl cyclase (GC). A fine-tuned NOS-GC cascade is essential for cell signaling. 
The malfunction of one or both of the enzymes has a drastic effect on the homeostasis of living 
organisms but also influences the growth and differentiation behavior of cells.106 Nitric oxide synthases 
(NOS; inducible, endothelial and neuronal) are a family of enzymes that oxidize L-arginine to L-citrulline, 
producing nitric oxide, which readily diffuses through membranes and plays a role in smooth-muscle 
relaxation, regulation of apoptosis, ion channel activity, mitochondrial function and immune 
response.107 While the -calcium-independent- inducible NOS (iNOS) is usually not linked to receptor-
dependent processes, as it is expressed by macrophages to produce locally high concentrations of the 
radical NO to kill pathogens and other cells, it is still involved in inflammatory vasodilation and other 
non-toxigenic pathways.108 Deficiencies in the neuronal and endothelial NOS (nNOS and eNOS, 
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respectively) are linked to muscular dystrophy and nephropathy109; iNOS has recently been suggested 
to be involved in compensating eNOS malfunctioning, with cardioprotective effects.110 
Guanylyl cyclases (GC) are widely distributed signal-transduction enzymes that, in response to various 
cellular stimuli, convert GTP into the second messenger cyclic 3,5-guanosine monophosphate (cGMP) 
and pyrophosphate (PPi). Binding of NO to the heme moiety of the soluble guanylyl cyclase (sGC) 
induces the transition from basal to activated sGC. Activated sGC quickly converts guanosine-5’-
triphosphate (GTP) to cGMP and pyrophosphate (PPi). cGMP acts as a ubiquitous second messenger in 
a variety of processes, through intracellular signaling cascades, regulating the activity of a number of 
downstream proteins, including cGMP-dependent protein kinase G (PKG), cGMP-dependent 
phosphodiesterases (PDE) and cyclic nucleotide-gated ion channels (CNP). These pathways are 
involved, for example, in smooth muscle relaxation and vasodilation or immunomodulation 111 in 
regulating cell growth initiation and differentiation106b, cholinergic neurotransmission 112 and well as in 
photo-transduction in the vertebrate retina 113 Aberrant cGMP signaling as a result of mutations in 
soluble GCs has been associated with a number of diseases, such as retinal dystrophies 
(Leber's`congenital amaurosis, dominant cone-rod dystrophy, cone dystrophy and central areolar 
choroidal dystrophy).111  
A possible tool in enzyme delivery, or even cell engineering, is the use of specialized reactive 
compartments, as the spatiotemporal compartmentalization of reactions is a fundamental aspect of 
cellular biology, allowing a more precise kinetic regulation 2, creating specialized environments and 
protecting them from the exterior.37a This concept has already been applied to nanotechnology, 
entrapping enzymes into nano-sized objects such as protein cages, or lipid/polymer based 
compartments.105 Polymersomes are particularly appealing to host in situ enzymatic reactions, as their 
membrane is more stable than that of liposomes and can be functionalized with different moieties to 
support targeting or immobilization on surfaces, while retaining biocompatibility.13, 38, 84 When loaded 
with enzymes, and rendered permeable for substrates/products, polymersomes serve as efficient 
catalytic nanocompartments based on the enzymatic reactions taking place inside.38 Beyond single-
enzyme catalytic nanocompartments (CNC), cascade reactions represent one step further in increasing 
the number of biotransformations and inducing multifunctionality within the same system. Such 
enzymatic cascades can be performed by co-encapsulated enzymes 24, 27, 39, but the co-encapsulation in 
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nanometric compartments of multiple enzymes is hindered by the low co-encapsulation efficiency.23b 
A way to solve this problem was achieved by encapsulating the enzymes in separated CNCs 41, 114 as 
demonstrated in Chapter 4.1.  
Here we developed a system of two catalytic nanocompartments of biological relevance, and show that 
it can act on cell signaling pathways, effectively integrating its functionality into native cell metabolism 
and physiology, instead of operating orthogonally on cells, with no cell communication. To achieve this, 
we chose an enzymatic cascade mediated by inducible nitric oxide synthase (iNOS) and soluble guanylyl 
cyclase (sGC) and encapsulated them into polymersomes whose membrane was equipped with a 
channel porin allowing a molecular flow through. A fine-tuned NOS-GC cascade reaction is essential for 
cell signaling. The malfunction of one or both of the enzymes has a drastic effect on the homeostasis of 
living organisms but also influences the growth and differentiation behavior of cells.106 Nitric oxide 
synthases (NOS; inducible, endothelial and neuronal) are a family of enzymes that oxidize L-arginine to 
L-citrulline, producing nitric oxide, which readily diffuses through membranes and plays a role in 
smooth-muscle relaxation, regulation of apoptosis, ion channel activity, mitochondrial function and 
immune response.107 The -calcium-independent- inducible NOS (iNOS), while usually associated to 
macrophage response, it is still involved in inflammatory vasodilation and other non-toxigenic 
pathways.108 Deficiencies in the neuronal and endothelial NOS are linked to muscular dystrophy and 
nephropathy109; iNOS has recently been suggested to be involved in compensating eNOS 
malfunctioning.110 
Soluble Guanylyl cyclases (sGC) is a signal transduction enzyme that, in response to various cellular 
stimuli, converts GTP into the second messenger cyclic 3,5-guanosine monophosphate (cGMP) and 
pyrophosphate (PPi), after the activation provided by the binding of NO. cGMP acts as a ubiquitous 
second messenger in a variety of processes, through intracellular signaling cascades, regulating the 
activity of a number of downstream proteins. These pathways are involved, for example, in smooth 
muscle relaxation and vasodilation or immunomodulation 111, cell growth initiation and differentiation 
106b, cholinergic neurotransmission 112 and in photo-transduction in the vertebrate retina.113 Aberrant 
cGMP signaling as a result of mutations in soluble GCs has been associated with a number of diseases, 
such as retinal dystrophies. 111 
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As such cascade is already present in cells, our CNCs could be the first metabolism-enhancing cascade 
derived from nano-sized compartments. The unique advantage of our binary CNC system derives from 
their ability of inducing changes in cell homeostasis without the addition of any other compound, only 
using the arginine and GTP naturally present in the cell or in the culture medium 115 The great 
importance of this enzymatic cascade prompted us to investigate whether the enzymes were 
encapsulated into CNCs composed of a PMOXA-PDMS-PMOXA membrane, to be protected from the 
external environment and be delivered to cells.23b, 116  We then characterized the assembled iNOS-CNCs 
and sGC-CNCs both physically (light scattering, electron microscopy, fluorescence microscopy, 
nanoparticle tracking) and functionally (fluorometric assays). We studied their biological activity on 
HeLa and smooth muscle C2C12 cells, using the intracellular concentration of calcium as a functionality 
assay to demonstrate whether the cascade could work in the culture medium in physiological 
conditions and elicit cellular responses. 
5.1.2 Physical characterization of CNCs 
Encapsulation of iNOS and sGC into individual CNCs 
We encapsulated the two enzymes into biocompatible PMOXA6-PDMS44-PMOXA6 polymeric 
assemblies via film rehydration.48, 117 This technique consists of  vacuum drying the block copolymer 
to obtain a film, then adding the rehydration buffer containing the molecules  of interest. Continuous 
stirring helps  the swelling of the copolymer film leading to self-assembly and formation of 
structures entrapping the solutes (Figure 38).  
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Figure 38 A: fabrication workflow of the CNCs. B: table of Rg, Rh and vesicle concentration for the CNCs with and without proteins (enzymes 
and OmpF). C: TEM micrograph of empty polymersomes. D: TEM micrograph of iNOS-CNC E: TEM micrograph of sGC-CNC. Scalebar for 
TEM micrographs: 200 nm. 
 
The PMOXA6-PDMS44-PMOXA6 block copolymer used in this study self-assembled into 
supramolecular structures with a radius of gyration Rg = 102 nm and radius of hydration Rh = 
103 ± 8; the Rh/Rg ratio (ρ-factor), being close to 1, meant that we obtained hollow vesicles, i.e. 
polymersomes (Figure 38B).118 Upon permeabilization of the membrane with OmpF and 
encapsulation of iNOS, the radii and spherical morphology of the CNC did not change (iNOS-
CNC, Rg =102 nm and Rh = 104 ± 9 nm, ρ-factor 0.99). Also, in the case of sGC-CNC upon 
permeabilization and enzyme encapsulation no changes in the compartments was observed 
(sGC-CNC, Rg = 104 nm and Rh = 101 ± 6 nm, ρ-factor 1.03), indicating the polymeric vesicular 
structures are unaffected by the presence of proteins either in the lumen or within the 
membrane.  
For an efficient tandem CNC reaction it is imperative to have a balance between the amounts 
of each compartment.  Using nanoparticle tracking analysis (NTA) we ensured that there was 
no significant difference in polymersome concentration between the two CNCs. Empty 
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polymersomes had a concentration 1.35 × 1012 ± 7.85 × 1010 vesicles mL-1, while iNOS-CNCs had 
a concentration of 1.72 × 1012 ± 4.27 × 1010 vesicles mL-1 and sGC-CNC a concentration of 1.82 × 
1012 ± 8.53 × 1010 vesicles mL-1 (Figure 38B).  
Using this method we could also reconfirm the radii, with Rh of 95.5 ± 19 nm for empty 
polymersomes, 94.95 ± 19 nm for iNOS-CNC and 95.85 ± 17 nm for sGC-CNC(Figure 39). The 
morphology of iNOS or sGC containing self-assembled nanostructures was observed by TEM, 
showing spherical shapes with the deflated membrane typical of polymersomes under vacuum 
(Figure 38C-E).  
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Figure 39 Size vs vesicle concentration (obtained by NTA) for empty vesicles, iNOS-CNC and sGC-CNC, showing the remarkably narrow 
size dispersivity. 
 
Having determined the concentration of each CNC, next we calculated the encapsulation 
efficiency as the amount of enzyme encapsulated per compartment. To achieve this, we 
fluorescently labelled each enzyme. iNOS was labeled with an average of 1 ± 0.3 ATTO488 dye 
molecules per enzyme while sGC was labeled with an average of 2 ± 0.9 DyLight633 dye 
molecules per enzymes. Having successfully labeled the enzymes we proceeded to measure 
fluorescence correlation spectroscopy (FCS) of labelled enzymes and of enzyme-loaded vesicles. 
This technique allows us to measure differences in diffusion times of fluorescent molecules and 
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correlate it to the hydrodynamic radius of the molecule/supramolecular structure. The shift to 
the right of the autocorrelation curves is evidence of an increase of diffusion time (Figure S2A-
B), respectively from the free dye to the dye-labelled enzyme and enzyme-loaded vesicle. From 
the measure diffusion times of enzyme loaded CNC, we confirmed once again the order of 
magnitude of the hydrodynamic radii: Rh of 94.32 ± 56 nm for iNOS-CNCs and 85.7 ± 33 nm for 
sGC-CNCs. Similar Rh were also found by fluorescently staining the vesicles’ membrane with the 
hydrophobic BODIPY 630/650 (115 ± 27 nm and 96 ± 37 nm, respectively), confirming again the 
same size of both CNCs; the small differences are all within the standard deviation.  
Finally, brightness measurements, serving to compare the brightness of vesicles and enzymes, 
allowed us to determined that iNOS CNCs contained 5 ± 4 enzymes per compartment and sGC-
CNC contained 3 ± 1 enzymes per compartment. Using a 2-component model, discriminating 
between enzyme and vesicle signal, we could see that 1% of iNOS was still free in solution after 
purification, and less than 0.1% of sGC was free in solution following purification, probably due 
to low unspecific adsorption on the membrane. The encapsulation efficiency, measured by 
recovering the un-encapsulated enzyme fraction by SEC, was 13% for iNOS and 89% for sGC. 
By performing a complete physico-chemical analysis of the polymeric CNC, we confirmed   that the 
CNCs self-assemble into spherical, hollow structures and are not influenced by the presence of OmpF 
or enzymes in the rehydration buffer, resulting in CNCs with similar polymersome concentrations, 
vesicle radii and amount of encapsulated enzyme.  
5.1.3 CNC activity 
The cascade reaction between iNOS and sGC free in solution was first tested using the GTP analog mant-
GTP that is transformed by sGC upon NO production into the fluorescent mant-cGMP final cascade 
product. The reaction proceeded with high activity, which ended in a plateau after 2 minutes (Figure 
40), as expected from the high turnover rate of both iNOS and sGC,119 thus showing that we could follow 
both reactions by measuring the final product mant-cGMP. 
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Figure 40 Reaction scheme and activity of free enzymes in a cascade (black), without NAPDH (blue) and without arginine (red). Values 
given as mean ± SD, n=3.  
The first enzyme of the cascade, iNOS, was then encapsulated inside polymersomes equipped with 
OmpF (iNOS-CNC), and its activity compared to iNOS free in solution, by monitoring the fluorogenic 
reaction between NO and DAF, finding the ratio 
𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦𝐶𝑁𝐶
𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦𝑓𝑟𝑒𝑒 𝑒𝑛𝑧𝑦𝑚𝑒
 
Equation 3 
to be 112 ± 47% (Figure 41). A CNC activity equal or higher to that of the free enzyme is not surprising, 
as it was already shown that encapsulated enzymes could theoretically reach the same or higher activity 
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than when free in solution thanks to the confinement effect, provided that the diffusion of substrates 
is not a limiting factor. 116 In this respect, we assume that the diffusion of arginine across OmpF is very 
fast, as already reported.120 OmpF-less CNCs show no activity.  
 
Figure 41 Reaction scheme and activity of free iNOS (black) iNOS-CNC (blue) and iNOS-CNC without OmpF (red), showing the similar values 
for both encapsulated and unencapsulated enzymes. Values given as mean ± SD, n=3.  
 However, when both iNOS and sGC are encapsulated within their respective CNCs, enzyme activity 
exhibits a significant decrease. In the timeframe of the unencapsulated cascade (10 minutes), no 
activity is detected; only after at least 4 hours, we begin to see an appreciable conversion to mant-
cGMP, continuing steadily for 12 hours, eventually reaching 49 ± 19 % of the maximal value obtained 
with the free enzymes. This severe decrease in activity is a limitation due to the diffusion of substrates 
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across OmpF, which does not affect iNOS-CNC, demonstrated in Figure 4; nor is it dependent on nitric 
oxide, a small and fast diffusing molecule that is not expected to be hindered by the CNCs’ membrane. 
The main limiting factor must be then ascribed to the diffusion of the substrate of sGC; the devised 
assay is based on the GTP-derivative mant-GTP (656 Da), whose weight is around the cut-off of OmpF,121 
strengthening the evidence that its bulkiness is the main limiting factor in the overall activity of the 
CNCs in the cascade (Figure 42). Such behavior reveals a complex scenario, where overall cascade 
kinetics find a bottleneck in the diffusion of the substrate. To confirm that the limitation was caused by 
the diffusion across the membrane of the modified GTP, we co-encapsulated mant-GTP together with 
sGC (inactive, before the presence of NO produced by the iNOS-CNC upstream), this time retained 
thanks to its extremely slow diffusion across OmpF to the bulk. Doing so yielded a 99 ± 9 % for Equation 
3 over the course of 12 hours, but with a completely different kinetic: we observe a fast reaction rate 
in the first few minutes, which plateaus after 2 hours. At the 4 hours’ mark, having consumed the co-
encapsulated substrate, the enzyme starts to rely on the external mant-GTP (Figure 5) now diffusing in, 
as seen in the previous scenario. The diffusion across the CNC membrane is thus confirmed to be the 
major limiting step for a cascade between CNCs, as already reported for other cascades between 
CNC.116 
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Figure 42 Scheme and activity of the cascade mediated by iNOS-CNC with: sGC-CNC (red) and mant-GTP co-encapsulated with sGC (blue). 
Values given as mean ± SD, n=3.  
 
 We can also exclude that the higher starting signal for co-encapsulated mant-GTP is due to its higher 
concentration, as no signal was detected with the same system but without the reaction taking place 
(Figure 43A). 
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Despite the limitations provided by the interplay between intrinsic CNC features (diffusion across 
OmpF) and assay-dependent limitations (the substrate’s size), we showed that the compartments 
worked in tandem, and successfully provided the final product cGMP with a slow and constant flow 
over a long period, akin to the controlled release of drugs. An additional benefit of encapsulation inside 
CNCs is enzyme resilience: when both free iNOS and sGC were subjected to the same workup and 
storage conditions as encapsulated enzymes, they lost activity (Figure 43 A), while the encapsulated 
ones were still functional. Enzymes non-specifically adsorbed to the vesicles’ outer membrane were 
also intrinsically unstable and had no catalytic activity (Figure 43 B) after workup and storage at 4 °C.  
The slightly lower signal of Figure 43 B would suggest that SEC purification completely removes any free 
enzyme.  Overall, such findings show that any unencapsulated enzyme remaining after the purification 
would retain no activity by the assay’s time. 
 
Figure 43 A: free enzyme activity after being subjected to the same workup of the CNCs, showing their inactivation. B: activity of free 
enzymes mixed together with empty vesicles and then purified by SEC. No activity can be observed, meaning that any enzyme unspecifically 
adsorbed to the outer membrane is inactive. 
 
 
5.1.4 Effect on HeLa cells 
To this day, CNCs have been used in biological settings as sensors, detoxifying agents, produce  or to 
release/activate prodrugs 38, meaning their effect was parallel to the cell metabolism and had a limited 
influence on the cell itself, with only one example aimed at complementing defective pathways.122 
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Having shown that a cascade reaction could produce cGMP as a second messenger, we set to study the 
interaction of our CNCs with live cells, using only the naturally present arginine and GTP substrates and 
without using mant-GTP, thus overcoming its bulkiness.115 In nature, the NO/cGMP signaling cascade 
acts on calcium channels resulting in an increase in free cytoplasmic calcium along with other 
downstream cellular effects. To determine if our CNCs integrate and function within the cellular 
metabolism either through extracellular or intracellular signaling, we chose to follow cytoplasmic 
calcium levels of cells exposed to the CNCs. This was accomplished by monitoring the fluorescence of 
the calcium-sensitive and cell-permeant Fluo-4-AM dye, added separately from the CNCs, by live cell 
imaging. Fluo-4-AM is uptaken by the cell and metabolized by esterases so that it is retained for a longer 
time, and increases its brightness when complexing calcium. PDMS-PMOXA polymersomes, known to 
be biocompatible 23b, 116, are unspecifically uptaken by cells over the course of hours 23b; with a cascade 
that does not require the addition of substrates, but can find them in the culture medium or within the 
cell, this means that the CNCs exert their activity as soon as they administered. For this reason, we 
analyzed two scenarios: the short-term effect of CNCs added to cells and the long-term effect after they 
had been uptaken. 
 By incubating Atto488- iNOS labeled CNCs and DY633 sGC labeled CNCs together with HeLa cells, we 
could see that they become internalized starting at 12 hours after administration, thus allowing to 
discriminate temporarily between extra- and intracellular action. The CNCs appeared to be internalized, 
thus enabling their intracellular function. (Figure 44, Figure 45A)  
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Figure 44 A and B: z-stack orthogonal views, at two different points, of HeLa cells showing the uptaken ATTO-488 iNOS-CNC (green) and 
DyLight 633 sGC-CNC (purple) within  the cells. Scalebar: 10 μm. 
 
 
Figure 45 A: CLSM micrographs of iNOS-ATTO488-labeled CNCs (green), sGC-DY Light 633-labeled sGC CNCs (purple), HeLa cells 
(brightfield) and overlay, after 14h of incubation. Scale bar: 10 μm. B: intracellular [Ca2+] of HeLa treated iNOS-CNC and sGC-CNC in cell 
medium. C: intracellular [Ca2+] of HeLa treated with NO-donor SNAP and cGMP. D: intracellular [Ca2+] of HeLa after the uptake of iNOS- 
and sGC-CNC. E: intracellular [Ca2+] of HeLa treated with iNOS-CNC only. F: intracellular [Ca2+] of HeLa treated with sGC-CNC only. G: 
intracellular [Ca2+] of HeLa with no treatment (orange) and intracellular [Ca2+] of HeLa treated with empty polymersomes (grey).  Values 
given as mean ± SD, n=11.  
When the CNCs (1 to 1 CNCs ratios) were added extracellularly to HeLa cell cultures there was a quick 
increase in fluorescence intensity (<5 minutes) within the cellular cytoplasm indicating that the cascade 
immediately induced the opening of calcium-specific channels, quickly increasing the intracellular [Ca2+] 
(Figure 45B). This was followed by a slow decrease (2.5 hours) in fluorescence back to resting levels, 
due to both the decrease in [Ca2+] and eventual excretion of the dye via active transport channels.123 
As a positive control, we added to the cell culture both the NO-donor SNAP and cGMP, i.e. directly the 
molecules derived from the reactions at similar concentrations as would be produced by the CNCs, and 
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observed a similar increase in [Ca2+] as when the CNCs were added (Figure 45C). Since the CNCs, or the 
reaction products SNAP and cGMP, are added to the cell culture and monitoring of internal [Ca2+] 
commences within a 5-minute delay, the signaling cascade exerts its effect primarily extracellularly.  
To study the intracellular effect of the CNCs on [Ca2+], we incubated the cells in presence of the CNCs 
for 24 h, followed by rigorous washing of the cells to remove non-uptaken CNCs and loading of the cells 
with the calcium sensitive Fluo-4-AM dye. Thanks to the slow and constant activity of sGC-CNCs –fueled 
by iNOS-CNC, even internalized CNCs continued to produce cGMP modulating intracellular [Ca2+] 
(Figure 45D). In fact, they show a very similar fluorescence profile when fresh medium and Fluo-4-AM 
were subsequently added, after a prior 24h incubation with the CNCs. The similar values obtained for 
internalized CNCs as for cells measured in presence of externally located CNCs, reveal that they retain 
their activity for a long time inside the cells, with long-term effects comparable to that of a single 
exposure.  
The addition of only iNOS- or sGC-CNCs showed a much lower activity, suggesting that only one kind of 
CNC is not enough to increase the calcium-derived fluorescence above a baseline signal (Figure 45E and 
F respectively). A slight increase in fluorescence is indeed observed due to interactions between the 
iNOS-CNC and native sGC or the sGC-CNC with trace endogenous NO; however, to obtain a complete 
and effective signaling cascade, both CNCs are required to ensure the quick production of NO and the 
action on its receptor sGC cause a drastic change in intracellular [Ca2+] levels. Almost no fluorescence 
was detected for either control untreated cells or cells treated with control empty vesicles (Figure 45G).  
To compare the rate of change in intracellular [Ca2+] we first normalized the mean fluorescence profiles, 
thus disregarding the differences in initial [Ca2+], and setting the profile of non-treated cells as the 
reference over time decrease. It is apparent that SNAP+cGMP treated cells follow a very similar kinetic 
to that of untreated cells, indicating that intracellular [Ca2+] levels return quickly back to base levels. 
Uptaken iNOS-CNC+sGC-CNC show an initial rate close to the reference, which then slows down after 
3-4h (Figure 46A-B). This second, slower rate of decrease could be due to further downstream 
intracellular signaling pathways that increase intracellular [Ca2+] with a delay and that cannot be 
accessed when the CNCs are extracellular. Interestingly, external iNOS-CNC+sGC-CNC and iNOS-CNC 
treated cells maintain a constant [Ca2+] for 3 hours, then dropping with a similar rate as the reference 
cells. External sGC-CNC induce a slower rate of Ca2+ release than the reference, likely due to the slow 
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production of cGMP. Such behavior shows clearly that the localization of the CNCs has different effects 
on the cell physiology, and that they can perform their function at least for 24h after being administered 
(Figure 46). 
 
 
Figure 46 A: normalized fluorescence profile of HeLa cells treated with cGMP+SNAP (red), iNOS-CNC + sGC-CNC (blue), uptaken iNOS-CNC 
+ sGC-CNC (green) and untreated (orange). B: normalized fluorescence profile of HeLa cells treated with iNOS-CNC (black), sGC-CNC 
(purple) and untreated (orange). 
The immediate effect observed on cells measured 5 minutes post CNC addition (Figure 45) cannot 
derive from the canonical, well-known effect of cGMP on cGMP-dependent protein kinases (PKG) and 
cGMP-gated ion channels124, as those are intracellular pathways. Rather, this must come from the effect 
of extracellular cGMP on glycine ion channels, inducing activation of calcium ion channels 125, along 
with the diffusion of NO to cells (which, on the other hand, involves the canonical pathways mentioned 
before). This is also in line with the fact that HeLa cells usually express a low amount of PKG.126 On the 
other hand, the detected intracellular activity should not be due to non-internalized CNCs (as they are 
removed by washing), but rather to cAMP-activated Ca2+ influx, as cyclic nucleotides cGMP and cAMP 
are known to crosstalk and interact with non-specific targets and, as mentioned, PKG is generally 
underexpressed in HeLa (Figure 47).124, 127 Overall, these findings suggest that the CNCs not only affect 
intracellular calcium levels, but also have different protein targets on the cell surface and further 
downstream proteins within the cytoplasm, resulting in different calcium release rates, depending on 
the CNC localization. 
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Figure 47 Mechanism of cell-CNC interaction and possible affected pathways in cells: the CNCs exert their action both extra- and 
intracellularly, and this can be monitored using the intracellular Ca2+ as biomarker.  
 
5.1.5 Effect on C2C12 cells 
Next we analyzed the effect of the CNCs on intracellular [Ca2+] in differentiated C2C12 myocytes, which 
are more sensitive to calcium levels.128 In muscle cells, the NO/cGMP signaling cascade results in a 
complex modulatory effect of [Ca2+], where an increase due to release of stored calcium is first observed 
followed by a slow depletion.129 For the positive control, where the NO-donor SNAP and cGMP were 
used, a high intracellular [Ca2+] concentration was measured (Figure 48A). The CNCs, both freshly added 
to the medium (Figure 48B) and uptaken CNCs (Figure 48C) showed high initial intracellular [Ca2+] 
values, marked by higher cellular variability (resulting in greater standard deviation).130 Furthermore, 
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the fluorescence signal, resulting from Fluo-4AM complexing intracellular [Ca2+], returned back to 
baseline levels in a shorter time frame as compared to HeLa cells, indicating a calcium depletion event. 
Added to the lower resilience of C2C12 cells, with some apoptosis events during imaging, it all hints to 
the higher susceptibility to calcium levels and derived stress. Such susceptibility plays a role in muscle 
dystrophy and atrophy (Movie S3).131 For the negative, no treatment-control, again only a baseline 
fluorescence was observed (Figure 48D).  
Muscle cells are thus more susceptible to the CNC cascade, as cGMP finds more targets, not only in the 
cell membrane or in the cytoplasm, but also regulates the release of calcium from the sarcoplasmic 
reticulum.129a 
 
 
Figure 48  A: intracellular [Ca2+] of C2C12 treated with NO-donor SNAP and cGMP. B: intracellular [Ca2+] of C2C12 treated iNOS-CNC and 
sGC-CNC in cell medium. C: intracellular [Ca2+] of HeLa after the uptake of iNOS- and sGC-CNC. D: intracellular [Ca2+] of C2C12 with no 
treatment. Values given as mean ± SD, n=11. 
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5.2 Conclusions 
Enzymatic cascades between different nanocompartments present both the challenge of 
communication between compartments and the advantage of increased enzyme stability and 
modularity. Such potential has only been partially investigated, with very few studies using catalytic 
nanocompartments as bio-active constructs.  
To fill such gap, we designed spatially segregated CNC, supporting cascade reactions in between that 
mimic sequential reactions between biosystems. First, our enzyme selection (UOX-HRP) allowed us to 
determine several parameters affecting both cross-membrane and inter-vesicle diffusion and their 
influence on reaction efficiency. A deep analysis of the factors affecting the overall efficiency indicated 
the protective role of the compartments, which provide a shield for the encapsulated enzymes, 
especially important in biological fluids and cell environment. This indicates as limiting factors for the 
overall reaction the diffusion through the membrane pores inserted into the walls of the compartments 
and the probability of the product of the first reaction to encounter CNCs containing the second enzyme 
and reach the encapsulated enzyme molecules for the second step of the cascade. A balance is 
necessary between the protective role of the nanocompartments and the factors decreasing the 
efficiency of the cascade reaction for translational applications. The presented study gave many insights 
on how a two-compartment cascade behaves, compared to ideal conditions. This cascade reaction in 
separate compartments was been successfully performed in serum and then used to decrease uric acid 
and H2O2 from the cellular milieu as a first step towards medical applications. Additionally, the 
combination of these enzymes allowed catalytic nanocompartments decrease uric acid and its derived 
H2O2, both involved in various pathologic conditions ranging from gout to oxidative stress. Never had 
two polymersomes been working in tandem and synergistically with cells to detoxify the cell medium. 
In the following study, we presented the first 2-compartment system of this kind ever, where iNOS and 
sGC operate in unison, as in a native cascade. We encapsulated them and characterized the derived 
CNCs both physically and functionally. We then studied their in vitro activity, as this cascade could use 
natively present substrates to produce an important bioactive compound, cGMP. The effect of cGMP 
production was monitored by measuring the intracellular calcium levels over time, showing that the 
concerted action of both iNOS-CNC and sGC-CNC was needed to elicit the highest response (inducing 
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calcium influx). These findings demonstrate that CNCs can act on cell physiology, using the substrates 
already present in the extracellular medium. Additionally, the production of both NO and cGMP paves 
the way to design more complex nanoassemblies with the potential to induce wide range cell changes, 
functioning as signaling agents for applications that range from pharmacology to tissue engineering and 
synthetic biology. Further research will have to elucidate the dose-response behavior to CNCs and 
confirm the molecular mechanisms of CNC-cell interaction. At first sight, this could look less impressive 
than an immediate application such as uric acid removal, but it is a very important step in transforming 
catalytic nanocompartments into real actors of synthetic biology, as they were shown to induce 
phenotype changes  without genetic manipulation, a possible step above traditional synthetic biology 
techniques.  
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6 The use of melittin to improve membrane permeability5 
The systems studied in Chapter 4 both suffered of a decrease in activity due to the difficult diffusion 
of solutes across OmpF, which was not fully compensated by the advantages of encapsulation. 
Additionally, it had been shown that the porin could insert in limited numbers (11 per vesicle).29b 
Because of this, we undertook the task of developing a new, agile method for selective 
permeabilization of PDMS-PMOXA-based membranes, using the natural peptide melittin, known to 
form pores in biological membranes. We decided to study not only its application, but also to use it 
as model for the interaction of any membrane-interacting peptide with polymeric membranes, 
deriving the fundamental molecular factors governing such interaction. 
 
6.1 Introduction  
The permeability of porous and stimuli responsive polymer membrane is an intrinsic characteristics 
of block copolymers that are used for formation of synthetic membranes whereas the selectivity of 
the membrane is simply based on pore size.132 In the case of photosensitizer-mediated permeation, 
the membrane permeability is induced by attachment of a photosensitizer to the polymers that 
slightly get more hydrophilic under light irradiation.133 However, all these approaches so far have 
caused either an irreversible change in the membrane integrity, thus leading to the total release of 
encapsulated cargo within polymersomes or enable nonspecific exchange between encapsulated 
cargo within the polymersomes and the environment.   
In order to introduce a selective transport of ions/molecules across the synthetic membrane, 
versatile membrane proteins (e.g. channel proteins and biopores) with specific functionality have 
been inserted into the synthetic membranes. Membrane protein insertion methods into synthetic 
membranes (mainly in the form of polymersomes) have similarities to those applied for the lipid 
membranes (liposomes).  Primarily, the reconstitution of membrane proteins into polymersomes 
have followed two general approaches; (i) spontaneous insertion of protein into polymersomes and 
                                                     
5 PARTS OF THIS CHAPTER HAVE BEEN PUBLISHED AND ADAPTED WITH PERMISSION FROM: 
Belluati, A*.; Mikhalevich, V*.; Yorulmaz Avsar, S.; Daubian, D.; Craciun, I.; Chami, M.; Meier, W. P.; Palivan, C. G., How Do 
the Properties of Amphiphilic Polymer Membranes Influence the Functional Insertion of Peptide Pores? 
Biomacromolecules 2019. 
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(ii) addition of protein into detergent stabilized polymersomes and followed by removal detergent by 
use of biobeads or dialysis.134 To date, outer membrane protein F (OmpF) 88, aquaporin Z (aqpZ) 135,  
nucleoside-specific protein (Tsx) 136, ferriochrome-iron receptor (FhuA)137, glycerol facilitator 
(GlpF)138, and alpha hemolysin (αHL)139 have been reconstituted in the polymersomes  whereas αHL 
140, aqpZ 141 and the cyclic nucleotide-modulated potassium channel MloK1 have been inserted into 
planar polymer membrane formed on solid support. Depending on the nature of the proteins that 
are inserted into the synthetic membranes, they have fine-tuned their permeability to different 
species. For example, OmpF serves as a molecular sieve, leading to concentration-driven diffusion of 
the solutes < 600 Da and aqpZ increases the water permeability whereas TsX mediate the specific 
transport of nucleosides and nucleotides. Despite a successful insertion of different membrane 
proteins into synthetic membranes with desired permeabilization, the protein-detergent-copolymer 
interactions make difficult to generalize the membrane protein reconstitution protocols for each 
membrane forming amphiphilic block copolymers and always need to be taken into account before 
the desired membrane protein is inserted into the polymer membrane of interest.  Moreover, since 
the membrane proteins possess a particular structure, the cut-off of the permeability obtained from 
the membrane protein after reconstitution cannot be tuned. Nevertheless, aforementioned 
drawbacks can be overcome by use of amphipathic (antibiotic) peptides instead of membrane 
proteins to induce the permeability in the synthetic membranes.  
Amphipathic peptides spontaneously insert into natural and synthetic membranes from aqueous 
solution to form pores (ion channels). 142 Melittin is a model pore forming peptide with 26 amino 
acids and makes cell membranes permeable by forming pores that cause the rapid loss of ions and 
small molecules. Melittin exists as a random coil in aqueous solution which undergoes a conformation 
change from random coil to amphipathic α-helical bent rod, when it comes into contact with the lipid 
bilayers. 143 Interaction of melittin with the lipid bilayer changes depending on melittin concentration 
and the composition of the lipid bilayer membranes.144 As the concentration of melittin increases on 
the lipid membrane, the melittin undergoes a dynamic reorientation and eventually produces a pore 
with the diameter of 1.3 nm to 5 nm. Melittin mediated pore formation in the lipid bilayer occurs  
according to either the barrel-stave or toroidal model.145 While lipid membranes are used as close 
mimics of the cell membrane, more recently the field for nanotechnology is shifting towards the use 
of either hybrid lipid/polymer membranes or completely synthetic ones to overcome the 
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shortcomings experienced with lipid membranes. To the best of our knowledge, there were no 
reports on interaction of neither melittin, nor analogue peptides with synthetic membranes and their 
ability to permeabilize synthetic membranes. Thus, our goal is to investigate the effects of molecular 
characteristics of amphiphilic block copolymers (e.g. f-ratio, dispersity, and block length) as well as 
membrane properties (e.g. membrane thickness and membrane curvature) on melittin-synthetic 
membrane interactions and their roles in membrane permeabilization.  
In this present study, we used a library of poly (2-methyl-2-oxazoline)-block-poly (dimethylsiloxane)-
block-poly (2-methyl-2-oxazoline) (PMOXAx-PDMSy-PMOXAx) triblock copolymers with different PDMS 
blocks (y=22, 34, 44, and 56), the dispersity ranging from 1.67 to 2.4 and f-ratios ranging from 0.13 to 
0.27 to create the synthetic membranes (polymersomes and supported polymer membranes).  
Resulting membranes have different membrane thickness. Ellipsometry and cryo-TEM was employed 
to estimate the membrane thickness of supported polymer membranes and polymersomes, 
respectively.  The interaction of melittin with polymer membranes were investigated by QCM-D and 
the functionality of inserted melittin in the polymer membrane was assessed via CLSM by recording the 
changes in fluorescence intensity upon addition of glucose.  Additionally, to investigate the effect of 
membrane curvature on melittin-membrane interactions and membrane permeabilization by melittin, 
nanometer and micrometer-sized polymer vesicles were prepared by rehydration method. Both DLS 
and TEM were employed to characterize the nanometer sized polymersomes while micrometer-sized 
GUVs were monitored by CLSM. The functionality of melittin within the GUVs was assessed by recording 
the changes in fluorescent intensity of encapsulated dyes whereas its functionality in polymersomes 
was evaluated by monitoring the catalytic activity. Collectively, our findings support that the insertion 
of melittin in the synthetic membranes offers a promising approach to permeabilize the stable 
polymeric membrane, which opens the door for development of new synthetic membrane based-
biosensors and enzyme delivery platforms. 
6.2 Starting polymer parameters 
Four different, already characterized, triblock copolymers were selected for this study, each with 
different block length, molecular weight, dispersity and f-fraction. In addition, the roughness of their 
resulting solid-supported planar membranes was measured by AFM, as an indication of the general 
relative roughness when in tridimensional assemblies (Table 6). 
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Table 6  Library of amphiphilic triblock copolymers with their respective characteristics: molecular weight (Mn), 
dispersity (Ð) and f-fraction.  
 
Code Block length 
Mn  
(g mol-1) 
Ð f-fraction 
    RMS48 
(nm) 
A3B22A3 PMOXA3-PDMS22-PMOXA3 227487 1.7587 0.2287 0.47 ± 0.14 
A6B34A6 PMOXA6-PDMS34-PMOXA6 367287 1.6787 0.2787 0.69  ± 0.04 
A6B44A6 PMOXA6-PDMS44-PMOXA6 441287 1.7187 0.2387 0.45 ± 0.16 
A5B56A5 PMOXA5-PDMS56-PMOXA5 6662146 2.4146 0.13146 0.96 ± 0.32 
 
6.3 Parameters influencing melittin insertion 
6.3.1 Membrane thickness and insertion technique 
In order to elucidate the molecular parameters affecting the functional insertion of melittin, for 
example the curvature of the membrane, and to estimate the number of pores/membrane we used 
vesicular assemblies (polymersomes and giant unilamellar vesicles, GUVs). We first selected GUVs, as 
their size is analogous to the cell size and thus resemble the curved membranes melittin encounters in 
nature and are known to be impermeable to most hydrophilic molecules.147 Furthermore, our 
experimental design allowed us to determine the size of the pores via CLSM, since melittin does not 
have a defined pore size as compared to other pores, e.g. α-haemolysin or as OmpF 148. The diameter 
of the melittin pore can vary depending on how many peptide monomers assemble within the same 
pore.149  
First, we confirmed the interaction of fluorescently labelled-melittin with GUVs by CLSM (Figure 49).  
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Figure 49  CLSM micrographs of GUVs FITC-melittin GUV. Green: FITC. Red: BODIPY 630/650. Scalebar: 5 µm. 
 
In this respect, we formed melittin-GUVs by different procedures: I) co-drying melittin with the 
polymer followed by self-assembly via rehydration (co-dried), II) addition of melittin to the rehydration 
buffer used for self-assembly of GUVs (in buffer) and III) addition of melittin to pre-formed vesicles (ex 
post). Fluorophore molecules of increasing molecular weights were added in the surrounding 
environment of melittin-GUVs and their diffusion into the cavity of the vesicles was determined, to 
evaluate the difference in the overall percentage of permeabilized vesicles upon functional insertion of 
melittin, as a function of membrane thickness and the three insertion approaches mentioned above. In 
addition, an interesting molecular aspect we explored was to establish whether the size of the GUVs 
play a role in the functional insertion of melittin, knowing that GUVs formed by film rehydration have 
a size dispersion.  
When melittin was co-dried with the block copolymers and then self-assembled by rehydration, the 
peptide was able to interact with the polymer during the self-assembly process. This resulted in a 
functional insertion even for the thickest polymer membrane of A5B56A5 (11.5 nm) with more than 80% 
permeability for molecules with sizes up to Rh = 0.97 nm (ATTO 488 NHS ester) (Figure 50A). 
Permeabilization around Rh 1.4 nm (4000 Da) molecules was substantial (70%) for all membranes, but 
only the thinnest membrane showed an acceptable permeabilization (44%) towards the larger Rh 2.3 
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nm molecules, meaning that the formation of pores that can accommodate the passage of molecules 
with Rh above 1 nm begins to be hindered for membrane thicknesses above 6 nm.  
Addition of co-dried melittin or to rehydration buffer resulted in a noticeable decrease in the 
permeabilization of the melittin-GUVs assembly. Molecules with Rh above 0.5 nm were able to diffuse 
only through A3B22A3 and A6B34A6 membranes (6.5 to 9 nm thickness) (Figure 50B), while for A5B56A5 
only 40% of the GUVs had large enough pores to allow passage of Rh 0.5 nm molecules.  
When melittin was added ex post (to formed vesicle) to test spontaneous insertion, only the thinnest 
membranes showed permeabilization, after 1 h incubation, above 70% for molecules with molecular 
weights of 4000 Da. For membranes with thicknesses above 9 nm, only 10% or less of the GUVs 
contained functional pores with a radius of up to 0.65 nm that did not increase in size over time (Figure 
50C). 
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Figure 50 Contour graphs of relative GUV permeabilization, plotted as hydrodynamic radius Rh vs membrane thickness when melittin is co-
dried with the film (A), added to the rehydration buffer (B) or added to the already-formed vesicles (C). 
 
The ability of melittin to insert and form pores strongly depends on its capability to interact strongly 
enough with the membrane and eventually change its orientation parallel to the polymer chains, thus 
allowing the formation of the pore.150 As PMOXA-b-PDMS-b-PMOXA membranes are more stable yet 
thicker than lipid membranes151, our results indicate that the precise moment of melittin addition is 
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crucial, because the insertion becomes more strenuous the later melittin comes into contact with the 
polymer chains, during the self-assembly process. We can thus state that the size of the pore, i.e. its 
stability, follows a distribution that depends on the membrane thickness and the stage at which melittin 
was added during their possible interaction. 
Several pore sizes have been reported for melittin; in our case, the pore radius varied between 0.49 
nm, smaller than the lower limit of about 1.3 nm reported in lipids by dye leakage assay and simulations 
152, to a maximum of 2.3 nm, which is in line with the maximum size reported by neutron and X-ray 
diffraction.145b, 149b 1.3 nm is the minimal reported size for a stable melittin pore insertion in lipid 
membranes; from our results, one possibility could be that, when only molecules smaller than 1.3 nm 
can diffuse through, melittin only perturbs the membrane, rather than forming stable pores, as it was 
reported for liposomes with diluted melittin.149b Membrane perturbations and transient pores in 
liposomes, classically, have only been shown to allow the passage of ions, blocking the passage of 
glucose as well 149b, 153; however, recent studies on liposomes suggest that melittin and related peptides 
form transient pores that enable molecules below 1 nm radius to diffuse through the membrane.154 
While the formation of transient pores is the most likely explanation for the passage of molecules with 
0.40<Rh<1 nm, we cannot exclude that stable pores were formed, where melittin either organized into 
narrower toroidal pores or formed barrel-stave pores, which are by their nature smaller in radius.145b, 
155  
 
6.3.2 Dependence of melittin insertion on curvature 
The permeabilizing ability of melittin has been shown to depend on the curvature of the lipid 
membranes 144b, 156 with a mechanism favored by positive curvature (i.e. outwards). The addition of 
melittin to pre-formed planar membranes or GUVs (Figure 51A and B) resulted in different 
permeabilization outcomes, with the planar membranes not favoring functional insertion. We thus 
postulated that the interaction of melittin with the membrane is not the only phenomenon affecting 
the insertion and the membrane curvature should be considered too. 
We selected sulforhodamine B (SRB, Rh 0.65 nm) as a model molecule representative for the size 
range of small biomolecules and found that, when measuring the size distribution of the GUVs with 
melittin added ex post, those permeabilized with SRB had radii 1.5 to 3 times smaller than the empty, 
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non-permeabilized GUVs, which means that membranes with smaller radius -higher curvature- favor 
melittin insertion and permeabilization (Figure 51C).  
 
Figure 51  An A3B22A3 ATTO488-filled GUV (A). An empty A3B22A3 GUV, with higher radius than the filled one (B). Average diameter of 
permeabilized (blue) and unpermeabilized (red) GUVs (C). Percentage of permeabilized vesicles as function of their average radius: ~30 
nm (black), ~45 nm (red), ~80 nm (blue), >0.5 µm (GUVs, magenta) (D). No permeabilization was observed for A5B56A5 GUVs. Scale bar: 5 
μm. Error bars given as ± SD, n=30 for GUVs (single vesicles), n=3 (replicates) for polymersomes. Significance levels: p<0.5 (*), p<0.01 (**), 
p<0.001 (***). 
 
Melittin co-dried or in the rehydration buffer did not result in a significant size difference, suggesting 
in this case that the functional insertion of melittin is not dependent on curvature, if it occurs while the 
membrane is not fully formed yet, and that melittin does not influence significantly the self-assembly 
process (Figure 52). 
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Figure 52 Radii of GUVs unpermeabilized, melittin in film (red), permeabilized, melittin in film (blue), unpermeabilized, melittin in buffer 
(green), permeabilized, melittin in buffer (black). As no appreciable difference can be observed, melittin does not change the radius of 
vesicles. Error bars given as ± SD, n = 3 
 
To further investigate our hypothesis regarding the membrane curvature dependence, we produced 
polymersomes. The triblock copolymer A3B22A3 was able to form hollow-sphere vesicles as well, with a 
ρ-factor of 1.01, determined by DLS and SLS (Figure 53, Figure 54).   
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Figure 53  TEM micrographs of polymersomes. A: A3B22B3. B: A6B34B6. C: A6B44B6. D: A5B56B5. Scalebar: 200 nm. 
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Figure 54  MIE plot (SLS) for A3B22B3 (red) and simulated R=125 nm (black), angle dependency. 
 
The triblock copolymers A6B34A6, A6B44A6 and A5B56A5 were already known to form them, and had 
already been characterized in size and membrane thickness, the latter further confirmed by cryo-TEM 
measurements (Figure 55, Table 7).69, 116, 146  
 
The vesicles were produced and a ρ-factor ≈ 1 (ratio between Rg and Rh) confirmed that A3B22A3 could 
form nanometric vesicles (ρ-factor  1.01), as it was previously shown for the other polymers as well.69, 
116, 146 TEM confirmed that the assemblies were vesicles (Figure S14). The extrusion at different size cut-
offs, albeit with high variation, showed a trend in line with the extrusion sizes (Figure 56). 
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Figure 55  Cryo-TEM micrographs of GUVs and polymersomes. A: A3B22A3. B: A5B56A5. 
 
 
Table 7 Vesicular membrane thickness determined by Cryo-
TEM. 
Code 
Vesicle membrane 
thickness (nm) 
A3B22A3 6.6 ± 0.6 
A6B34A6 9.2 ± 0.5 95 
A6B44A6 10.7 ± 0.7 95 
A5B56A5 11.5 ± 0.9 
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Figure 56  Rh of polymersomes, after extrusion at 50 nm (black), 100 nm (red), 200 nm (blue). 
We encapsulated SRB within the polymersomes at self-quenching concentration and evaluated its 
release after addition of melittin to the pre-formed polymersomes, increasing its fluorescence due to 
dilution (Figure 52), verified that sucrose used to form GUVs does not perturb the membrane stability 
(Figure 57) and studied the effect of increased membrane curvature by decreasing their radii.  
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Figure 57 Relative fluorescence of SRB-filled polymersomes in PBS to polymersomes in sucrose. 100% intensity means no change in 
fluorescence. 
The permeabilization percentage, for polymersomes with a Rh of 120-130 nm, was between 90% and 
100% for A3B22A3. Interestingly, for A6B34A6 and A6B44A6 that showed at most 10% permeabilization in 
GUVs, in the smaller polymersomes with higher curvature permeabilization increased to 70% and 65% 
respectively. Moreover, A5B56A5 which could not be permeabilized when GUVs were formed, in the case 
of small A5B56A5 polymersomes 57% permeabilization could be attained. However, further extrusion to 
smaller average radii (circa 45 and 30 nm) did not significantly increase the permeabilization process 
(Figure 51D). With a passive, gradient-driven diffusion through the pore, there is no difference between 
SRB “entering into” (GUV assay) and “being released from” (dye leakage assay in polymersomes), thus 
allowing us to compare the effect of different curvatures even though the experimental setups are 
different.  
6.4 Quantification of membrane-associated melittin 
FITC-melittin was used to quantify the amount of peptide monomers per polymersome by 
fluorescence correlation spectroscopy, FCS. Melittin was inserted by the approaches presented above: 
I) co-drying with the polymers and rehydration (co-dried), II) addition to the rehydration buffer (in 
buffer) and III) addition to pre-formed polymersomes (ex post): the brightness of single vesicles was 
compared to that of peptides in solution. When melittin was co-dried with the copolymer prior to their 
rehydration and self-assembly process, the highest number of peptide monomers/polymersome (213 
± 23) was obtained with A3B22A3 copolymers, while the lowest number (95 ± 2) was determined for 
A6B44A6 copolymers. A similar trend was obtained when melittin was added in the rehydration buffer, 
prior to the self-assembly process, only with slightly lower number of monomers/vesicle (182 ± 27 for 
A3B22A3 to 94 ± 19 for A5B56A5) (Figure 58A). When melittin was added to the pre-formed 
polymersomes, the number of monomers decreases with the decrease of vesicle size (e.g. from 47 ± 14 
to 25 ± 10 for A3B22A3), which is easily explained by the smaller polymersome surface (Figure 58B). The 
emerging trend appears to be that, the earlier melittin is added, for example co-dried vs in buffer vs ex 
post, the more it is incorporated into the membrane, as the membrane is less stable and can 
accommodate more easily the peptide.    
However, the surface density of the melittin monomer is not sufficient to explain its interaction with 
polymer membranes, since it does not consider the molecular features of block copolymers (dispersity 
     114 
and f-ratio) and surface roughness of resulting polymer membranes. For example, dispersity of the 
copolymers affects the interaction of melittin with polymer that is with shorter chains whilst the f ratio 
contributes to the electrostatic interactions between the polymer membrane and melittin. In addition, 
higher roughness of the membrane means a larger interface for the melittin interaction. Therefore, by 
considering the molecular characteristics of block copolymers, surface roughness of the resulting 
polymer membranes as well as melittin surface density, we calculated the volumetric density (ρeff) of 
melittin on supported polymer membranes, considering a parallelepiped-shaped box, using the 
equation:  
𝜌𝑒𝑓𝑓 =
σ × 𝑓 × Ð
𝑅𝑀𝑆
 
Equation 4 
Where 𝜌eff is volumetric density of melittin, σ is the surface density of melittin, f is the ratio between 
the molar mass of the hydrophilic block and total molar mass of the block copolymer, Ð is the dispersity 
of the block copolymer, defined as the ratio of the weight to number average molar masses, and RMS 
is the root mean square obtained from AFM measurements.48   
This resulted in a description of interface interaction between the polymer membrane and peptide, 
indicating how easy the peptide interacts with a synthetic membrane. If the interaction between 
melittin and the membrane is based on the membrane characteristics, it also has an influence on the 
ability of the peptide to stably insert within the polymer membrane.  The relationship between 𝜌eff and 
membrane thickness (θ) shows an exponential decay, equal to:  
𝜌𝑒𝑓𝑓 = 6.20 × 𝑒
0.03(
−θ
1.11) 
Equation 5 
Where Ɵ is the membrane thickness in nm. Using the membrane thickness measured by Cryo-TEM 
(Table 3, Figure S11) and we assumed the same membrane roughness as measured with AFM (since 
the membrane cannot be smooth on a vesicle). We could observe an inversely proportional 
dependence on thickness for ρeff, showing that our proposed model holds true for polymersomes 
(Figure 58C and D). When looking at melittin insertion according to the curvature, we could see that, 
when the surface density increased (smaller radius, thus higher curvature), the decay was exponential 
and faster, again confirming the importance of curvature for the insertion (Figure 58D). Additionally, 
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the interaction and adsorption of melittin is favored for membranes with a higher roughness (higher 
surface area), whereas melittin insertion is favored for membranes with a lower thickness (ease of 
penetration). 
 
Figure 58 Number of melittin monomers when melittin is added, either co-dried or in the rehydration buffer, to A3B22A3 (green), A6B34A6 
(red), A6B44A6 (blue) and A5B56A5 (magenta) A. Number of melittin monomers when melittin is added to pre-formed vesicles (ex post) at 
different Rh, to: A3B22A3 (green), A6B34A6 (red), A6B44A6 (blue) and A5B56A5 (magenta) B. ρeff dependence of melittin on membranes thickness 
added in film (red), in buffer (green) and ex post (Rh 100 nm) (grey) C. ρeff dependence of melittin on membrane thickness added ex post 
at Rh 100 nm (magenta), Rh 45 nm (blue) and Rh 30 nm (grey) D. Error bars given as ± SD, n = 30. 
 
If we consider the surface density of melittin measured on planar membranes and extrapolate it to the 
surface density on a model vesicle with a radius 100 nm, we should obtain a melittin density between 
1800 times (for A3B22A3) to 10000 times (for A6B44A4) higher than what we measured with FCS.48 We 
can thus conclude, thanks to the discrepancy between surface density and permeabilization efficiency 
between planar membranes and polymersomes that the interaction of melittin and its ability to form 
pores is quantitatively different depending on the curvature.  
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6.4.1 Pore number estimate 
We can only make estimations regarding the melittin pores per vesicle, as we could not take into 
account their structure: in this case, melittin ranged from 1 to 15 pores per vesicle depending on radius 
(ex post to preformed vesicles), while melittin co-dried reaches up to 71 pores per vesicle. Extrapolating 
these calculations for GUVs, A3B22A3 would reach more than 350 pores per GUV, while the thicker 
A6B34A6 and A6B44A6 have less than 50 per GUV (Figure 59).Melittin pores are reported to be composed 
by 3 to 9 monomers157; if we assume a tetrameric pore, with minimal size 1.3 nm, enough for SRB 149c, 
we can estimate the maximal number of pores per vesicle, knowing the number of monomers per 
vesicle mv  
𝑛𝑚𝑎𝑥 = 
𝑚𝑣
4
 
Equation 6 
Which we can correct for the permeabilized fraction f, indicating how many of these monomers on a 
vesicle are actually in the correct conformation 
𝑛𝑐𝑜𝑟𝑟 =  𝑛 × 𝑓 
Equation 7 
Knowing the mean Rh allows us to build a linear regression curve to estimate the number of functional 
pores of a GUV, ranging from 71 ± 7 for melittin added in film to A3B22A3 to 5 ± 1 for melittin ex post 1.5 
in A6B44A6, which is in the same order of magnitude of what reported in the literature with melittin and 
related peptides 158. (Figure 59 A) When melittin is added ex post, the number of pores decreases with 
the decrease of vesicle size (from 15 to 1 pore), since melittin has to spread among more vesicles (Figure 
59 B).  
Assuming that polymersomes behave similarly to GUVs with melittin and form pores in the same way, 
we see a discrepancy between theoretical pores/vesicle (melittin in film or in the rehydration buffer) 
and permeabilization efficiency found in GUVs, smaller than what expected from such an amount of 
pores (Figure 59 C,D).  
As previously mentioned, a possible explanation is that interaction with the membrane (measured by 
FCS) is only one factor in permeabilization, suggesting that there are other physico-chemical properties, 
namely membrane stiffness and thickness, playing a role; in phospholipids, the main differences arise 
from the different ratios of lipids.150, 159  
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Figure 59 A: maximal number of melittin pores per vesicles when melittin is added to the film (black), to the buffer (red), or ex post (blue). 
B: maximal number of melittin pores per vesicles when melittin is added post at Rh 100 nm (black), 45 nm (red) and 30 nm (blue). C: 
predicted number of pores per vesicle on GUVs with melittin added to the film (red) and to the buffer (blue). D: regression curve of melittin 
per vesicle for polymersomes (left) and predicted number of pores for GUVs when melittin is added ex post (x axis in logarithmic scale).  
Error bars given as ± SD, n = 30. 
 
6.5 Application to biosensing 
A crucial aspect of melittin insertion in curved membranes is the functional insertion of melittin. By 
encapsulating the enzyme GOX into polymersomes, we obtained vesicles where the enzyme would only 
be active if glucose could flow through. These GOX catalytic nanocompartments (GOX-CNCs) produce 
hydrogen peroxide by the in situ enzymatic reaction of GOX. H2O2 produced inside is released into the 
surroundings in presence of the melittin pores, and can be determined by using horseradish peroxidase, 
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HRP, present in the surroundings GOX-CNCs. The released H2O2 together with the substrate Amplex 
Ultra Red take part in the enzymatic reaction catalyzed by HRP resulting in the highly fluorescent 
product resorufin, which can be easily detected. The limited size of the involved molecules showed that 
the catalytic efficiency, relative to the same enzyme concentration free in solution, was close to 100% 
for A3B22B3 regardless of the insertion approaches, meaning that there were enough pores not to affect 
catalysis via diffusion; for other polymers, the activity co-dried had a minimum of 75%. The 
polymersomes with a thicker membrane show a decreased catalytic activity when melittin was added 
in the rehydration buffer, especially pronounced for A5B55B5, which only reaches 40% activity. When 
melittin is added ex post to pre-formed vesicles, both the thicker A6B44B6 and A5B55B5 have lower 
activity, down to 25% for the latter. Again, these results confirm that melittin inserts with different 
degrees of ease depending on the polymer characteristics, while the insertion strategy influences the 
insertion amount. In the absence of melittin, we observed trace residual activity, stemming from either 
the autoxidation of Amplex Ultra Red or polymer-enzyme unspecific binding, which we already 
identified as playing a small role in this kind of systems (Figure 6).116  
By adopting this enzymatic reaction, the insertion of melittin can be verified easily in nanometric 
polymersomes irrespective of the insertion approach. The use of substrates with different sizes would 
also allow us to discriminate between additional pore widths, thus yielding a general approach to probe 
the structure and characteristics of inserted pores within membranes. Additionally, this is the first, 
proof of concept, use of melittin to produce functional catalytic nanocompartments, for either glucose 
sensing or anticancer ROS therapy.160  
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Figure 60 Reaction scheme and activity of GOX-CNC with melittin co-dried (red), melittin in the rehydration buffer (blue), melittin ex post 
(green) and without melittin (black). Error bars given as ± SD, n = 30. 
 
6.6 Conclusions 
The use of pore-forming peptides to permeabilize polymeric membranes is an attractive alternative 
to pore proteins such as OmpF or α-HL, as they can form wide pores. In this regard, melittin was used 
as a model to elucidate the parameters that affect its insertion into PMOXA-b-PDMS-b-PMOXA 
membranes. We studied the “natural” insertion route that happens on cells, i.e. insertion into already-
formed membranes (ex post), and the insertion when the membrane is not fully formed (co-dried and 
in the rehydration buffer), showing that in all cases it depends on inherent polymer characteristics 
(thickness, hydrophilic ratio, dispersity, membrane roughness) and assembly-specific curvature. In fact, 
we showed how the increase in curvature (from GUVs to polymersomes) increases the insertion 
efficiency with the same polymer. It was also possible to quantify the melittin surface density and 
estimate the pore density. This is the first time that such molecular parameters were related to peptide-
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polymer assemblies and will be useful for the study and engineering of any peptide insertion into 
synthetic membranes. Such physical considerations might also be applied to natural membranes. 
Furthermore, the permeabilization towards glucose was shown to be an evolution of the well-known 
GOX-HRP biosensing cascade. Our results show that melittin is a good candidate for both triggered and 
built-in vesicle permeabilization of membranes, provided that the key molecular membrane 
parameters and curvature are considered and optimized, and could probably be generalized for most 
interactions between polymer membranes and peptides. Further research will elucidate the influence 
of relative peptide: polymer ratio, the shape of the pores and the behavior of other membrane-forming 
peptides. 
 
 
7 DNA functionalization of CNCs as higher-order 
organization strategy6 
Having developed a more straightforward way to permeabilize our polymersomes, another question 
arose: would fixing the relative positions of the CNCs, and their distance too, improve the cascade 
efficiency? After all, we had seen in Chapter 4 that intervesicular distance does play a role in such 
systems. Encapsulating enzymes separately would keep their ratios constant, while linking the resulting 
vesicles would additionally give a way to always deliver one together with the other, avoiding the issues 
with co-delivery. 
7.1 Introduction to DNA clustering 
DNA is a very interesting molecule, where the very tight pairings between complementary bases allow 
the recognition of specific sequences at very low concentrations. DNA has already been used as a key 
tether to promote self-organization of super-assemblies with emergent properties, for example to 
target and cluster enzymes to specific structures. 161  The unique features of DNA enable also the 
organization of nanostructures into larger superstructures with well-defined orientations, depending 
                                                     
6 PARTS OF THIS CHAPTER HAVE BEEN ADAPTED FROM A MANUSCRIPT IN PREPARATION 
     121 
on their intrinsic architecture, DNA origamis.1,2 Most DNA-based supramolecular structures use DNA-
linked rigid nanostructures, e.g. gold nanoparticles, which are brought together by the pairing of DNA 
strands.162 Recently, soft nanostructures such as liposomes and polymersomes have been subjected to 
DNA-mediated organization.13, 163 In the case of liposomes, DNA-mediated assembly led to their 
precipitation from solution or membrane fusion.163-164 For polymersomes, the first reported example 
of clustered vesicles13 (Figure 61) was followed by a report on the cluster’s capability of adhering to cell 
surface and direct activation of cell receptors after a biotransformation,165 thus making the DNA also a 
targeting moiety; the cluster size hindered unspecific uptake, making the clusters coat the cell surface. 
Clustering is also found in cells: for instance, lysosomes are reported to cluster in cells, interacting with 
endosomes while retaining their integrity, an evidence that distance control is important in cellular 
biology too.166 
 
Figure 61. The first example of polymersome clusters, showing different architectures, based on the relative sizes of the vesicles involved. 
From left to right: concept figure, TEM micrograph and CLSM images of clusters with differently labeled polymersomes. Adapted with 
permission from13. 
 
7.2 A cascade in clusters: GOX-LPO 
7.2.1 Introduction 
Having a solid base on how the clusters were formed, we applied that knowledge to produce 
catalytically active clusters. This time, we used a diblock PDMS26-PMOXA12 to produce vesicles due to 
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the better DNA conjugation yield diblocks provide.13 As a model cascade to apply in clusters, we decided 
to use glucose oxidase (GOX) and lactoperoxidase (LPO): GOX oxidizes glucose into gluconic acid and 
H2O2, the latter is used by LPO to oxidize a variety of substrates. More generally, the oxidase-peroxidase 
system is an antibacterial cascade found in many animal secretions (mucus, tears, saliva, milk), as 
peroxidases can produce bacteriostatic compounds such as hypothiocyanates (OSCN-) from 
thiocyanates (SCN-), thanks to the hydrogen peroxide coming from organic substrates (Figure 62), and 
has been suggested for biomedical applications such as oral plaque treatment or as counter to 
opportunistic infections developed in cystic fibrosis.167 Moreover, the GOX-LPO cascade has been long 
studied as both an anticancer and antiviral system.168 On these grounds, we chose such cascade for its 
robustness and biological relevance as model to study how distance affects a CNC system, for future 
nanotechnological applications. Additionally, based on the findings of Chapter 6, we elected to use 
melittin instead of OmpF, to improve both the fabrication process and the overall catalytic efficiency. 
 
Figure 62. The concept of the GOX-LPO cascade in biological systems, using the widely-present glucose and thiocyanate to produce 
cytotoxic hyopthiocyanate. 
7.2.2 Physical characterization 
We chose to produce polymersomes made of the block copolymer PDMS26-PMOXA12, where 50% of 
the polymer component was the PEGylated, azide-functionalized PDMS26-PMOXA12-PEG4-N3, to provide 
enough functional groups for the attachment of a dibenzocyclooctine (DBCO)-functionalized DNA, to 
link DNA to the vesicles via strain-assisted alkyne-azide cycloaddition (SPAAC).13  
We encapsulated GOX and LPO separately, the same way as previously delineated in Chapter 4, adding 
melittin to the rehydration buffer, rehydrating the same polymer amount. The ratio between Rh and Rg 
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showed the production of vesicular structures, with LPO-CNCs with a greater radius, even after 
extrusion. The vesicle concentration, determined by NTA, consequently showed a slightly higher 
number of vesicles for GOX-CNC, being smaller. The final enzyme concentration, calculated by 
recovering the unencapsulated fraction via SEC, showed a roughly similar amount of enzyme 
encapsulated (Table 8). TEM imaging confirmed the usual vesicular shape of CNCs (Figure 63). 
Table 8 Physical parameters of the azide-functionalized CNCs 
 GOX-CNC LPO-CNC 
Rh 119 ± 8 nm 170 ± 24 nm 
Rg 110 nm 150 nm 
Rg/Rh 0.9 0.9 
Vesicle concentration 1.66*1011 + 8.569 1.17*1011 +7.589 
Enz. concentration 246 µg/mL 220 µg/mL 
 
 
Figure 63 A TEM micrograph of GOX-CNC. B TEM micrograph of LPO-CNC. 
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We labeled both GOX (with ATTO 488) and LPO (with DyLight 633), and then encapsulated them. The 
FCS curves, as expected, showed that the enzymes could be both labeled and associated to the vesicles 
(Figure 64). 
 
Figure 64 A FCS autocorrelation curves of free ATTO 488 (black), GOX-ATTO 488 (red) and GOX-ATTO488 –loaded CNCs. Dots: raw data. 
Line: fitted model. B FCS autocorrelation curves of free DyLight 633 (black), LPO-DyLight 633 (red) and LPO- DyLight 633 –loaded CNCs.  
The intensity of the single species (free enzyme, enzyme, CNC) allowed us to quantify the average 
number of dyes per enzyme and the enzyme molecules per vesicle, showing a great variability for LPO-
CNCs. Additionally, using a two-component autocorrelation fit, we could determine that only 2% of the 
enzyme in the sample is still free after purification (Table 9). 
Table 9 Quantification of several enzyme- and vesicle-related parameters via 
FCS 
 GOX (ATTO 488) LPO (DyLight 633) 
Dye/enzyme 1 ± 0.24 4 ± 2 
Enzyme/vesicle 11 ± 4 52 ± 32 
Free enzyme % 2 ± 1  2 ± 1 
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7.2.3 CNC functionality 
Having obtained CNC, we tested their activity. The main question was the insertion of melittin in the 
polymer membrane, and whether enzymes were unspecifically adsorbed on the outer membrane 
leaflet. We thus compared melittin-incorporating and melittin-free vesicles, studying the CNCs outside 
their cascade; both GOX-CNCs and LPO-CNCs showed that melittin was necessary to detect activity, also 
indirectly showing that no appreciable amounts of enzyme were not encapsulated and still active 
(Figure 65): the colored ABTS derivative could be produced thanks to either CNC, but only when melittin 
permeabilized the membrane. To test GOX-CNCs, we used their cascade with LPO free in solution, 
without the constraints of encapsulation. 
 
Figure 65 A Enzymatic activity of GOX-CNC with melittin (blue), without melittin CNCs (black) and substrates alone (red), using LPO as 
reporter enzyme. B Enzymatic activity of LPO-CNC with melittin (blue), without melittin CNCs (black) and substrates alone (blue).  Error 
bars given as ±SD, n=3.  
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7.2.4 Cluster formation 
With functional CNCs, we could move on to DNA conjugation. We selected to complementary strands, 
both presenting 5’ non-complementary thymine sequences, as spacers to improve DNA hybridization 
(Table 10).  
Table 10 DNA strands used for this study 
11T-22a DBCO-5’-TTT TTT TTT TTC CTC GTC CTG CTA ATC CTG TTA-3’ 
11T-22b DBCO-5’-TTT TTT TTT TTT  AAC AGG ATT AGC AGA GCG AGG-3’ 
To quantify the amount of DNA strands per vesicle, we hybridized the vesicle-bound DNA with its dye-
labeled complementary strand, so that vesicles could be detectable via FCS (Figure 66). 
 
Figure 66 Labeling technique used to quantify DNA via FCS. 
FCS revealed broad dispersion of the conjugation efficiency, with 11T-22a per vesicle ranging from less 
than 10 to more than 130 strands per vesicle, and smaller overall amounts for 22b (Table 11). 
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However, the detected amounts were enough to obtain clusters: by mixing 1:1 volume ratios of CNCs, 
we could observe the clustering thanks to the constant increase of Rh, plateauing around 14 hours of 
clustering (Figure 67 A), plateauing at around 700 nm diameter. TEM confirmed the presence of small 
clusters (3-4 vesicles) (Figure 67 B). The average DH of a single vesicle pair would be around 580 nm, so 
it would imply less than 2 vesicles per cluster, but we must remark that DLS assumes a spherical object 
and is thus not ideal for the ellipsoidal assemblies seen in TEM, being influenced by their rotational 
diffusion and yielding a Rh that is an weighted average of its radii(Table 8);169moreover, the soft vesicles 
deform when close enough, make the whole assembly smaller than the sum of the vesicles.13 Future 
research will use fluorescence cross-correlation spectroscopy (FCCS) to have a better insight in the 
distribution of different GOX/LPO CNCs in the clusters.23b, 84 
 
Figure 67 A DLS profile of the cluster size, over time. B TEM micrograph of CNC clusters. 
 
Table 11 Quantification of the DNA strands via FCS 
 11T-22a (22b-ATTO488) 22b (22a-Cy5) 
DNA/vesicle 69 ± 64 34 ± 28 
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7.2.5 CNC activity: effect of distance 
Once the clusters were formed, we needed to determine the mean distance between vesicles, both 
when clustered and unclustered. Adapting a more refined model, developed for hard particles and 
taking into account their size dispersity, relative CNC concentration and the volume occupied by 
vesicles.170  
 
⟨𝐷⟩ = 𝑑 [𝜉 (
𝜋
6𝜙 
)
1
3
𝑒(1.5 𝑙𝑛
2𝜎 ) − 𝑒(0.5 𝑙𝑛
2𝜎 )] 
Equation 8 
In Equation 8, the mean intervesicle distance ⟨D⟩ depends on the mean size d, the spatial distribution 
parameter ξ (fixed to 1.1170), the volume fraction occupied by vesicles ϕ and the geometric standard 
deviation σ. For our system, however, not all vesicles were equal, as the “bridging molecule”, H2O2, 
could only go from a GOX- to a LPO-CNC, and we had to consider both their relative concentrations and 
sizes. The ratios between the d and ϕ (relative size and frequency) of GOX- and LPO CNCs, i.e. the 
probability of hydrogen peroxide to encounter the right CNC once diffused out of GOX-CNC, yielded the 
weight that we used to sum the contributions of the CNCs populations, obtaining ⟨D⟩ = 2.3 µm. Had we 
used the model developed for UOX-CNC and HRP-CNC23a, we would have calculated a similar value, 2.2 
µm.  
For clustered vesicles, the distance estimation relies on the average length of the DNA strand. Having 
both paired and unpaired bases, the average DNA length L –in nm– (and vesicle-to-vesicle surface 
distance) is based on Equation 9. 171 
𝐿 = 𝑛𝐵𝑃 × 0.34 + 𝑛𝑆 × 0.676 
Equation 9 
Where nBP is the number of paired bases and ns the number of unpaired bases. For the used strands, 
we estimated 14.9 nm, which is in the range of the synaptic cleft101 and some inter-organelle distances 
found in cells. 172 
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To mimic the conditions of action in the lungs, a possible target organ of such system, we observed the 
oxidation of the LPO substrate 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) to yield a 
colored compound, with the glucose concentration found in lungs.173 The final concentration of 
enzymes was kept constant, both with and without clusters, thus varying only the distance; the inter-
cluster distance, calculated with Equation 8, yielded again ⟨D⟩ = 2.3 µm, at the used enzyme 
concentrations, so we could consider it as constant.  
The comparison with clusters clearly shows an increase in enzymatic activity, not reaching the plateau 
even after 2.5 hours, whereas unclustered CNCs reach it after 30 minutes, at a much lower level (Figure 
68). 
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Figure 68 A. Concept of a clustered GOX-LPO-CNC cascade. B. Enzymatic activity of LPO over 150 minutes of CNC clusters (red), unclustered 
CNCs (black) and ABTS autoxidation (blue). Error bands given as ±SD, n=3. 
7.2.6 Cell localization  
Finally, we studied the localization of CNC clusters on A549 cells. This cell line, being a lung carcinoma, 
could act as a model both for lung protection from bacterial infections, as a model for cancer targeting 
and ROS therapy.174 We clustered the ATTO-488 and DyLight633-labeled CNCs previously used for FCS, 
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and showed their attachment and colocalization, confirming their potential for targeted biomedical 
applications Figure 69. 
 
Figure 69 Localization on A549 cells of  clustered GOX-CNC (green) and LPO-CNC (red), the transmission channel and the composite picture, 
and control performed by adding PBS instead of clusters. Scalebar: 5 µm. 
7.3 Conclusions 
The distance between enzymes is an important aspect in the optimization of nanotechnological 
cascades, aimed at offsetting limiting factors such as membrane diffusion and increase the overall 
efficiency of the system. We developed a very simple proof of concept, based on two widely used 
enzymes, to study whether tethering vesicles via DNA could be a good candidate for this task, and 
showed the extent of such approach. Using DNA also offers the possibility of tuning, base by base, the 
intervesicle distance, ranging from distances typical of paracrine signaling for unclustered vesicles102 to 
those of some inter-organelle interactions 166, 172  or synaptic signaling101 for clusters, thus offering the 
possibility of using CNCs as non-living models for compartment communication. The behavior of hybrid 
polymer-DNA assemblies allowed them to interact with cell surfaces and localize there. The future 
optimization of enzyme loading and sample concentration will allow to further develop this approach 
for localized therapeutic or biosensing applications. 
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8 Overall conclusions and outlook 
Whereas artificial life is still just hypothetical concept, mimicking living matter, or some of its aspects, 
is an attractive way to improve man-made materials, endowing them with specific abilities of cells, 
namely their compartmentalization, environmental sensitivity, internal plasticity, biotransformation 
capabilities, selective permeability and controlled distances. We first investigated proper cell-like 
structures, where we developed internal compartments with the dual function of segregating artificial 
organelles and receptors, which could then trigger enzymatic activity or ion permeability, thus inducing 
internal architecture modifications, in the form of cytoskeleton formation, as a first example of how 
nature-mimicking materials such as PDMS-PMOXA and PMOXA-PCL can acquire complex cell-like 
behaviors when combined with natural proteins. These sui generis chemo-enzymatic cascades were the 
first example of complex response from polymeric cell mimics. 
We then moved to a smaller scale, using sub-micrometer vesicles, to make them act both as downsized 
cell-mimics and artificial organelles in actual cells, directly acting onto them. Aiming for more constant 
encapsulation outcomes, we opted to overcome co-encapsulation issues stemming from the film 
rehydration technique by encapsulating the enzymes separately. In this case we used fully enzymatic 
cascades, closer to what is found in nature, forming enzyme-loaded polymersomes that we named 
catalytic nanocompartments, CNCs. With UOX-CNC and HRP-CNC we described in depth the role of the 
membrane in slowing down the flow of molecules across the membrane, permeabilized by OmpF, and 
studied the influence of inter-vesicle distance. This compartmentalization, albeit hindering the diffusion 
of molecules, helped the reaction by creating local high concentrations of enzyme, and protected the 
proteins from external degrading agents. This allowed them to work in human serum, performing 
similarly to free enzymes in removing uric acid in hyperuricemia-like conditions. They were also able to 
help human cells survive better, detoxifying high concentrations of uric acid, which is a metabolic 
pathway absent in humans, thanks to our orthogonal approach.  
The same kind of CNCs, this time harboring iNOS and sGC, were used to produce the second messenger 
cGMP, both extra- and intracellularly, in both HeLa and C2C12 cells. This led to the quick and sharp 
increase of cytoplasmic Ca2+, dependent on the several, complex pathways activated by cGMP. For the 
first time, we truly integrated these CNCs, as artificial organelles, into pre-existing human pathways, an 
overexpression effect that would otherwise be achieved by genetic or metabolic engineering.  
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These two systems, however, suffered from the bottleneck represented by OmpF, one of the main 
factors limiting the transfer rate across the membrane. This brought us to investigate an alternative 
way to permeabilized PDMS-PMOXA membranes, a way that we found in melittin. The parameters 
governing the interaction between melittin and our synthetic membranes were studied, extrapolating 
general rules for membrane-peptide interactions, namely the importance of membrane thickness, 
curvature and stage of the self-assembly process at which it was added. The pores produced by melittin 
allowed the production of HRP-CNCs not suffering from the cross-membrane diffusion problems seen 
with OmpF. 
Finally, we tackled the problem of distance, by tethering CNCs together with complementary DNA 
strands, so that enzymes linked in a cascade would be also physically associated, basically recovering 
the enzyme proximity lost with the segregation into separate vesicles. The GOX-LPO cascade was shown 
to be more effective when the CNCs are clustered at distances of a few nm, channeling the molecules 
in common between the two enzymatic reactions, and proved to be a potential application to the study 
of inter-organelle and intercellular communication. Additionally, DNA made the clusters coat epithelial 
cells, suggesting a future use as in situ therapeutic agents to act on a specific microenvironment.  
Moreover, the use of semi-synthetic materials should be investigated more in depth, having the 
potential of bridging the well-known biochemical logics and the growing field of pure molecular logics. 
Our designs showed high versatility and robustness, demonstrating that multicompartment and/or 
multivesicular, polymer-based assemblies offer an ideal scaffold for the development of complex cell-
inspired responsive systems for future applications in biosensing, catalysis and medicine.  
 
9 Experimental 
9.1 Chapter 3 
9.1.1 Materials 
All chemicals were purchased from Sigma Aldrich and were used without further purification, unless 
stated otherwise. 
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9.1.2 Synthesis of PMOXA5-b-PDMS58-b-PMOXA5 
The amphiphilic triblock copolymer poly(2-methyl-2-oxazoline)5-block-poly(dimethylsiloxane)58-block-
poly(2-methyl-2-oxazoline)5 (PMOXA5-b-PDMS58-b-PMOXA5) was synthesized according to previously 
published protocols. 175  
Briefly, the hydroxyl-terminated PDMS (OH-PDMS-OH) was synthesized by acid-catalyzed 
polycondensation. After purification OH-PDMS-OH was reacted with trifluoromethanesulfonic acid in 
anhydrous hexane to form bitriflate-activated PDMS macroinitiator. Following filtration of the reaction 
mixture and evaporation of hexane, anhydrous ethyl acetate was added, in the presence of which the 
PDMS macroinitiator reacted with distilled 2-methyl-2-oxazoline (MOXA) in a symmetric cationic ring-
opening polymerization. After quenching the reaction with TEA/water (1:4 v/v), impurities were 
removed by ultrafiltration in water/EtOH (1:1 v/v). Finally, the solvent was removed by vacuum 
distillation and the resulting bihydroxyl-terminated triblock copolymer PMOXA5-b-PDMS58-b-PMOXA5 
was dried under vacuum. 
9.1.3 Synthesis of PMOXA88-g(SS)-PCL238 
The synthesis of the reduction sensitive graft copolymer PMOXA88-g(SS)-PCL238 (poly(2-methyl-2-
oxazoline)88-graft(SS)-poly(ε-caprolactone)238) was performed according to a previously published 
method. 66b In short, the monomer ε-caprolactone and α-benzyl carboxylate-ε-caprolactone were 
copolymerized using EtOH as an initiator. Pyridyl disulfide functionalized poly (ε-caprolactone) PCL-co-
PBCL was synthesized by varying molar ratios of the reaction partners in toluene at 110°C. PCL-co-PBCL 
was reduced by Pd/C at RT for 42 h under hydrogen to form PCL-co-PCCL. Then 2-pyridylthio cysteamine 
hydrochloride was added in the presence of N,N'-dicyclohexylcarbodiimid to form PCL-co-PPCL. Thiol-
disulfide exchange reaction was performed, where PCL-co-PPCL and PMOXA-SH were dissolved in DMF 
and a catalytic amount of acetic acid was continuously added to the mixture and stirred at RT under 
argon for three days. Finally, PMOXA88-g(SS)-PCL238 was purified by precipitation from cold MeOH and 
a white solid was obtained. 66b 
9.1.4 PMOXA6-b-PDMS65-b-PMOXA6 
This copolymer was purchased in Polymer Source Inc. The polymer was used either without any further 
purification steps or we functionalized it with PEG4-N3, according to the previously published protocol. 
13 Commercially available PMOXA6-PDMS65-PMOXA6-OH (200 mg, 0.034 mmol), was dissolved into 5 mL 
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dry DMF, then succinic anhydride (16 mg, 0.16 mmol), 4-dimethylaminopyridine (15 mg, 0.12 mmol) 
and TEA (17 mg, 0.16 mmol) were added. The mixture was stirred for 24 h at 60°C. Finally, 180 mg 
colorless solid product was obtained after the ultrafiltration with a yield of 90%. The resulting PMOXA8-
PDMS56-PMOXA8-COOH (100 mg, 0.011 mmol) was first dissolved in dry DMF, then 11-azido-3,6,9-
trioxaundecan-1- amine (44 mg, 0.20 mmol), N, N'-dicyclohexylcarbodiimide (42 mg, 0.20 mmol) and 
4-dimethylaminopyridine (1.2 mg, 0.01 mmol) were added into the above solution. The mixture was 
stirred for 24 h, at RT. Finally, 86 mg colorless solid product was obtained with a yield of 86%. 1H NMR 
(500 MHz, Chloroform-d) δ 3.24-3.72 ppm (m, 55H), 2.00-2.32 ppm (m, 32H), 0.40-0.58 ppm (m, 4H), 
0.06 (m, 351H). IR: 2961, 2114, 1736, 1635, 1420, 1263, 1007, 787, 682 cm–1. 
A thin film of PMOXA5-b-PDMS58-b-PMOXA5 (4 mg mL-1 in EtOH) was formed by rotary evaporation of 
EtOH (100 rpm at 40 °C, 100 mbar for 5 min and 7 mbar for 15min). The film was dried overnight under 
high vacuum (2 x 10-1 mbar). For polymersome formation, the film was gently dislodged using a spatula 
and subsequently rehydrated in phosphate buffered saline (PBS) (1X, pH = 7.2, BioConcept) and SRB 
(final concentration 100 µM). 
Lipase adsorbed polymersomes (LipVes) were formed by adding lipase (4 mL, 0.2 mg/mL, 100 kU, from 
porcine pancreas, Sigma-Aldrich) to already formed PBS loaded polymersomes based on PMOXA5-b-
PDMS58-b-PMOXA5. For sodium loaded Ves5 (Na+Ves), the film was rehydrated in PBS (pH 7.2). 
Remaining non-adsorbed lipase was removed by size exclusion). Samples were stirred overnight at RT 
and then extruded 15 times through a 100 nm Whatman Nuclepore filter. Size exclusion 
chromatography (SEC) was equilibrated to remove remaining non-encapsulated (dyes, salts) or non-
adsorbed (lipase) cargo against PBS and for Na+Ves against HEPES (300 mM, pH 7.2). The polymersome 
fractions were collected and stored at 4°C. 66a, 176 
9.1.5 Solvent Switch Technique 
Graft-nanoparticles (NP-Graft, reduction sensitive) were formed using a solvent switch technique. 66b 
For DGGR-NP, the lipase substrate 1,2-Di-O-lauryl-rac-glycero-3-(glutaric acid 6-methylresorufin ester, 
Sigma-Aldrich) (DGGR, 52 μL, 2.5 mM) in 1:1 EtOH:DMSO was added to polymer (1 mg) in DMF (248 μL) 
under continuous stirring to form DGGR loaded NP-Graft. The resulting turbid mixture was dialyzed 
against NaCl (150 mM) for at least 48 hours with 5 changes of buffer. After a final dialysis against PBS 
(pH 7.2), NP-Graft were stored at 4°C. 61 
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For the assembly of gramicidin A- or Ionomycin- loaded nanoparticles (gANP, IonoNP), gA (15 μL, 1 mM, 
from B. aneurinolyticus) or ionomycin (15 μL, 1.3 mM, from S. conglobatus) in DMSO were added to 
polymer (1 mg) in DMF (285 μL). Here, the gANP or IonoNPwere dialyzed against HEPES. Non-
encapsulated cargo (DGGR, gA or IoNo) was removed from the NP-Graft solution by dialysis as described 
above. Based on previous results, we know that the reduction sensitive NP-Graft are stable in PBS and 
also in more complex environments, such as cell culture medium. 66b  
9.1.6 Preparation of Multicompartments  
For multicompartment assembly, films of PMOXA5-b-PDMS58-b-PMOXA5 (40 μL, 6 mg mL-1) were 
rehydrated with sucrose solution (190 μL, 300 mM) and the corresponding nanostructures (10 μL) in 
PBS unless stated otherwise. For two-type multicompartments we typically used 10 μL of each type 
nanostructures (in PBS) in 200 µL of 300 mM sucrose solution, unless stated otherwise. In general, film 
rehydration and storage of giant vesicles compartmentalized with fluorescent nanostructures were 
carried out at RT in the dark without stirring. To minimize the disruption of giant vesicles that would 
result in the formation of mostly nano-sized polymersomes, samples were always handled with great 
care (minimal agitation).  
For the assembly of lipase containing multicompartments, we used lipase (40 μL, 100 kU, type VI from 
porcine pancreas, Sigma-Aldrich) (0.2 mg/mL) in PBS, DGGR loaded NP-Graft (20 μL) in sucrose (300 
mM, 180 μL) as rehydration solution. To determine the loading efficiency of DGGR loaded NP-Graft and 
lipase, we tested 40 single GUVs and obtained the histogram along diagonal of fluorescence.61 Similarly, 
for the two-type multicompartment for enzymatic reaction, we added 30 µL of lipase (0.1 mg ml-1) 
adsorbed polymersomes (LipVes) in PBS and 20 µL of DGGR loaded NP-Graft in 150 µL of sucrose (300 
mM) to the thin polymer film. Unadsorbed lipase was recovered via SEC and quantified at 280 nm with 
Nanodrop 2000 (ThermoFisher Inc.). 
For gANP, 30 μL were added to 270 μL Asante Natrium Green 2 (ANG2, TEFlabs) solution (25 μM in 300 
mM sucrose) to the polymer film. Similarly, for two-type multicompartment to study ion channel 
recruitment, we loaded the GUVs with 30 µL gANP-Graft, 30 µL of sodium loaded Ves5 (Na+Ves) to 140 
µL ANG2 in 300 mM sucrose (25 µM) as a rehydration solution. 
The non-encapsulated nanostructures and ANG2 were removed from exterior solution by changing the 
supernatant with HEPES (300 mM, twice daily for 5 days). To determine the loading efficiency of gA 
     137 
loaded NP-Graft and ANG2, we tested 40 single GUVs and obtained the histogram along diagonal of 
fluorescence.  
9.1.7 Preparation of Actin GUVs 
G-Actin loaded giant vesicles (Actin GUVs) were prepared by spontaneous swelling in the absence of 
stirring also called film rehydration. A mixture of PMOXA5-PDMS65-PMOXA5 (60 μL, 10 mg/mL, Polymer 
Source Inc.) in EtOH and N3-functionalised PMOXA5-PDMS65-PMOXA5 (0.3 μL, 90 mg/mL) was put to a 
glass vial. A thin polymer film was formed on the bottom of the vial by removing all traces of EtOH in a 
vacuum chamber (Plasma Cleaner, PDC-002, Harrick Plasma) for one hour. The films were rehydrated 
in the dark with the actin rehydration solution containing the monomeric protein G-actin (24 μL, 1 
mg/mL, Hypermol, rabbit alpha-actin skeletal muscle), ATTO488 labelled G-actin (ATTO488-actin, 2 μL, 
1 mg/mL, Hypermol, rabbit alpha-actin skeletal muscle), and the crosslinking agent filamin (4 μL, 1 
mg/mL, Hypermol, turkey smooth muscle, ~1:100 actin:filamin ratio, 92% purity) and sucrose (170 μL, 
300 mM, containing 0.02 % NaN3) overnight in the fridge and stored for some days until further 
characterization.  
G-actin, ATTO488- G-actin and filamin in solution (1 mg/mL) was stored for up to 1 week in ice in the 
fridge and non-solubilized G-actin at -80°C for long term storage.  
9.1.8 Preparation of Actin MCs 
For G-actin loaded multicompartments (Actin MCs) we prepared the sample similarly as for the 
formation of Actin GUVs. Instead of adding the pores to the surrounding GUV solution, we rehydrated 
with the actin components (actin, ATTO488-actin, filamin) and in addition with pore-loaded NP-Graft 
(IoNo loaded NP-Graft or gA loaded NP-Graft, 20 μL) and sucrose (300 mM). For 2-comp Actin MCs, we 
loaded 20 μL SRBVes and 20 μL IoNo loaded NP-Graft) and sucrose (300 mM).  
9.1.9 Preparation of F-actin 
F-actin was prepared in solution by adding monomeric protein G-actin (24 μL, 1 mg/mL, Hypermol, 
rabbit alpha-actin skeletal muscle) and ATTO488-Actin (2 μL, 1 mg/mL, Hypermol, rabbit alpha-actin 
skeletal muscle) with salt solutions (100 mM KCl, 70 mM MgCl2, 70 mM CaCl2) or for control with salt-
free solution (300 mM HEPES, pH 7.2). 
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9.1.10 Fluorescence Imaging  
Giant vesicles were imaged using an LSM 880 confocal laser scanning microscope (Carl Zeiss, Jena, 
Germany) with a water immersion objective (C-Apochromat, M=40, NA 1.2). The pinhole for each 
channel was set to 91 μm and the MBS 488/561/633 filter was used. The transmission PMT (T-PMT) 
option was used to record bright field images. Imaging settings were kept constant for each experiment. 
Image processing was carried out with LSM Image Browser (Zeiss) and plot profile from ImageJ. 
For imaging of lipase (or LipVes) and DGGR loaded NP-Graft entrapped multicompartments, we added 
30 μL of these multicompartments in 232.5 μL PBS with DTT (30 μL, 100 mM) or PBS (262.5 μL) for the 
controls. Additionally, we added Orlistat (7.5 μL, 2.5 mM) to the 8-well chambers to assure the 
inactivation of non-encapsulated lipase or LipVes outside of the giant vesicles. The activity in giant 
vesicles after 2, 24 and 48 hours of incubation in presence of DTT was assayed via CLSM, exciting at 561 
nm using beam splitter MBS 488/561 and pinhole of 44 μm.  
To study the induced incorporation of gA for the import of sodium ions into the giant vesicles, we added 
gA loaded NP-Graft and ANG2 entrapped multicompartments (20 μL) in PBS (250 μL) and DTT (30 μL, 
100 mM) in PBS or HEPES buffer for the controls to the 8-well. For studying of the export of sodium ions 
through the gA pores, we added gA loaded NP-Graft (20 μL) and sodium ions entrapped 
multicompartments, ANG2 (20 μL, 100 μM) in HEPES (300 mM), HEPES (50 μL, 300 mM) and DTT (10 μL, 
100 mM) in HEPES (300 mM) or HEPES (300 mM) for the control to the observation chamber. For the 
two-type multicompartment, Na+Ves, gA loaded NP-Graft and ANG2 co-loaded into giant vesicles, 
where these multicompartments (20 μL) were added to DTT (20 μL, 100 mM) and HEPES (160 μL, 300 
mM, pH 7.2) or in HEPES (180 μL, 300 mM, pH 7.2) for the controls to the 8-well observation chamber. 
A 488 nm diode laser, beam splitter MBS 488 and a pinhole of 40 μm was used. 
For Actin GUV CLSM imaging we used a 488 nm diode laser for actin filaments and a 633 nm for 
Bodipy630/650 adsorbed GUV membrane. To induce actin polymerization within the polymeric GUVs, 
we added Actin GUVs (30 μL) with salt/pore solutions (i) KCl (250 μL, 200 mM) and gA (2 μL, 1 mM), (ii) 
MgCl2 (250 μL, 150 mM) and IoNo (2 μL, 1.3 mM) and (iii) CaCl2 (250 μL, 150 mM) and IoNo (2 μL, 1.3 
mM). As a control we used salt-free HEPES (250 μL, 300 mM, pH 7.2) with or without pores (2 μL). For 
inducing actin polymerization in multicompartments, we added Actin MCs (20 μL) in corresponding salt 
solution (250 μL) and DTT (30 μL, 100 mM) and as the control we used HEPES (300 mM, pH 7.2). Here, 
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no pores were added additionally to the surrounding giant solution. By summing up several confocal 
fluorescence images along the z-axis in the equatorial plane (x-y plane), we could extract z-stack 
projections of Actin GUVs/MCs with filaments out-of-plane. For the compartmentalized actin samples, 
we added Bodipy630/650 (10 μL, 72 μM) to each well of the observation chamber to visualize the GUV 
membrane.  
9.1.11 Fluorescence Correlation Spectroscopy  
Fluorescence correlation spectroscopy (FCS) experiments were carried out with an inverted laser 
scanning confocal microscope (LSM 880 and LSM 510-META/Confocor2, Carl Zeiss) using a water 
immersion objective (Zeiss C/Apochromat, M=40, NA=1.2). A helium/neon laser (wavelength 633 nm) 
and an Argon laser (wavelength 488 nm) with appropriate filters (MBS 488/56/633 for 633 nm laser; 
MBS 488 for 488 nm laser) were used. The fluorescence intensity was recorded on an avalanche 
photodiode. The pinhole size (19 μm for 633 nm laser and 45 μm for 488 nm laser, 1AU) was adjusted 
before recording FCS curves of the respective free dye. 
For the calibration of the confocal volume, the diffusion constants of the nanostructures and the free 
dye were used. Free fluorophores were measured for 5 s at RT with 30 measurements recorded, 
whereas dye loaded nanostructures were measured for 10 s with 10 repeats. Typically, 80% of the FCS 
curves were suitable and included in the analysis. The experimental autocorrelation curves were fitted 
according to the following equation for samples with one component diffusion model:  
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Equation 10 
  
 
Where N represents the average number of particles in the observation volume, τD is the diffusional 
correlation time, and R is the structural parameter which was set to 5. In the next equation, the diffusion 
coefficient D was calculated using the relation between τD and the x-y dimension of the confocal volume 
(ωxy).  
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Equation 11 
  
(15) 
The Einstein-Stokes equation using the diffusion coefficient D, the Boltzmann’s constant kB, absolute 
temperature T, viscosity of the surrounding medium η was used to calculate the hydrodynamic radius 
(RH) of the nanostructures.  
 
𝐷 =
𝑘𝐵𝑇
6𝜋𝜂𝑅𝐻
 
Equation 12 
 
(16) 
Multicompartments were located in microscopy chambers in the bright field imaging mode of the CLSM 
and a focus in the center of a giant vesicle was marked. Due to higher density (encapsulated sucrose) 
compared to the outer solution (buffer), the giant vesicles sank to the bottom of the observation 
chamber. This allowed us to first identify the center of the giant vesicles by bright field imaging and 
positioning of the confocal volume accordingly, followed by FCS measurement to obtain the 
corresponding diffusion times. Subsequently, ten times 10 s were recorded at RT for each FCS 
measurement cycle per multicompartment. After the recordings were normalized and fitted. For the 
analysis, a customized python script (available on request)61 was applied to select good fits. Only 
measurements in the lumen of the giant vesicles, to detect the subcompartments were targeted. Giant 
vesicles that were moving out of focus during the measurements were also excluded from the analysis. 
Processing was the same for individual FCS/CLSM measurements. Diffusion time count rate (CR), CPM, 
numbers of particles, and hydrodynamic diameter from individual FCS measurements were averaged. 
The data extracted from the FCS data (N, CR) were presented as average +/- standard error of mean 
(SEM) from 40 measurements that were based on at least three independent samples for each type of 
multicompartment, except the time point at 8 h that was from 5 measurements. Data were statistically 
analyzed by one-way ANOVA (analysis of variance) using a customized python script (available on 
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request). Additionally, HSD (honestly significant difference procedure) test for comparing differences 
between multiple groups was run if significant differences was found (p<0.05).  
For Actin-MCs, we co-loaded giant polymersomes with SRB loaded polymersome and IoNo loaded NP-
Graft. After 24 h incubation of DTT or HEPES for control we measured FCS using a 561 laser (wavelength 
561 nm, 1 AU) utilizing a beam splitter of MBS 488/561 to study the viscosity changes.  
9.1.12 Transmission Electron Microscopy 
Nanostructures (5 μL) were adsorbed on copper grids for 1 min, washed with water, and blotted to 
remove excess liquid. Specimens were negatively stained with uranyl acetate (2%) for 15 sec, washed 
and blotted. Transmission Electron Microscopy (TEM) micrographs were recorded on a Philips CM100 
with an accelerating voltage of 80 kV.  
9.1.13 Pyrene-F-Actin polymerization assays 
For pyrene-F-Actin (10%, Hypermol, rabbit alpha-actin skeletal muscle, 99% purity) in 100 mM of the 
salts buffers (KCl, MgCl2, CaCl2) and as a control in salt-free HEPES (300 mM, pH 7.2) were added to 300 
mM sucrose (final volume 200 μL), in a black flat-bottomed 96-well plate (Thermo Fisher Scientific). The 
measurements were carried out with a SpectraMax M5e microplate reader (Molecular Devices), 
followed for 90 minutes. Ex/Em 365/407 nm. 
9.1.14 Preparation of Actin GUVs for 3D-SIM. 
Actin GUVs (15 μL), IoNo (2 μL, 1.3 mM) and MgCl2 or CaCl2  (275 μL, 150 mM) were added each in a well 
of a sterile obervation chambers (μ-Slide 8 Well Glass Bottom, #1.5H, Ibidi). In addition, Actin GUVs (15 
μL), gA (2 μL, 1 mM), and KCl (275 μL, 200 mM) were added to a well. All salt solutions contained NaN3 
(0.02%) and the sample was incubated for 48 h in the fridge for the actin polymerization.  
 
9.1.15 3D-SIM super-resolution Microscopy 
Three-dimensional structured illumination microscopy (3D-SIM) was performed on a DeltaVision OMX-
Blaze V4 system (GE Healthcare) equipped with 405, 445, 488, 514, 568 and 642 nm solid-state lasers. 
Images were acquired using a Plan Apo N 60x, 1.42 NA oil immersion objective lens (Olympus) and 4 
liquid-cooled sCMOS cameras (pco.edge 5.5, full frame 2560 x 2160; PCO). Exciting light was directed 
through a movable optical grating to generate a fine-striped interference pattern on the sample plane. 
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The pattern was shifted laterally through five phases and three angular rotations of 60° for each z 
section. The 488 nm laser line was used and the optical z-sections were separated by 0.125 μm. Laser 
power was attenuated to 50% with an exposure of 20 milliseconds.  
9.1.16 3D-SIM Image Reconstruction  
Raw 3D-SIM images were processed and reconstructed using the DeltaVision OMX SoftWoRx software 
package (v6.1.3, GE Healthcare). The resulting size of the reconstructed images was of 512 x 512 pixels 
from an initial set of 256 x 256 raw images. The channels were aligned in the image plane and around 
the optical axis using predetermined shifts as measured using a target lens and the SoftWoRx alignment 
tool.  
9.1.17 Enzymatic Assays  
Enzymatic fluorescence assays were performed using a Spectramax M5 microplate reader (Molecular 
Devices), in a black flat-bottomed 96- well plate (Thermo Fisher Scientific), final volume in either PBS 
(200 μL) or sucrose (200 μL, 300 mM). The increase of fluorescence (ex: 529 nm, em: 600 nm) was 
monitored for 20 minutes at RT and measured in triplicate. With respect to the experiment, lipase was 
added to a final concentration of 10 μg/mL, DGGR (25 μM), DTT (10 mM), Orlistat (655 μM) and the 
DGGR loaded NP-Graft (10 μL) suspension were added. 
9.1.18 Quantification of actin inhibition  
Actin MCs with Iono NP-Graft were prepared as previously described. Together with 10 mM DTT, LatA, 
ChaetA, CytB and CytD were added to a final concentration of 0.2 mM. GUVs in random locations were 
imaged with z-stacks, in order to localize any possible filament (between a minimum of 15 to a 
maximum of 50 GUVs per sample, depending on the sample). The image series were then analyzed, to 
count the amount of GUVs with polymerized actin still visible after treatment, which was related to the 
untreated sample (set as 100%). The standard deviation was calculated for a binomial distribution. The 
values were compared through with one-way ANOVA, significance was determined with post hoc 
Tukey’s test. 
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9.2 Chapter 4 
9.2.1 Materials 
Dulbecco’s Modified Eagle Medium with 4.5 g L-1 D-Glucose (DMEM-GlutaMax) was purchased from 
Gibco life technologies. Fetal calf serum (FCS) was purchased from BioConcept. CellTiter 96® Aqueous 
One Solution Cell Proliferation Assay (MTS) was purchased from Promega. Soluble guanylyl cyclase was 
purchased from SantaCruz Biotechnology (USA); DyLight 633 NHS ester and Fetal calf serum (FCS) were 
purchased from ThermoFisher Scientific (USA); mant-GTP (2'-(or-3')-O-(N-Methylanthraniloyl) 
Guanosine 5'-Triphosphate, Trisodium Salt) was purchased from Jena Bioscience (Germany); Nitric 
Oxide Cofactors (NOC) mix containing flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), 
and calmodulin was purchased from Oxford Biomedical Research (USA). FluoroBrite Dulbecco’s 
Modified Eagle Medium (DMEM) live cell imaging medium was from Gibco Life Sciences (USA).  All The 
triblock copolymer PMOXA6-PDMS44-PMOXA6 was kindly provided by Prof. Meier and synthetized by 
Dr. Samuel Lörcher and Dr. Adrian Dinu.87, 177 All other reagents and enzymes were purchased from 
Sigma-Aldrich unless otherwise specified. 
9.2.2 OmpF expression and extraction 
Wild-type OmpF was obtained according to a previously reported protocol,29a with a few modifications: 
bacteria was grown at 30 °C for 6 hours on Terrific Broth (TB) (Difco, USA) and all ultracentrifugations 
were performed at room temperature (RT).  
9.2.3 Preparation of catalytic nanocompartments 
All CNCs were prepared at RT using the triblock copolymer PMOXA6-PDMS44-PMOXA6 (obtained 
according to a previously reported procedure87) and wild-type OmpF, via the film rehydration 
technique. Films were rehydrated to a final polymer concentration of 4 mg mL-1 with 0.25 mg of UOX 
or HRP in PBS (pH 7) and 50 μl of previously dialyzed OmpF (60 μg mL-1 final concentration) or an 
equivalent volume of dialyzed octyl glucopyranoside (Anatrace, USA) 3% for the non-permeabilized 
CNC. Samples were extruded through an Avanti mini-extruder (Avanti Polar Lipids, USA) with a 200 nm 
pore diameter polycarbonate membrane (11 times). Non-encapsulated enzyme was removed through 
size exclusion chromatography (SEC) (Sepharose 4B column; 30 cm length). 
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9.2.4 CNC characterization — Static and Dynamic light scattering  
9.2.4.1 Chapter 4.1  
Light scattering (LS) experiments were performed at 25 °C, using an ALV/CGS–8F goniometer 
(Langen/Hessen, Germany) equipped with a frequency-doubled He-Ne laser (LS instruments, λ = 633). 
Static light scattering (SLS) was performed in 5° steps between 50° and 135° and analyzed with Zimm 
plot software (LS Instruments). Dynamic light scattering (DLS) was performed at 90° and analyzed 
through nonlinear decay-time analysis supported by cumulant fit.  
9.2.4.2 Chapter 5 
SLS and DLS experiments were performed on a setup from LS instruments (Switzerland), equipped with 
a He-Ne 21 mW laser (λ = 632.8 nm) at scattering angles from 30° to 55° at 25 °C. The radius of gyration 
(Rg) was obtained from the SLS data with a Guinier plot. The intensity versus angle curve of a diluted 
sample (to supress multiple scattering) was fit with a linear regression and the slope of the curve m was 
used to calculate Rg according to the equation 
𝑅𝑔 = 10
9 × √3𝑚 
Equation 13 
In the case of DLS, second order cumulant analysis of the data between 30° and 155° was performed to 
obtain the hydrodynamic radius (Rh). 
9.2.5 CNC characterization — Transmission electron microscopy (TEM) 
CNC suspensions in PBS at 0.25 mg mL-1 were deposited on glow-discharged carbon grids (Quantifoil, 
Germany) stained with 1.5% uranyl acetate solution and deposited on carbon-coated copper grids. A 
transmission electron microscope (Philips Morgagni 268D) at 293 K was used.  
9.2.6 CNC characterization — Fluorescence correlation spectroscopy 
9.2.6.1 Chapter 4.1 
Vesicles were labeled with BODIPY 630/650 SE (Thermo Fisher Scientific, USA) 100 nM. All 
measurements were carried out using a CLSM 880 confocal laser microscope (Carl Zeiss, Germany) with 
a 40x, 1.2 water immersion C-Apochromat objective lens. Measurements were performed at RT using 
a sample volume of 20 μL on a 22x50 mm glass slide. A HeNe laser at 633 nm was used for excitation of 
the BODIPY fluorophore, at 1% attenuation and pinhole 62 μm. The fluorescence signal was measured 
in real time and the autocorrelation function was calculated by the software calculator QuickFit 3.0.178 
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Measurements were recorded over 5 s and each measurement was repeated 30 times. Experimental 
auto correlation curves were fitted using a two-component model including triplet state, slightly 
modifying Equation 10:  
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Equation 14 
Where f1 and f2 are respectively the fraction of the particles of the corresponding component 1 (dye) or 
2 (vesicles), τD1 represents the diffusion time of the dye and τD2 the diffusion time of the vesicles, T the 
fraction of fluorophores in triplet state with triplet time τtrip, N is the number of particles and R the 
structural parameter, fixed at 5, according to the manufacturer’s guidelines. The τtrip and τD of free dye 
were determined independently, and subsequently fixed in the fitting procedure for dye-stained 
vesicles. The confocal volume of 1 fL, was obtained by a calibration with free BODIPY and was necessary 
to determine the concentration of fluorescent particles (knowing the number of particles detected in 
the volume).  
9.2.6.2 Chapter 5 
Stock solutions of iNOS (5 mg mL-1) and GC (5 µg mL-1) were prepared in 0.1M Na2CO3 buffer. 5µL of a 
1.5 mM Atto-488 NHS ester in DMSO solution was added to 1 ml of the iNOS stock solution and 5µL of 
1.5 mM DyLight 633-NHS ester in DMSO was added to 1 ml of sGC solution. Both labelling reactions 
were mixed overnight at 4 oC. Free dye was removed by dialysis (Spectrapore dialysis tube, MWCO 
12kDA, Spectrum Laboratories Inc) against PBS at 4 oC for 3 days with frequent buffer exchanges. Upon 
purification, labelled enzymes were used directly and polymersomes were formed as previously 
described. Labelled sGC was recovered from an OmpF-free sample and used for quantification. A 
488nm argon laser was used to excite ATTO 488 and a 633 nm HeNe laser was used for DyLight633 and 
BODIPY 630/650. The two lasers were passed through MBS488 and MBS488/561/633 filters and the 
signals were detected in the range of 500-532 nm and 657-690 nm, respectively. The pinholes were 
adjusted to maximize the count rate using the respective free dye in PBS and the sample volumes were 
20 μL. Fluorescent fluctuations over time were recorded for 20 x 5 s. The raw data was processed and 
analyzed using Zeiss software. Autocorrelation curves were fitted by a two-component model (except 
for dye-only samples).  
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The degree of labelling (DOL) was obtained from the ratio of the counts per molecule (CPM)  
𝐷𝑂𝐿 =
𝐶𝑃𝑀𝑙𝑎𝑏𝑒𝑙𝑙𝑒𝑑 𝑒𝑛𝑧𝑦𝑚𝑒
𝐶𝑃𝑀𝑓𝑟𝑒𝑒 𝑑𝑦𝑒
 
Equation 15 
and, similarly, the number of enzymes per vesicle was calculated as 
𝑁𝑒𝑛𝑧𝑦𝑚𝑒𝑠 =
𝐶𝑃𝑀𝑣𝑒𝑠𝑖𝑐𝑙𝑒
𝐶𝑃𝑀𝑙𝑎𝑏𝑒𝑙𝑙𝑒𝑑 𝑒𝑛𝑧𝑦𝑚𝑒
 
Equation 16 
To confirm that the increase in enzyme diffusion times originated only from their encapsulation, BODIPY 
630/650 was used to label the vesicles’ membranes and compare τD2 (vesicles). A fraction of less than 
1% of free dye was detected in this case. 
The Rh of the vesicles was calculated, assuming a spherical object, deriving the Stokes-Einstein relation 
(Equation 12). 
9.2.7 Nanoparticle tracking analysis (NTA) 
NTA was used as further analysis of particle size and concentration, on a NanoSight NS300 (Malvern 
Panalytical Ltd., UK), using a flow cell (100 μL min-1), 1:1000 concentration in freshly filtered PBS, 
yielding particle Rh and concentration (particle mL-1). 
9.2.8 Enzyme quantification 
9.2.8.1 Chapter 4.1 
The non-encapsulated enzyme fraction was recovered via SEC and the enhanced Pierce™ Bicinchonic 
Acid (BCA) assay was performed according to the supplier’s protocol (Thermo Fisher Scientific, USA); 
instead of the BSA standards, both UOX (35 U mg-1) and HRP (300 U mg-1) calibration curves were 
prepared for the quantification of the respective samples. The amount of unencapsulated protein was 
multiplied by the volume recovered from the column and then subtracted from the amount initially 
added to the rehydration solution, yielding the total amount of enzymes within the vesicles, divided by 
the volume of the vesicle (first fraction), i.e. the final concentration of the protein. This was performed 
on samples with no inserted OmpF, assuming that the presence of the porin would not influence the 
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encapsulation efficiency. The number of enzyme molecules was then divided by the number of vesicles, 
obtaining the number of enzymes per vesicle. 
9.2.8.2 Chapter 5 
For iNOS, the unencapsulated protein was recovered and quantified using the bicinchonic acid assay 
(BCA) kit from ThermoFisher Scientific, and a BSA calibration curve. As the expected final sGC 
concentration was below the lower sensitivity limit for BCA (5 µg mL-1), unencapsulated DyLight 633-
labelled sGC was recovered and its absorbance at both 280 and 627 nm was measured with Nanodrop 
200 UV-Vis spectrophotometer (ThermoFisher Scientific).  
The DOL was confirmed using the equation: 
𝐷𝑂𝐿 =
𝐴𝑚𝑎𝑥  𝜀𝑝𝑟𝑜𝑡
(𝐴280 − 𝐴𝑚𝑎𝑥  𝐶280) 𝜀𝑚𝑎𝑥
 
Equation 17 
The protein concentration measured at 280 nm was estimated for a 70 kDA protein (BRENDA) with 
ε=72000 M-1 cm-1 (eXPAsY). 
The total amount of both unencapsulated iNOS and sGC was calculated based on the volume and 
subtracted from the amount originally added, yielding the total concentration in CNCs and the 
encapsulation efficiency.  
9.2.9 Enzyme activity and kinetics 
9.2.9.1 Chapter 4.1 
Kinetic parameters were calculated using the Michaelis-Menten model:  
𝑣 =
𝑉𝑚𝑎𝑥[𝑆]0
𝐾𝑀 + [𝑆]0
 
𝑘𝑐𝑎𝑡 =
𝑉𝑚𝑎𝑥
[𝐸]0
 
Equation 18 
Where v is the velocity of the enzyme, Vmax is the maximum velocity at saturating concentration, [S]0 is 
initial the concentration of the substrate S, KM is the Michaelis-Menten constant. kcat is the turnover 
number, the number of chemical conversions per second, [E]0 is the concentration of catalytic sites 
(both for UOX and HRP it is equivalent with the concentration of enzyme). 
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In all experiments involving a cascade reaction, UOX was added in excess to HRP, to partially 
compensate for the former enzyme’s lower activity, so that the ratio between production (from UOX, 
35 U mg-1) and consumption (from HRP, 350 U mg-1) of hydrogen peroxide would not be the limiting 
factor. All enzymatic measurements were performed using a Spectramax M5 microplate reader 
(Molecular Devices, USA), in a in a 96-well, flat bottomed UV-transparent plate (Corning, USA) for uric 
acid absorbance (290 nm) or in a black plate (Thermo Fisher Scientific) for resorufin fluorescence 
(excitation 570 nm / emission 595 nm). The final volume in each well was of 200 µL in PBS. UOX 
concentration was increased ten-fold in cascade reaction experiments, to counter the slower native 
activity per weight of the enzyme, compared to the downstream enzyme HRP. Both uric acid 
consumption and resorufin production were quantified by means of calibration curves (R2 > 0.9 for both 
curves). Each experiment was performed in triplicate and data was collected over 15 minutes (10 for 
the measurement of kinetic parameters). 
9.2.9.1.1 UOX kinetics 
UOX or UOX-loaded CNC (final concentration of 3 µg mL-1) were incubated in presence of increasing 
concentrations of the substrate uric acid (25, 100, 200, 400 and 800 µM) and the initial velocity of the 
enzymatic reaction was determined. The consumption of uric acid was monitored and the data fitted 
with Graphpad Prism 7 software, obtaining KM, Vmax and kcat values.  
9.2.9.1.2 HRP kinetics 
HRP or HRP-loaded CNC (final concentration of 3 µg mL-1) were incubated in the presence of 10 µM 
H2O2 and increasing concentrations of Amplex Ultra Red (AR) (Invitrogen) ranging from 0.2 to 20 µM. 
The initial velocity of the enzymatic reaction was determined by monitoring the formation of resorufin. 
The data was fitted using Graphpad Prism 7 software, obtaining KM, Vmax and kcat values. 
9.2.9.1.3 UOX-HRP cascade kinetics 
Both reactions were examined when in a cascade: UOX or UOX-loaded CNC (final concentration of 3 µg 
mL-1) were added to HRP or HRP-loaded CNC (final concentration 300 ng mL-1) and both uric acid and 
AR were alternatively varied according to the previously listed concentrations. 
9.2.9.1.4 Amplex Ultra Red conversion assay in a cascade 
The same cascade reaction was tested at different conditions: UOX or UOX-loaded CNC (final 
concentration of 3 µg mL-1) were added to HRP or HRP-loaded CNC (final concentration 300 ng mL-1), 
uric acid to a final concentration of 10 µM and AR to a final concentration of 1 µM, unless in controls 
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where either substrate was missing and was substituted by the same volume of PBS. The reaction 
profile in presence of catalase (1000 U mg-1, final concentration of 10 μg mL-1) was blanked against the 
reaction profile of catalase alone in presence of AR, as catalase too has a heme center capable of 
reacting with the fluorogenic molecule. 
9.2.9.2 Chapter 5 
Enzymatic assays were performed using a Spectramax M5e microplate reader (Molecular Devices, USA) 
in a 96-well, flat bottomed black plate (Thermo Fisher Scientific) for fluorescence. The final volume in 
each well was of 200 µL in PBS. Both free and encapsulated enzymes were added at the same 
concentration to compare the influence of encapsulation on their activity (50 μg mL-1 for iNOS and 0.05 
μg mL-1 for sGC). For iNOS activity, 10 μM arginine was used as substrate and 4,5-diaminofluorescein 
(DAF-2) was used to detect the reaction, as it reacts with NO forming a fluorescent triazole (Ex. 495 Em. 
515 nm)179 and additional NADPH (final 25 μM) was added to the reactions, so that it was always in 
excess. Blanking was always performed. 
For sGC activity assays, the same concentrations of arginine and NADPH were used, with 20 μM of 
mant-GTP added. Upon its conversion to mant-cGMP, it increases its fluorescence (Ex. 280 Em. 430 
nm). 180 When mant-GTP was co-encapsulated, the values were blanked with a vesicle only solution. 
For long-running measurements (12 hours), a quartz cuvette was instead used, volume 2.5 mL, with the 
same concentrations as above. 
9.2.10 Catalytic nanocompartment resilience to degrading agents 
Concentrations were 3 µg mL-1 for UOX or UOX-CNC and 300 ng mL-1 for HRP or HRP-CNC. For the heat 
resistance assay, aliquots of the polymersome were incubated at 37, 50, 60 and 75 °C for either 10 or 
30 minutes. For the chemical and enzymatic resistance assays, aliquots were incubated with 6 M 
guanidine hydrochloride (GdnHCl) for 1 hour and 0.1 mg ml-1 Proteinase K for 2 hours (37 °C), 
respectively. The production of resorufin was compared to that of the cascade reaction with no 
additional elements and the ratio was calculated. To verify unspecific binding, the same amount of 
enzyme (either UOX or HRP) was added to pre-formed empty vesicles and then purified with the same 
protocol, then mixed with vesicles encapsulating the other enzyme and the cascade kinetics were 
followed. 
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9.2.11 Activity of CNCs in serum 
Activity in biological fluid was tested in human blood serum (instead of PBS) in which uric acid was 
dissolved to a final concentration of 500 μM at 37 °C, mimicking hyperuricemia. UOX or UOX-CNCs were 
added to reach a final concentration of 18 μg ml-1, HRP or HRP-CNC to 900 ng ml-1, AR to 10 μM. The 
decrease of absorbance at 290 nm was monitored over the course of 6 hours. The degradation of uric 
acid was defined as  
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑢𝑟𝑎𝑡𝑒 𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 =  
∆𝐴𝑏𝑠290𝑤𝑖𝑡ℎ 𝑒𝑛𝑧𝑦𝑚𝑒
𝑚𝑖𝑛
∆𝐴𝑏𝑠290𝑛𝑜 𝑒𝑛𝑧𝑦𝑚𝑒
𝑚𝑖𝑛
 
Equation 19 
 
9.2.12 Dependence of distance over reaction efficiency 
Knowing the amount of CNCs in a given volume as a result of FCS measurements, it was possible to 
calculate the mean inter-vesicle distance, assuming a cubic space occupied by the compartments, as  
1
√𝑁
𝑉
3
 
Equation 20 
where N is the number of particles (sum of UOX and HRP vesicles) and V is the reaction volume. UOX-
CNCs were kept at constant concentration and HRP-CNCs were added in concentrations 2x, 1x, 0.5x, 
0.25, 0.1x, 0.02x, 0.01x and 0.005x, thus increasing the overall distance between vesicles, which was 
calculated with N=NUOX-CNC+NHRP-CNC. Again, resorufin production was monitored as described. 
9.2.13 Cell culturing  
9.2.13.1 Chapter 4.1 
HEK293T cells were cultured in a humidified atmosphere with 5% CO2 at 37 oC in Dulbecco’s Modified 
Eagle Medium with GlutaMAXTM-I (4.5 g L-1 D-Glucose, Gibco life technologies)) and supplemented with 
10% Fetal calf serum (FCS, BioConcept), 100 U mL-1 penicillin and 100 µg mL-1 streptomycin (Sigma 
Aldrich). 
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9.2.13.2 Chapter 5 
HeLa cells (epithelioid cervix carcinoma, human; ATCC, CCL-2) were cultured in DMEM with 
GlutaMAXTM-I supplemented with 10% fetal calf serum (FCS), 100 units/mL penicillin and 100 µg/mL 
Streptomycin. C2C12 cells (muscle myoblasts, mouse, ATCC, CRL-1772) were cultured in DMEM with 
GlutaMAXTM-I supplemented with 20% FCS, 100 units/mL penicillin and 100 µg/mL Streptomycin. Cells 
were maintained at 37 oC and 5% CO2. 
9.2.14 Cell viability assay-MTS 
For cell viability assessment, a CellTiter 96® Aqueous One Solution Cell Proliferation Assay (MTS, 
Promega) was used according to manufacturer instructions. Cells were seeded (5 000 cells/well in 100 
µL cell culture medium) in a 96-well plate and incubated for 24 h. After 24 h the UOX-HRP-CNCs 
(concentrations ranging from 1.18 to 18 µg mL-1 of total polymer) were diluted in PBS and added to the 
cells to reach a final volume of 200 µ/well. After 24 h incubation in presence of the CNCs, 20 µL MTS 
reagent was added to each well. After 4 h absorbance was measured at 490 nm using a Spectramax 
M5e plate reader. Background absorbance from control wells containing all assay components without 
cells was subtracted from each well and data normalized to control cells containing all components 
except CNCs.  
9.2.15 Cell viability in presence of uric acid  
Cells were seeded at a density of 5 000 cells/well in 100 µL cell culture medium, in a 96-well plate and 
incubated for 24 h. Next, cells were dosed with 250 or 500 µM of uric acid, final concentration, in the 
presence or absence of UOX-HRP-CNCs (18 µg mL-1 for UOX and 0.9 µg mL-1 for HRP, final concentrations 
in 200 µL final volume) or in the presence of free enzymes (UOX and HRP) at the same concentration. 
AR (1 µM, final concentration in 200 µL final volume) was added to each well as a co-substrate for the 
HRP-CNCs. After a 24 h incubation period, 20 µL MTS reagent was added to each well. The absorbance 
was measured at 490 nm after 4 h. Background absorbance from control wells containing all assay 
components apart from the cells was subtracted from each well and data normalized to control cells 
containing all components except CNCs and uric acid.  
9.2.16 Live cell imaging of Hela cells 
Freshly trypsinized HeLa cells were seeded at a density of 6 x104 cells per well in an 8-well glass bottom 
ibidi plate. After 24 h, the cell supernatant was removed and replaced with 0.1 mM Fluo-4-AM in 
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FluoroBrite DMEM live cell imaging medium supplemented with 10% FCS and 1% 
Penicillin/Streptomycin. The cells were incubated for 20 min in presence of the calcium sensitive dye, 
followed by rinsing 3 times and addition of 300 µL live cell imaging medium. The cells were then dossed 
with 100 µL of either (a) 1 mg mL-1 iNOS-CNCs and 1 mg mL-1 sGC-CNC in PBS; (b) 1 mg mL-1 iNOS-CNC 
in PBS alone; (c) 1 mg mL-1 sGC-CNC in PBS alone; (d) 2 mg mL-1 empty polymersomes as an internal 
control to ensure the polymer does not cause interference; (e) 0.22 mM NO-donor SNAP and 0.2 mM 
cGMP in PBS as a positive control; (f) PBS only as a negative control.  
After dosing, cells were immediately visualized by confocal laser scanning microscopy (CLSM) on a LSM 
880 confocal laser microscope with a 40x, 1.2 water immersion C-Apochromat objective lens, using 
ATTO 488 laser and light path parameters. Cells were imaged continuously for 12 hours, in an enclosed 
incubator at 37 °C and 5% CO2, with 1 frame/minute capture and constant diffraction-based refocusing.  
To visualize the CNC uptake and also determine the effect of the CNCs after uptake, the procedure 
described above was slightly modified. Cells were plated at the same seeding density and cultured for 
24 h. After 24 h the supernatant was removed and replaced with 300 µL supplemented DMEM and 100 
µL of (a) 1 mg mL-1 iNOS-ATTO488-labeled CNCs and 1 mg mL-1 sGC-DY Light 633-labeled CNCs in PBS; 
or (b) 1 mg/mL-1 iNOS-CNCs and 1 mg mL-1 sGC-CNC in PBS. After a 24 h incubation the supernatant was 
removed. In the case of the fluorescently labelled CNCs, the cells were directly imaged via CLSM. In the 
case of the non-labelled CNCs (sample b above), the supernatant was replaced with the 0.1 mM Fluo-
4-AM solution. The cells were incubated for 20 min in presence of Fluo-4-AM, followed by rinsing 3 
times and addition of 400 µL live cell imaging medium.  
9.2.17 Live cell imaging of C2C12 cells 
Freshly trypsinized C2C12 cells were seeded at a density of 3x103 cells per well in an 8-well glass bottom 
Ibidi plate. After 24 h, the cell supernatant was removed and replaced with differentiating medium 
(DMEM supplemented with 2% horse serum). The cells were differentiated for 5 days. After 5 days the 
supernatant was removed and replaced with 0.1 mM Fluo-4-AM in live cell imaging medium as 
described above. The cells were incubated for 20 min in presence of the calcium sensitive dye, followed 
by rinsing 3 times and addition of 300 µL live cell imaging medium. The cells were then dossed with 100 
µL of either (a) 1 mg mL-1 iNOS-CNCs and 1 mg mL-1 sGC-CNC in PBS; (b) 0.22 mM NO-donor SNAP and 
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0.2 mM cGMP in PBS as a positive control; (c) PBS only as a negative control. After dosing, cells were 
immediately visualized by CLSM using the same settings described above for the HeLa live cell imaging.  
To determine the effect of CNCs after uptake, the procedure described above was slightly modified. 
C2C12 cells were plated at the same seeding density and differentiated for 5 days as described above. 
After 5 days the supernatant was removed and replaced with 300 µL supplemented DMEM and 100 µL 
solution of 1 mg mL-1 iNOS-CNCs and 1 mg mL-1 sGC-CNC in PBS. After a 24 h incubation, the supernatant 
was replaced with the 0.1 mM Fluo-4-AM solution. The cells were incubated for 20 min in presence of 
Fluo-4-AM, followed by rinsing 3 times and addition of 400 µL live cell imaging medium. 
9.2.18 Statistics 
9.2.18.1 Chapter 4.1 
Multiple t-tests were run using Graphpad Prism 7 software, comparing datasets, without assuming 
constant SD. Statistical significance (p<0.05) was corrected using the Holm-Sidak method. Significance 
was marked as * p < 0.05, ** p < 0.01, *** p < 0.001, sample size was always n = 3. 
9.2.18.2 Chapter 5 
Similarly, multiple t-tests were run using Originlab 2019 software, with the same parameters. Sample 
size was n = 3 for enzymatic assays, n = 11 for cell imaging assays. 
9.3 Chapter 6 
9.3.1 Materials 
BODIPY 630/650 and ATTO 488-NHS ester were purchased from ThermoFisher Scientific (USA). FITC-
melittin was purchased from Genscript (USA). All other reported compounds were purchased from 
Sigma-Aldrich (USA) unless otherwise stated. 
9.3.2 Synthesis of amphiphilic copolymers 
A small library of amphiphilic PMOXAx-b-PDMSy-b-PMOXAx triblock copolymers was synthesized 
according to a reported synthesis procedure (Table 6), and formed polymersomes by film rehydration 
method.87, 146  
9.3.3 Preparation of GUVs 
Stock solutions at 6 mg mL-1 block copolymers in ethanol were prepared. 40 µL of each copolymer stock 
solution was added to a 1.5 mL glass vial and dried overnight under vacuum. Next day, 300 µL of a 300 
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mM solution of sucrose containing 0.2% sodium azide was added to the dried polymer film and 
rehydrated overnight. 
Melittin was added to the copolymer GUVs in three ways: I) co-dried with the copolymer to form a 
mixed copolymer film (co-dried), so that it would have a final 15 µM concentration after rehydration, 
II) added to the rehydration buffer of the copolymer film to a final concentration of 15 µM (in 
rehydration buffer) and III) added to pre-formed vesicle suspension, to a final concentration of 15 µM 
(ex post). 
9.3.4 Confocal laser scanning microscopy (CLSM) of GUVs 
GUVs were visualized in plasma-activated Nunc® Lab-Tek 8-well chambers (Thermo Fisher Scientific, 
USA), using Zeiss 880 CLSM microscope (Zeiss, Germany) with a water-immersion objective (C-
Apochromat 40x/1.2 W Korr FCS M27).5 μL of GUV suspension was added to a final 5 µM solution of 
BODIPY 630/650 and, respectively i) 200 µM of carboxyfluorescein (CF), ii) 200 µM of sulforhodamine 
B (SRB), iii) 200 µM of ATTO 488 NHS ester iv) 0.1 mg mL-1 fluorescein isothiocyanate (FITC) conjugated 
to dextran 4000, v) FITC-dextran 10000 Da and vi) FITC-melittin in a total of 200 μL of PBS. . 
GUVs (diameter ≥ 1 µm) were imaged, by BODIPY 630/650 staining the membrane to discriminate 
between hollow vesicles and spherical polymeric aggregates. To image the GUVs, 488 nm argon laser, 
561 nm DPSS 5561-10 laser and 633 nm HeNe laser were used. For CF, ATTO 488-NHS ester and FITC, 
an argon laser (488 nm) was used, with 493-629 nm filters, MBS 488; for SRB a DPSS (561 nm) with 563-
629 nm filters, MBS T80/R20; for BODIPY, a diode laser (633 nm) was used, MBS 488/561/633. Pinhole 
aperture was always 39 µm except for SRB experiments, where it was 41 µm. An n = 30 vesicles per 
sample was imaged and the fraction of filled vesicles was calculated. 
The hydrodynamic radius Rh of CF (MW 376 Da), SRB (MW 558 Da) and ATTO 488-NHS ester (981 Da) 
was estimated according to the empirical ratio for small molecules, where MW is the molecular 
weight181 
𝑅ℎ = 0.00083327 ×  𝑀𝑊 + 0.18  
Equation 21 
The Rh for FITC-dextrans (4 kDa, 10 kDa) was obtained from Sigma Aldrich specifications. 
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9.3.5 Preparation of empty polymersomes 
For nanometer-sized polymersomes, 4 mg mL-1 of copolymer solutions in ethanol were dried and 
rehydrated with 1 mL PBS for 24 h under constant stirring. Either melittin or FITC-labeled melittin, to a 
final concentration of 15 µM, was added in three scenarios: i to the polymer solution and co-dried along 
with the polymer (co-dried), added to the rehydration (in rehydration buffer) and added to the 
polymersomes suspension (ex post). All polymersome solutions were extruded through an Avanti mini-
extruder (Avanti Polar Lipids, USA) with 200, 100 or 50 nm polycarbonate membrane (11 times) and 
purified by size exclusion chromatography (SEC) (Sepharose 2B column; 20 cm length). 
9.3.6 Light scattering of polymersomes 
The dynamic light scattering (DLS) measurements to determine the hydrodynamic radius (Rh) were 
performed on a Zetasizer Nano ZSP at 25 °C. 5 µL of polymersomes were added to an 800 µL PBS 
solution in the cuvette. The measurement angle was 173° and the data was analyzed by number 
distribution. Multi-angle DLS was performed on a setup from LS instruments (Switzerland), equipped 
with a He-Ne 21 mW laser (λ = 632.8 nm) at scattering angles from 30° to 150° at 25 °C. Second order 
cumulant analysis of the data for various angles was performed to obtain the Rh. 
Static light scattering (SLS) measurement for A3B22A3 was performed on a setup from LS instruments 
(Switzerland), equipped with a He-Ne 21 mW laser (λ = 632.8 nm) at scattering angles from 30° to 150° 
at 25 °C. The radius of gyration (Rg) was obtained from the SLS data using a MIE fit. The Intensity versus 
angle curve of a diluted sample (to suppress multiple scattering) was fit using the Mie scattering model 
(MiePlot, UK) for η=1.35 and 5% polydispersity. Rg was then calculated using the obtained R and the 
formula for a spherical structure: Rg²= (3/5)R². 
𝑅𝑔
2 = 
3
5
𝑅2 
Equation 22 
9.3.7 Transmission electron microscopy (TEM) 
4 μL of polymersomes (1:4 dilution) were absorbed on copper grids with 400 mesh square. The grids 
were further stained with 2% uranyl acetate and the negatively stained image of nanostructures was 
performed on a transmission electron microscope (Philips CM100) at an acceleration voltage of 80 kV.  
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9.3.8 Fluorescence correlation spectroscopy (FCS) 
FCS measurements were obtained with a Zeiss 880 laser-scanning microscope in FCS mode. All 
measurements were performed at room temperature (RT) using a sample volume of 12 μL on a 22x50 
mm, 1.5 mm thick glass slide. Free FITC-melittin was measured with a 488 nm argon laser, MBS 488, 1% 
attenuator, pinhole 34 µm, thirty repetitions for 2 seconds each. At the same conditions, 12 µL of FITC-
melittin vesicles (prepared by “co-dried”, “in rehydration buffer” and “ex post” procedures) were 
measured.   
Experimental autocorrelation curves were fitted using: i) a one-component model including triplet state 
for the “co-dried” and “in rehydration buffer” preparation methods and ii) a two-component fit for “ex 
post” preparation method. The software ZEN 2.3 was used for analysis of the data, using Equation 
10and Equation 14. 
The ratio of the resulting average counts per molecules (CPM) yielded the average melittin monomers 
per vesicle mv: 
𝑚𝑣 = 
𝐶𝑃𝑀𝑚𝑒𝑙𝑖𝑡𝑡𝑖𝑛
4
𝐶𝑃𝑀𝑣𝑒𝑠𝑖𝑐𝑙𝑒𝑠
 
Equation 23 
CPMmelittin was divided by 4 as in solution melittin assembles into a tetramer. The maximal amount of 
melittin pores was obtained based on the minimal number of peptides per pore (3). 
𝑛𝑝𝑜𝑙𝑦𝑚𝑒𝑟𝑠𝑜𝑚𝑒 = 
𝑚𝑣
3
 
Equation 24 
For melittin added to the copolymer film and to the rehydration buffer, the maximal number of pores 
in GUVs was simply extrapolated using:  
𝑛𝐺𝑈𝑉 = 
𝑅𝐺𝑈𝑉 × 𝑛𝑝𝑜𝑙𝑦𝑚𝑒𝑟𝑠𝑜𝑚𝑒
𝑅𝑝𝑜𝑙𝑦𝑚𝑒𝑟𝑠𝑜𝑚𝑒
 
Equation 25 
With RGUV being the average radius measured from CLSM micrographs. 
For melittin added to pre-formed polymersomes (“ex post”), a linear regression curve was fitted 
through the average number of polymersomes with different sizes and extrapolated to obtain the 
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corresponding RGUV, which was then multiplied by the permeabilization efficiency of GUVs to SRB to 
obtain the curvature-corrected number of pores. 
9.3.9 Dye leakage assay  
4 mg mL-1 of copolymer was dried and then rehydrated with 1 mL of 250 µM solution of SRB. The 
solution was then extruded with 200, 100 and 50 nm filters and purified by SEC (Sepharose 2B, 20 cm 
column). Melittin solution in PBS (15 µM final concentration) was added to the polymersome 
suspension. SRB fluorescence intensity (excitation 565 nm / emission 586 nm) was measured using a 
Spectramax M5 microplate reader (Molecular Devices, USA), in a flat bottom black 96-well plate 
(Thermo Fisher Scientific), final volume of the sample 200 µL. The increase in fluorescence intensity was 
monitored after 20 minutes and related to the fluorescence of the same sample treated with 1% Triton 
X-100, yielding the maximum fluorescence value that would be achieved if the dye was completely free 
to diffuse. 
9.3.10 Catalytic nanocompartment (CNC) formation and characterization   
1 mL of 0.25 mg mL-1 GOX in PBS was added to 4 mg of dried copolymer film and upon rehydration 
overnight under constant stirring the solution was extruded, yielding a dispersion of GOX catalytic 
nanocompartments in PBS (GOX-CNC). 15 µM of melittin was added in three scenarios: i) co-dried 
together with the copolymers (co-dried), ii) in the rehydration buffer of the copolymer films (in 
rehydration buffer) and iii) in the solution of pre-formed polymersomes after their extrusion (ex post). 
All solutions were extruded with 200 nm filters and then purified by SEC as described above. 
The non-encapsulated enzyme fraction, separated by SEC, was then recovered and measured at 280 
nm with a Nanodrop 2000 UV-Vis spectrophotometer (Thermo Fisher Scientific, USA). The amount of 
un-encapsulated protein was multiplied by the volume recovered from the column and then subtracted 
from the amount initially added to the rehydration solution, yielding the total amount of enzyme 
molecules within the polymersomes, divided by the volume of the polymersome (first fraction), i.e. the 
final concentration of the protein. The calculation of the number of enzyme/polymersome was 
performed on samples with no melittin, because the presence of the hydrophobic peptide does not 
influence the encapsulation efficiency of hydrophilic enzymes. The concentration of GOX enzymes was 
obtained as 60 µg mL-1 in all cases. 
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All enzymatic tests were performed using the same concentration for the free and encapsulated 
enzymes (concentrations specified below), respectively with a fluorescence endpoint measurement 
after 5 minutes. 
D-glucose (final concentration, 10 µM) and the fluorogenic Amplex Ultra Red (Thermo Fisher 
Scientific, USA) (final concentration 2.5 µM) were used to measure the activity of GOX-CNCs 
(Spectramax M5e, fluorescence excitation 570 nm / emission 595 nm). GOX, either free or 
encapsulated, and free HRP were used at final concentration of 1.5 µg mL-1 and 50 ng mL-1, respectively. 
9.3.11 Cryogenic transmission electron microscopy (Cryo-TEM)  
A 4 µL aliquot of polymersome solution was adsorbed onto holey carbon-coated grid (Lacey, Tedpella, 
USA), blotted off with Whatman 1 filter paper and vitrified into liquid ethane at -178 °C using a Leica 
GP plunger (Leica, Austria). Frozen grids were transferred onto a Talos electron microscope (FEI, USA) 
using a Gatan 626 cryo-holder. Electron micrographs were recorded at an accelerating voltage of 200 
kV and a nominal magnification of 57000 x, using a low-dose system (20 e- Å-2) and keeping the sample 
at low temperature. Micrographs were recorded on a CETA camera. Micrographs were obtained and 
the membrane thickness was measured as previously described.95 Briefly, the polymersome 
micrographs were analyzed with ImageJ, measuring 30 times the length of the darker portion of the 
membrane. The pixel size on the images corresponds to 2.02 Å.  
9.3.12 Statistical analysis of the datasets 
Multiple two-sample t-tests were performed using Origin 2016 software, comparing datasets, without 
assuming constant standard deviation (SD). Statistical significance (p < 0.05) was corrected using the 
Holm-Sidak method. Significance was marked as * p < 0.05, ** p < 0.01, *** p < 0.001, sample size was 
n = 30 for single imaged GUVs and 3 replicates for polymersome experiments. 
9.4 Chapter 6 
9.4.1 Materials 
DyLight 633 NHS ester and ATTO 488-NHS ester were purchased from ThermoFisher Scientific (USA). 
All other reported compounds were purchased from Sigma-Aldrich (USA) unless otherwise stated. 
9.4.2 Synthesis of diblock copolymers 
The COOH-terminated diblock PMOXA12-b-PDMS26 was synthesized according to the already reported 
procedure.13 Briefly, OH-terminated PMOXA12-b-PDMS26 was dissolved into 5 mL anhydrous 
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chloroform, then succinic anhydride (6.5 mg, 0.066 mmol), 4-dimethylaminopyridine (1.32 mg, 0.011 
mmol) and TEA (8.7 mg, 0.088 mmol) were added. After deoxygenating by three vacuum-argon cycles, 
the mixture was stirred for another 72 h at RT under the Ar atmosphere. Finally, 180 mg 
colorless solid product was obtained after the ultrafiltration, yield 90%. 1H NMR (400 MHz, CDCl3): δ 
3.20-3.60 ppm (m, 170H), 2.00-2.20 ppm (m, 115H), 1.50 ppm (b, 2H), 1.20 ppm (m, 4H), 0.80 ppm (t, 
3H), 0.45 ppm (m, 4H), 0 ppm (m, 456H) (Figure 70). To produce PMOXA12-b-PDMS26-PEG-N3, the 
polymer (100 mg) was then first dissolved into anhydrous chloroform, then 11-azido-3,6,9-
trioxaundecan-1-amine (11.80 mg, 0.055 mmol), N, N'-dicyclohexylcarbodiimide (15.6 mg, 0.078 mmol) 
and 4-dimethylaminopyridine (1.2 mg, 0.01 mmol) were added into the above solution. After 
deoxygenating three times, the mixture was further stirred for another 48 h, at RT. Finally, a colorless 
solid product was obtained after the ultrafiltration. 
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Figure 70 (A) 1H NMR spectra of PDMS26-PMOXA12-COOH and (B) its GPC trace. 
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9.4.3 Preparation of CNCs 
CNCs were prepared at RT, with 50% (molar ratio) of the polymer . Films were rehydrated to a final 
polymer concentration of 10 mg mL-1 with 1 mg of GOX or LPO in PBS (pH 7) and 25 μl of melittin 1 mM 
(from bee venom). Samples were extruded through an Avanti mini-extruder (Avanti Polar Lipids, USA) 
with a 200 nm pore diameter polycarbonate membrane for GOX; LPO-CNCs were first extruded through 
400 nm and then 200 nm, 11 times each. Non-encapsulated enzyme was removed through size 
exclusion chromatography (SEC) (Sepharose 4B column; 30 cm length). 
9.4.4 Catalytic nanocompartment characterization — Static and Dynamic light scattering  
SLS and DLS experiments were performed on a setup from LS instruments (Switzerland), equipped with 
a He-Ne 21 mW laser (λ = 632.8 nm) at scattering angles from 30° to 55° at 25 °C. The radius of gyration 
(Rg) was obtained from the SLS data with a Guinier plot. The intensity versus angle curve of a diluted 
sample (to supress multiple scattering) was fit with a linear regression and the slope of the curve m was 
used to calculate Rg according to the equation 
𝑅𝑔 = 10
9 × √3𝑚 
Equation 26 
In the case of DLS, second order cumulant analysis of the data between 30° and 155° was performed to 
obtain the Rh. 
Clustering was followed on a Zetasizer Nano ZSP (Malvern Instruments, UK) at 20 °C, where 50 μL of 
each DNA-functionalized CNC were added to 200 μL of PBS, measuring the Rh for 14 hours. 
9.4.5 Catalytic nanocompartment characterization — Transmission electron microscopy (TEM) 
CNC suspensions in PBS at 0.25 mg mL-1 were deposited on glow-discharged carbon grids (Quantifoil, 
Germany) stained with 1.5% uranyl acetate solution and deposited on carbon-coated copper grids. A 
transmission electron microscope (Philips Morgagni 268D) at 293 K was used.  
9.4.6 Nanoparticle tracking analysis (NTA) 
NTA was used as further analysis of particle size and concentration, on a NanoSight NS300 (Malvern 
Panalytical Ltd., UK), using a flow cell (100 μL min-1), 1:1000 concentration in freshly filtered PBS, 
yielding particle Rh and concentration (particle mL-1). 
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9.4.7 Enzyme quantification 
Unencapsulated enzyme was recovered from melittin-less samples, and quantified at 280 nm, using a 
Nanodrop 2000 UV-Vis spectrophotometer. 
9.4.8 DNA functionalization and clustering 
200 μM Stock solutions of the DBCO-modified DNA strands (Microsynth, Switzerland) were prepared in 
nuclease-free water. 50 μL of each solution was added to 150 μL of corresponding CNCs, and made to 
react at 37 °C overnight. The vesicles were thus purified with a 10 cm-Sepharose 2B column, mixed 1:1 
(volumetrically) and let to rest at 4°C overnight to allow clustering for further experiments. 
9.4.9 Fluorescence correlation spectroscopy 
Stock solutions of GOX (2 mg mL-1) and LPO (2 mg mL-1) were prepared in 0.1M Na2CO3 buffer. 5µL of a 
1.5 mM Atto-488 NHS ester in DMSO solution was added to 1 ml of the GOX stock solution and 5µL of 
1.5 mM DyLight 633-NHS ester in DMSO was added to 1 ml of LPO solution. Both labelling reactions 
were mixed overnight at 4 oC. Free dye was removed by spin filtration with Amicon Spin Filters 30 
MWCO (Merck, Germany). Upon purification, labelled enzymes were used directly and polymersomes 
were formed as previously described, with no melittin added. A 488nm argon laser was used to excite 
ATTO 488 and a 633 nm HeNe laser was used for DyLight633. The two lasers were passed through 
MBS488 and MBS488/561/633 filters and the signals were detected in the range of 500-532 nm and 
657-690 nm, respectively. The pinholes were adjusted to maximize the count rate using the respective 
free dye in PBS and the sample volumes were 15 μL. Fluorescent fluctuations over time were recorded 
for 20 x 5 s. The raw data was processed and analyzed using Zeiss software. Autocorrelation curves 
were fitted by a two-component model (Equation 12), except for dye-only samples.  
The degree of labelling (DOL) was obtained from the ratio of the counts per molecule (CPM) (Equation 
15). 
To quantify DNA, 11T-less strands (thus, 22a and 22b) were used, labeled with Cy5 and ATTO488, 
respectively. An excess amount (10 μL of a 200 μM stock) was added to vesicles with complementary 
strands, clustered and then purified via SEC. Fits were defined using Equation 12, the amount of DNA 
per vesicles with Equation 15. 
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9.4.10 Enzymatic assays 
Enzymatic assays were performed using a Spectramax iD3 microplate reader (Molecular Devices, USA) 
in a 96-well, flat bottomed transparent plate (Corning, USA) for absorbance. The final volume in each 
well was 200 µL in PBS. 
9.4.10.1 GOX-CNC  
20 μL of GOX-CNCs (with or without melittin), glucose (final concentration 60 μM), free LPO (final 
concentration 2 μg mL-1) and ABTS (final concentration 50 μM) were added to each well. The change in 
absorbance at 420 nm was monitored for 10 minutes. 
9.4.10.2 LPO-CNC  
For LPO-CNCs, 20 μL of LPO-CNCs (with or without melittin), H2O2 (final concentration 10 μM) and ABTS 
(final concentration 50 μM) were added to each well. The change in absorbance at 420 nm was 
monitored for 10 minutes. 
9.4.10.3 GOX-LPO cascade  
Knowing the sample concentration after workup, GOX-CNC (free or clustered) were added at a final 
concentration of 8 µg mL-1 and LPO-CNC (likewise) to 7 µg mL-1, with 60 μM glucose and 50 μM ABTS. 
To mimic a biological setting, the reaction was followed at 37 °C for 2.5 hours. 
 
9.4.11 Live cell imaging of A549 cells 
Freshly trypsinized A549 human carcinoma cells were seeded at a density of 6 x104 cells per well in an 
8-well glass bottom ibidi plate. After 24 h, the cell supernatant was removed and replaced with 
fluorescently-labeled CNC clusters, or PBS. The cells were incubated for 24h in presence of the calcium 
sensitive dye, followed by rinsing 3 times and addition of 300 µL live cell imaging medium.  
Cells were then visualized by confocal laser scanning microscopy (CLSM) on a LSM 880 confocal laser 
microscope with a 40x, 1.2 water immersion C-Apochromat objective lens, using ATTO 488 laser and 
DyLight 633 light path parameters.  
9.5 List of abbreviations 
Polymers 
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BCP 2-hydroxy-4-(methacryloyloxy)-benzophenone 
P(Asp-AP) Poly[(5-aminopentyl)-α,β-aspartamide 
P(CPTMA-co-PEMA) 
Poly(methacryloyloxy)ethyl camptothecin oxalate (CPTMA) and 
poly(methacryloyloxy)ethyl camptothecin oxalate 2-(piperidin-1-yl)ethyl methacrylate  
P(S-co-TMI) Poly(styrene-co-3‐isopropenyl‐α,α‐dimethylbenzene isocyanate) 
PAA Poly(acrylic acid) 
PAH Polyallylamine 
PB Poly(butadiene) 
PDA Poly(dopamine) 
PDEAEM Poly(2-(diethylamino)ethyl methacrylate) 
PDMIBM Poly(3,4- dimethyl maleic imido butyl methacrylate) 
PDMS Poly(dimethylsiloxane) 
PEG/PEO Poly(ethylene glycol)/Poly(ethylene oxide) 
PHPMA Poly(2-hydroxypropyl methacrylate) 
PHPMA-co-PPFMA Poly(hexyl methacrylate)-co-poly(pentafluorophenyl methacrylate) 
PIAT Polyisocyanoalanine(2-thiophene-3-yl-ethyl)amide 
PLGA Poly(lactic-glycolic acid) 
PLL Poly(l-lysine) 
PMA Poly(methacrylic acid) 
PMAc Poly(methacrylic acid) co-(cholesteryl methacrylate) 
PMOXA Poly(2-methyloxazoline) 
PNMD 
Poly(N-isopropyl acrylamide)-block-Poly(methacrylic acid-co-3,4- dimethyl maleic 
imidobutyl methacrylate) 
PNVP Poly(N-vinyl pyrrolidone) 
Poly(Ser-S-NI) Polyserine 2-nitroimidazole modified via a thioether moiety 
PPG Poly(propylene glycol) 
PS Polystyrene 
RGD Arginylglycylaspartic acid 
 
 
 
Proteins 
AO Ascorbate oxidase 
ADH Alcohol dehydrogenase 
AGE N-acyl-d-glucosamine 2-epimerase 
Alc Alcalase 
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CalB Lipase B from Candida antarctica 
Cat Catalase 
Ccox Cytochrome C oxidase 
CSS CMP-sialic acid synthetase 
cytC Cytochrome C 
GLDH Glutamate dehydrogenase 
GlpF Glycerol facilitator 
GOX Glucose oxidase 
GTR Glutathione reductase 
Hb Hemoglobin 
HRP Horseradish peroxidase 
Lac Laccase 
L-ASNase L-asparaginase 
iNOS Inducible nitric oxidase synthase 
LPO Lactoperoxidase 
Mb Myoglobin 
NAL N-acetylneuraminate lyase 
OmpF Outer membrane protein F 
PA Penicillin acylase 
PAL Phenylalanine ammonia lyase 
PAMO Phenylacetone Monooxygenase 
PGM Phosphoglucomutase 
RDH Ribitol-dehydrogenase 
sGC Soluble guanylyl cyclase 
SOD Superoxide dismutase 
Tr Trypsin 
UOX Urate oxidase 
α-HL α-haemolysin 
β-Gal  B-galactosidase 
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